{"entity":"cme","id":"ent_cme","name":"CME Group","wikidata":"Q1023876","page":"https://asof.is/record/cme","summary":"CME Group is a futures company and one of the largest options and futures exchanges, located in Chicago, Illinois, United States, headquartered in Chicago. It reported revenue of $6.52B for the period ended December 31, 2025.","title":"CME Group: revenue $6.52B","key_facts":[{"label":"Headquarters","value":"Chicago","claim":"clm_2566C71C835D"},{"label":"Revenue","value":"$6.52B","recorded":"6,520,600,000 United States dollar","note":"to 2025-12-31","claim":"clm_BA779D647BE6"},{"label":"Ticker","value":"CME · Nasdaq","claim":"clm_A00A1CE9A109"}],"faq":[{"question":"Where is CME Group headquartered?","answer":"Chicago."},{"question":"What is CME Group's revenue?","answer":"$6.52B for the period ended December 31, 2025."}],"as_of":null,"known_by":null,"since":null,"fact_pages":[{"predicate":"headquarters","page":"https://asof.is/record/cme/headquarters","md":"https://asof.is/record/cme/headquarters.md","json":"https://asof.is/v1/entities/cme/headquarters"},{"predicate":"revenue","page":"https://asof.is/record/cme/revenue","md":"https://asof.is/record/cme/revenue.md","json":"https://asof.is/v1/entities/cme/revenue"},{"predicate":"net_income","page":"https://asof.is/record/cme/net_income","md":"https://asof.is/record/cme/net_income.md","json":"https://asof.is/v1/entities/cme/net_income"},{"predicate":"operating_income","page":"https://asof.is/record/cme/operating_income","md":"https://asof.is/record/cme/operating_income.md","json":"https://asof.is/v1/entities/cme/operating_income"},{"predicate":"quarterly_revenue","page":"https://asof.is/record/cme/quarterly_revenue","md":"https://asof.is/record/cme/quarterly_revenue.md","json":"https://asof.is/v1/entities/cme/quarterly_revenue"}],"products":[],"coverage":{"entity":"cme","name":"CME Group","kind":"organization","sources":[{"source":"wikidata","item":"Q1023876","covers":"dated statements whose reference URL is the source: leadership, ownership, names, founding, headquarters; never financial figures"},{"source":"wikidata-products","covers":"products it makes, develops or publishes, as released claims, when the release date cites a reference URL; a rotating scan, a few dozen entities a run"},{"source":"sec","cik":1156375,"ticker":"CME","covers":"annual and quarterly figures from XBRL, registrant name, tickers and fiscal year end; officer and director changes (8-K Item 5.02) and material events (other 8-K items)"}],"holds":{"claims":449,"open":20,"retracted":0,"first":"2001-08-07","predicates":{"total_assets":{"claims":71,"open":1,"kind":"fact"},"quarterly_net_income":{"claims":44,"open":1,"kind":"fact"},"total_equity":{"claims":76,"open":1,"kind":"fact"},"quarterly_operating_income":{"claims":56,"open":1,"kind":"fact"},"quarterly_revenue":{"claims":56,"open":1,"kind":"fact"},"operating_income":{"claims":19,"open":1,"kind":"fact"},"cash_and_equivalents":{"claims":76,"open":1,"kind":"fact"},"net_income":{"claims":19,"open":1,"kind":"fact"},"revenue":{"claims":19,"open":1,"kind":"fact"},"headquarters":{"claims":1,"open":1,"kind":"fact"},"shares_outstanding":{"claims":2,"open":1,"kind":"fact"},"sic_industry":{"claims":1,"open":1,"kind":"identifier"},"state_of_incorporation":{"claims":1,"open":1,"kind":"identifier"},"cik":{"claims":1,"open":1,"kind":"identifier"},"registrant_name":{"claims":2,"open":1,"kind":"fact"},"listed_on":{"claims":1,"open":1,"kind":"fact"},"ticker":{"claims":1,"open":1,"kind":"identifier"},"ceo":{"claims":1,"open":1,"kind":"fact"},"fiscal_year_end":{"claims":1,"open":1,"kind":"identifier"},"country":{"claims":1,"open":1,"kind":"fact"}}},"freshness":[{"origin":"sec","label":"SEC EDGAR filings: XBRL figures, registry fields, 8-K officer changes and events (sec_ingest.py, sec_officers.py, sec_events.py)","claims":447,"last_added":"2026-11-08","last_checked":"2026-11-08","last_verified":null},{"origin":"verification","label":"a page the web verifier found (verify_claims.py)","claims":1,"last_added":"2026-11-08","last_checked":"2026-11-09","last_verified":null},{"origin":"wikidata","label":"Wikidata statements that cite a reference URL (wikidata_ingest.py)","claims":1,"last_added":"2026-11-08","last_checked":"2026-11-10","last_verified":null}],"gaps":["posts: no official feed speaks for it (pipeline/feeds.json primary_for); what it holds comes from Wikidata, filings and other publishers' feeds"],"group":[],"group_complete":true,"rule":"sources: what the pipeline reads for this entity, from its config (pipeline/entities.json, feeds.json, sec_companies.json, huggingface_authors.json). holds: its public claims by predicate; open is held today; kind fact is what entity_state answers by default, event is for timeline. freshness, per ingest (origin): last_added is the day it last put a new claim here (first_seen_at), last_checked the day one was last checked against its source (checked_on), last_verified the day reverify.py last confirmed one against Wikidata (value_json.verified_at). Only checked claims are public, so a fact missing here is unknown, not absent. gaps: what the record does not cover for this entity, so an empty answer is not read as news."},"claims":[{"id":"clm_170CD2D5F4C8","predicate":"cash_and_equivalents","value":"2,198,500,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 2,198,500,000 United States dollar\", as of 2026-09-30. Claim clm_170CD2D5F4C8, https://asof.is/claim/clm_170CD2D5F4C8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637526000068/0001156375-26-000068-index.htm.","url":"https://asof.is/claim/clm_170CD2D5F4C8","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637526000068/0001156375-26-000068-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-23T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2026, filed 2026-10-23"}},{"id":"clm_1E63D1140747","predicate":"total_assets","value":"192,092,500,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 192,092,500,000 United States dollar\", as of 2026-09-30. Claim clm_1E63D1140747, https://asof.is/claim/clm_1E63D1140747, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637526000068/0001156375-26-000068-index.htm.","url":"https://asof.is/claim/clm_1E63D1140747","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637526000068/0001156375-26-000068-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-23T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2026, filed 2026-10-23"}},{"id":"clm_4220960D8CBF","predicate":"total_equity","value":"26,560,300,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 26,560,300,000 United States dollar\", as of 2026-09-30. Claim clm_4220960D8CBF, https://asof.is/claim/clm_4220960D8CBF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637526000068/0001156375-26-000068-index.htm.","url":"https://asof.is/claim/clm_4220960D8CBF","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637526000068/0001156375-26-000068-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-23T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2026, filed 2026-10-23"}},{"id":"clm_AD95B405EF60","predicate":"quarterly_operating_income","value":"1,141,400,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 1,141,400,000 United States dollar\", as of 2026-09-30. Claim clm_AD95B405EF60, https://asof.is/claim/clm_AD95B405EF60, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637526000068/0001156375-26-000068-index.htm.","url":"https://asof.is/claim/clm_AD95B405EF60","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637526000068/0001156375-26-000068-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-23T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2026, filed 2026-10-23"}},{"id":"clm_EE592402CAB2","predicate":"quarterly_revenue","value":"1,737,300,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 1,737,300,000 United States dollar\", as of 2026-09-30. Claim clm_EE592402CAB2, https://asof.is/claim/clm_EE592402CAB2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637526000068/0001156375-26-000068-index.htm.","url":"https://asof.is/claim/clm_EE592402CAB2","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637526000068/0001156375-26-000068-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-23T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2026, filed 2026-10-23"}},{"id":"clm_F01119B64E55","predicate":"quarterly_net_income","value":"1,036,900,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 1,036,900,000 United States dollar\", as of 2026-09-30. Claim clm_F01119B64E55, https://asof.is/claim/clm_F01119B64E55, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637526000068/0001156375-26-000068-index.htm.","url":"https://asof.is/claim/clm_F01119B64E55","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637526000068/0001156375-26-000068-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-23T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2026, filed 2026-10-23"}},{"id":"clm_1140133654ED","predicate":"quarterly_operating_income","value":"1,107,100,000 United States dollar","valid_from":"2026-06-30","valid_to":"2026-09-30","published":"2026-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 1,107,100,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_1140133654ED, https://asof.is/claim/clm_1140133654ED, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637526000047/0001156375-26-000047-index.htm.","url":"https://asof.is/claim/clm_1140133654ED","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_AD95B405EF60","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637526000047/0001156375-26-000047-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2026","published_at":"2026-07-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2026, filed 2026-07-24"}},{"id":"clm_1BFED19A6789","predicate":"quarterly_revenue","value":"1,706,200,000 United States dollar","valid_from":"2026-06-30","valid_to":"2026-09-30","published":"2026-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 1,706,200,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_1BFED19A6789, https://asof.is/claim/clm_1BFED19A6789, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637526000047/0001156375-26-000047-index.htm.","url":"https://asof.is/claim/clm_1BFED19A6789","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_EE592402CAB2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637526000047/0001156375-26-000047-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2026","published_at":"2026-07-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2026, filed 2026-07-24"}},{"id":"clm_62583C73CBAE","predicate":"cash_and_equivalents","value":"2,144,200,000 United States dollar","valid_from":"2026-06-30","valid_to":"2026-09-30","published":"2026-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 2,144,200,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_62583C73CBAE, https://asof.is/claim/clm_62583C73CBAE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637526000047/0001156375-26-000047-index.htm.","url":"https://asof.is/claim/clm_62583C73CBAE","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_170CD2D5F4C8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637526000047/0001156375-26-000047-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2026","published_at":"2026-07-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2026, filed 2026-07-24"}},{"id":"clm_701909769B7B","predicate":"total_equity","value":"26,520,400,000 United States dollar","valid_from":"2026-06-30","valid_to":"2026-09-30","published":"2026-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 26,520,400,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_701909769B7B, https://asof.is/claim/clm_701909769B7B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637526000047/0001156375-26-000047-index.htm.","url":"https://asof.is/claim/clm_701909769B7B","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4220960D8CBF","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637526000047/0001156375-26-000047-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2026","published_at":"2026-07-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2026, filed 2026-07-24"}},{"id":"clm_7B3F4749DE97","predicate":"quarterly_net_income","value":"1,041,800,000 United States dollar","valid_from":"2026-06-30","valid_to":"2026-09-30","published":"2026-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 1,041,800,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_7B3F4749DE97, https://asof.is/claim/clm_7B3F4749DE97, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637526000047/0001156375-26-000047-index.htm.","url":"https://asof.is/claim/clm_7B3F4749DE97","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F01119B64E55","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637526000047/0001156375-26-000047-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2026","published_at":"2026-07-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2026, filed 2026-07-24"}},{"id":"clm_9F4A5C9D4112","predicate":"total_assets","value":"194,676,600,000 United States dollar","valid_from":"2026-06-30","valid_to":"2026-09-30","published":"2026-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 194,676,600,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_9F4A5C9D4112, https://asof.is/claim/clm_9F4A5C9D4112, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637526000047/0001156375-26-000047-index.htm.","url":"https://asof.is/claim/clm_9F4A5C9D4112","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1E63D1140747","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637526000047/0001156375-26-000047-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2026","published_at":"2026-07-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2026, filed 2026-07-24"}},{"id":"clm_40246522870F","predicate":"total_assets","value":"201,993,500,000 United States dollar","valid_from":"2026-03-31","valid_to":"2026-06-30","published":"2026-04-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 201,993,500,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_40246522870F, https://asof.is/claim/clm_40246522870F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637526000020/0001156375-26-000020-index.htm.","url":"https://asof.is/claim/clm_40246522870F","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9F4A5C9D4112","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637526000020/0001156375-26-000020-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2026","published_at":"2026-04-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2026, filed 2026-04-24"}},{"id":"clm_614002DE264D","predicate":"quarterly_operating_income","value":"1,309,700,000 United States dollar","valid_from":"2026-03-31","valid_to":"2026-06-30","published":"2026-04-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 1,309,700,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_614002DE264D, https://asof.is/claim/clm_614002DE264D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637526000020/0001156375-26-000020-index.htm.","url":"https://asof.is/claim/clm_614002DE264D","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1140133654ED","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637526000020/0001156375-26-000020-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2026","published_at":"2026-04-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2026, filed 2026-04-24"}},{"id":"clm_886F239D91CC","predicate":"quarterly_revenue","value":"1,880,100,000 United States dollar","valid_from":"2026-03-31","valid_to":"2026-06-30","published":"2026-04-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 1,880,100,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_886F239D91CC, https://asof.is/claim/clm_886F239D91CC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637526000020/0001156375-26-000020-index.htm.","url":"https://asof.is/claim/clm_886F239D91CC","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1BFED19A6789","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637526000020/0001156375-26-000020-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2026","published_at":"2026-04-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2026, filed 2026-04-24"}},{"id":"clm_8EE171E5094B","predicate":"total_equity","value":"26,618,200,000 United States dollar","valid_from":"2026-03-31","valid_to":"2026-06-30","published":"2026-04-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 26,618,200,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_8EE171E5094B, https://asof.is/claim/clm_8EE171E5094B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637526000020/0001156375-26-000020-index.htm.","url":"https://asof.is/claim/clm_8EE171E5094B","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_701909769B7B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637526000020/0001156375-26-000020-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2026","published_at":"2026-04-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2026, filed 2026-04-24"}},{"id":"clm_BE202C9EF6CD","predicate":"cash_and_equivalents","value":"2,391,200,000 United States dollar","valid_from":"2026-03-31","valid_to":"2026-06-30","published":"2026-04-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 2,391,200,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_BE202C9EF6CD, https://asof.is/claim/clm_BE202C9EF6CD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637526000020/0001156375-26-000020-index.htm.","url":"https://asof.is/claim/clm_BE202C9EF6CD","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_62583C73CBAE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637526000020/0001156375-26-000020-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2026","published_at":"2026-04-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2026, filed 2026-04-24"}},{"id":"clm_304455E6889B","predicate":"total_equity","value":"28,728,200,000 United States dollar","valid_from":"2025-12-31","valid_to":"2026-03-31","published":"2026-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 28,728,200,000 United States dollar\", as of 2025-12-31 (until 2026-03-31). Claim clm_304455E6889B, https://asof.is/claim/clm_304455E6889B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637526000009/0001156375-26-000009-index.htm.","url":"https://asof.is/claim/clm_304455E6889B","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8EE171E5094B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637526000009/0001156375-26-000009-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2025, filed 2026-02-26"}},{"id":"clm_317892EB6916","predicate":"total_assets","value":"198,424,200,000 United States dollar","valid_from":"2025-12-31","valid_to":"2026-03-31","published":"2026-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 198,424,200,000 United States dollar\", as of 2025-12-31 (until 2026-03-31). Claim clm_317892EB6916, https://asof.is/claim/clm_317892EB6916, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637526000009/0001156375-26-000009-index.htm.","url":"https://asof.is/claim/clm_317892EB6916","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_40246522870F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637526000009/0001156375-26-000009-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2025, filed 2026-02-26"}},{"id":"clm_3740E3F68A7E","predicate":"cash_and_equivalents","value":"4,416,900,000 United States dollar","valid_from":"2025-12-31","valid_to":"2026-03-31","published":"2026-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 4,416,900,000 United States dollar\", as of 2025-12-31 (until 2026-03-31). Claim clm_3740E3F68A7E, https://asof.is/claim/clm_3740E3F68A7E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637526000009/0001156375-26-000009-index.htm.","url":"https://asof.is/claim/clm_3740E3F68A7E","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BE202C9EF6CD","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637526000009/0001156375-26-000009-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2025, filed 2026-02-26"}},{"id":"clm_82E9485C51ED","predicate":"operating_income","value":"4,229,500,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group operating income: 4,229,500,000 United States dollar\", as of 2025-12-31. Claim clm_82E9485C51ED, https://asof.is/claim/clm_82E9485C51ED, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637526000009/0001156375-26-000009-index.htm.","url":"https://asof.is/claim/clm_82E9485C51ED","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637526000009/0001156375-26-000009-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2025, filed 2026-02-26"}},{"id":"clm_A6C6295489F9","predicate":"net_income","value":"4,072,200,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group net income: 4,072,200,000 United States dollar\", as of 2025-12-31. Claim clm_A6C6295489F9, https://asof.is/claim/clm_A6C6295489F9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637526000009/0001156375-26-000009-index.htm.","url":"https://asof.is/claim/clm_A6C6295489F9","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637526000009/0001156375-26-000009-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2025, filed 2026-02-26"}},{"id":"clm_BA779D647BE6","predicate":"revenue","value":"6,520,600,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group revenue: 6,520,600,000 United States dollar\", as of 2025-12-31. Claim clm_BA779D647BE6, https://asof.is/claim/clm_BA779D647BE6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637526000009/0001156375-26-000009-index.htm.","url":"https://asof.is/claim/clm_BA779D647BE6","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637526000009/0001156375-26-000009-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2025, filed 2026-02-26"}},{"id":"clm_18F9EEA55BAD","predicate":"quarterly_revenue","value":"1,537,600,000 United States dollar","valid_from":"2025-09-30","valid_to":"2026-03-31","published":"2025-10-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 1,537,600,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_18F9EEA55BAD, https://asof.is/claim/clm_18F9EEA55BAD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637525000206/0001156375-25-000206-index.htm.","url":"https://asof.is/claim/clm_18F9EEA55BAD","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_886F239D91CC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637525000206/0001156375-25-000206-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2025, filed 2025-10-24"}},{"id":"clm_3CD0D0BD259F","predicate":"quarterly_operating_income","value":"972,600,000 United States dollar","valid_from":"2025-09-30","valid_to":"2026-03-31","published":"2025-10-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 972,600,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_3CD0D0BD259F, https://asof.is/claim/clm_3CD0D0BD259F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637525000206/0001156375-25-000206-index.htm.","url":"https://asof.is/claim/clm_3CD0D0BD259F","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_614002DE264D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637525000206/0001156375-25-000206-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2025, filed 2025-10-24"}},{"id":"clm_599DCB8B186A","predicate":"total_equity","value":"28,190,300,000 United States dollar","valid_from":"2025-09-30","valid_to":"2025-12-31","published":"2025-10-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 28,190,300,000 United States dollar\", as of 2025-09-30 (until 2025-12-31). Claim clm_599DCB8B186A, https://asof.is/claim/clm_599DCB8B186A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637525000206/0001156375-25-000206-index.htm.","url":"https://asof.is/claim/clm_599DCB8B186A","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_304455E6889B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637525000206/0001156375-25-000206-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2025, filed 2025-10-24"}},{"id":"clm_783E76A4FD88","predicate":"cash_and_equivalents","value":"2,446,800,000 United States dollar","valid_from":"2025-09-30","valid_to":"2025-12-31","published":"2025-10-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 2,446,800,000 United States dollar\", as of 2025-09-30 (until 2025-12-31). Claim clm_783E76A4FD88, https://asof.is/claim/clm_783E76A4FD88, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637525000206/0001156375-25-000206-index.htm.","url":"https://asof.is/claim/clm_783E76A4FD88","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3740E3F68A7E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637525000206/0001156375-25-000206-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2025, filed 2025-10-24"}},{"id":"clm_D87AFA3BAFCD","predicate":"quarterly_net_income","value":"908,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2026-06-30","published":"2026-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 908,000,000 United States dollar\", as of 2025-09-30 (until 2026-06-30). Claim clm_D87AFA3BAFCD, https://asof.is/claim/clm_D87AFA3BAFCD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637526000068/0001156375-26-000068-index.htm.","url":"https://asof.is/claim/clm_D87AFA3BAFCD","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7B3F4749DE97","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637526000068/0001156375-26-000068-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-23T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2026, filed 2026-10-23"}},{"id":"clm_E01F85F32B3D","predicate":"total_assets","value":"187,144,600,000 United States dollar","valid_from":"2025-09-30","valid_to":"2025-12-31","published":"2025-10-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 187,144,600,000 United States dollar\", as of 2025-09-30 (until 2025-12-31). Claim clm_E01F85F32B3D, https://asof.is/claim/clm_E01F85F32B3D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637525000206/0001156375-25-000206-index.htm.","url":"https://asof.is/claim/clm_E01F85F32B3D","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_317892EB6916","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637525000206/0001156375-25-000206-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2025, filed 2025-10-24"}},{"id":"clm_40289DBF4BDC","predicate":"total_assets","value":"179,907,000,000 United States dollar","valid_from":"2025-06-30","valid_to":"2025-09-30","published":"2025-07-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 179,907,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_40289DBF4BDC, https://asof.is/claim/clm_40289DBF4BDC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637525000182/0001156375-25-000182-index.htm.","url":"https://asof.is/claim/clm_40289DBF4BDC","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E01F85F32B3D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637525000182/0001156375-25-000182-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2025","published_at":"2025-07-25T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2025, filed 2025-07-25"}},{"id":"clm_46FAA739221D","predicate":"quarterly_operating_income","value":"1,129,300,000 United States dollar","valid_from":"2025-06-30","valid_to":"2025-09-30","published":"2025-07-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 1,129,300,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_46FAA739221D, https://asof.is/claim/clm_46FAA739221D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637525000182/0001156375-25-000182-index.htm.","url":"https://asof.is/claim/clm_46FAA739221D","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3CD0D0BD259F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637525000182/0001156375-25-000182-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2025","published_at":"2025-07-25T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2025, filed 2025-07-25"}},{"id":"clm_AC0317628284","predicate":"quarterly_net_income","value":"1,025,100,000 United States dollar","valid_from":"2025-06-30","valid_to":"2025-09-30","published":"2026-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 1,025,100,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_AC0317628284, https://asof.is/claim/clm_AC0317628284, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637526000047/0001156375-26-000047-index.htm.","url":"https://asof.is/claim/clm_AC0317628284","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D87AFA3BAFCD","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637526000047/0001156375-26-000047-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2026","published_at":"2026-07-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2026, filed 2026-07-24"}},{"id":"clm_E24895A4BFE2","predicate":"total_equity","value":"27,739,000,000 United States dollar","valid_from":"2025-06-30","valid_to":"2025-09-30","published":"2025-07-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 27,739,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_E24895A4BFE2, https://asof.is/claim/clm_E24895A4BFE2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637525000182/0001156375-25-000182-index.htm.","url":"https://asof.is/claim/clm_E24895A4BFE2","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_599DCB8B186A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637525000182/0001156375-25-000182-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2025","published_at":"2025-07-25T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2025, filed 2025-07-25"}},{"id":"clm_E8511BB4A19A","predicate":"cash_and_equivalents","value":"1,981,300,000 United States dollar","valid_from":"2025-06-30","valid_to":"2025-09-30","published":"2025-07-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,981,300,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_E8511BB4A19A, https://asof.is/claim/clm_E8511BB4A19A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637525000182/0001156375-25-000182-index.htm.","url":"https://asof.is/claim/clm_E8511BB4A19A","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_783E76A4FD88","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637525000182/0001156375-25-000182-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2025","published_at":"2025-07-25T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2025, filed 2025-07-25"}},{"id":"clm_FA00037237E2","predicate":"quarterly_revenue","value":"1,692,000,000 United States dollar","valid_from":"2025-06-30","valid_to":"2025-09-30","published":"2025-07-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 1,692,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_FA00037237E2, https://asof.is/claim/clm_FA00037237E2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637525000182/0001156375-25-000182-index.htm.","url":"https://asof.is/claim/clm_FA00037237E2","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_18F9EEA55BAD","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637525000182/0001156375-25-000182-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2025","published_at":"2025-07-25T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2025, filed 2025-07-25"}},{"id":"clm_4B31B7BFB82C","predicate":"cash_and_equivalents","value":"1,405,300,000 United States dollar","valid_from":"2025-03-31","valid_to":"2025-06-30","published":"2025-04-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,405,300,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_4B31B7BFB82C, https://asof.is/claim/clm_4B31B7BFB82C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637525000103/0001156375-25-000103-index.htm.","url":"https://asof.is/claim/clm_4B31B7BFB82C","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E8511BB4A19A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637525000103/0001156375-25-000103-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2025","published_at":"2025-04-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2025, filed 2025-04-30"}},{"id":"clm_8F27E12A8EBB","predicate":"total_equity","value":"27,030,700,000 United States dollar","valid_from":"2025-03-31","valid_to":"2025-06-30","published":"2025-04-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 27,030,700,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_8F27E12A8EBB, https://asof.is/claim/clm_8F27E12A8EBB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637525000103/0001156375-25-000103-index.htm.","url":"https://asof.is/claim/clm_8F27E12A8EBB","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E24895A4BFE2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637525000103/0001156375-25-000103-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2025","published_at":"2025-04-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2025, filed 2025-04-30"}},{"id":"clm_BCE769119FAC","predicate":"quarterly_operating_income","value":"1,108,000,000 United States dollar","valid_from":"2025-03-31","valid_to":"2025-06-30","published":"2025-04-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 1,108,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_BCE769119FAC, https://asof.is/claim/clm_BCE769119FAC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637525000103/0001156375-25-000103-index.htm.","url":"https://asof.is/claim/clm_BCE769119FAC","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_46FAA739221D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637525000103/0001156375-25-000103-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2025","published_at":"2025-04-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2025, filed 2025-04-30"}},{"id":"clm_C53AE5625544","predicate":"quarterly_revenue","value":"1,642,300,000 United States dollar","valid_from":"2025-03-31","valid_to":"2025-06-30","published":"2025-04-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 1,642,300,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_C53AE5625544, https://asof.is/claim/clm_C53AE5625544, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637525000103/0001156375-25-000103-index.htm.","url":"https://asof.is/claim/clm_C53AE5625544","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_FA00037237E2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637525000103/0001156375-25-000103-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2025","published_at":"2025-04-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2025, filed 2025-04-30"}},{"id":"clm_EA288BCFF086","predicate":"total_assets","value":"157,831,600,000 United States dollar","valid_from":"2025-03-31","valid_to":"2025-06-30","published":"2025-04-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 157,831,600,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_EA288BCFF086, https://asof.is/claim/clm_EA288BCFF086, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637525000103/0001156375-25-000103-index.htm.","url":"https://asof.is/claim/clm_EA288BCFF086","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_40289DBF4BDC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637525000103/0001156375-25-000103-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2025","published_at":"2025-04-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2025, filed 2025-04-30"}},{"id":"clm_092A092569E8","predicate":"cash_and_equivalents","value":"2,892,400,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-03-31","published":"2025-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 2,892,400,000 United States dollar\", as of 2024-12-31 (until 2025-03-31). Claim clm_092A092569E8, https://asof.is/claim/clm_092A092569E8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637525000021/0001156375-25-000021-index.htm.","url":"https://asof.is/claim/clm_092A092569E8","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4B31B7BFB82C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637525000021/0001156375-25-000021-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2024, filed 2025-02-27"}},{"id":"clm_0D3B64CA7E89","predicate":"total_equity","value":"26,486,900,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-03-31","published":"2025-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 26,486,900,000 United States dollar\", as of 2024-12-31 (until 2025-03-31). Claim clm_0D3B64CA7E89, https://asof.is/claim/clm_0D3B64CA7E89, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637525000021/0001156375-25-000021-index.htm.","url":"https://asof.is/claim/clm_0D3B64CA7E89","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8F27E12A8EBB","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637525000021/0001156375-25-000021-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2024, filed 2025-02-27"}},{"id":"clm_538397AFAA43","predicate":"revenue","value":"6,130,100,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group revenue: 6,130,100,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_538397AFAA43, https://asof.is/claim/clm_538397AFAA43, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637525000021/0001156375-25-000021-index.htm.","url":"https://asof.is/claim/clm_538397AFAA43","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BA779D647BE6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637525000021/0001156375-25-000021-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2024, filed 2025-02-27"}},{"id":"clm_916F1A91188B","predicate":"operating_income","value":"3,931,500,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group operating income: 3,931,500,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_916F1A91188B, https://asof.is/claim/clm_916F1A91188B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637525000021/0001156375-25-000021-index.htm.","url":"https://asof.is/claim/clm_916F1A91188B","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_82E9485C51ED","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637525000021/0001156375-25-000021-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2024, filed 2025-02-27"}},{"id":"clm_ED49169B8EDE","predicate":"total_assets","value":"137,447,000,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-03-31","published":"2025-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 137,447,000,000 United States dollar\", as of 2024-12-31 (until 2025-03-31). Claim clm_ED49169B8EDE, https://asof.is/claim/clm_ED49169B8EDE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637525000021/0001156375-25-000021-index.htm.","url":"https://asof.is/claim/clm_ED49169B8EDE","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_EA288BCFF086","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637525000021/0001156375-25-000021-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2024, filed 2025-02-27"}},{"id":"clm_EE5F09DEEA75","predicate":"net_income","value":"3,525,800,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group net income: 3,525,800,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_EE5F09DEEA75, https://asof.is/claim/clm_EE5F09DEEA75, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637525000021/0001156375-25-000021-index.htm.","url":"https://asof.is/claim/clm_EE5F09DEEA75","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A6C6295489F9","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637525000021/0001156375-25-000021-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2024, filed 2025-02-27"}},{"id":"clm_445DF1B551AA","predicate":"total_equity","value":"28,216,200,000 United States dollar","valid_from":"2024-09-30","valid_to":"2024-12-31","published":"2024-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 28,216,200,000 United States dollar\", as of 2024-09-30 (until 2024-12-31). Claim clm_445DF1B551AA, https://asof.is/claim/clm_445DF1B551AA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637524000200/0001156375-24-000200-index.htm.","url":"https://asof.is/claim/clm_445DF1B551AA","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0D3B64CA7E89","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637524000200/0001156375-24-000200-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2024","published_at":"2024-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2024, filed 2024-11-08"}},{"id":"clm_4ED23EBDA77B","predicate":"total_assets","value":"137,795,100,000 United States dollar","valid_from":"2024-09-30","valid_to":"2024-12-31","published":"2024-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 137,795,100,000 United States dollar\", as of 2024-09-30 (until 2024-12-31). Claim clm_4ED23EBDA77B, https://asof.is/claim/clm_4ED23EBDA77B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637524000200/0001156375-24-000200-index.htm.","url":"https://asof.is/claim/clm_4ED23EBDA77B","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_ED49169B8EDE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637524000200/0001156375-24-000200-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2024","published_at":"2024-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2024, filed 2024-11-08"}},{"id":"clm_6BA7F3A922FC","predicate":"quarterly_revenue","value":"1,584,400,000 United States dollar","valid_from":"2024-09-30","valid_to":"2025-03-31","published":"2024-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 1,584,400,000 United States dollar\", as of 2024-09-30 (until 2025-03-31). Claim clm_6BA7F3A922FC, https://asof.is/claim/clm_6BA7F3A922FC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637524000200/0001156375-24-000200-index.htm.","url":"https://asof.is/claim/clm_6BA7F3A922FC","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C53AE5625544","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637524000200/0001156375-24-000200-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2024","published_at":"2024-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2024, filed 2024-11-08"}},{"id":"clm_A6A8A3657F5C","predicate":"cash_and_equivalents","value":"2,322,100,000 United States dollar","valid_from":"2024-09-30","valid_to":"2024-12-31","published":"2024-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 2,322,100,000 United States dollar\", as of 2024-09-30 (until 2024-12-31). Claim clm_A6A8A3657F5C, https://asof.is/claim/clm_A6A8A3657F5C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637524000200/0001156375-24-000200-index.htm.","url":"https://asof.is/claim/clm_A6A8A3657F5C","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_092A092569E8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637524000200/0001156375-24-000200-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2024","published_at":"2024-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2024, filed 2024-11-08"}},{"id":"clm_BD76635C9781","predicate":"quarterly_operating_income","value":"1,024,200,000 United States dollar","valid_from":"2024-09-30","valid_to":"2025-03-31","published":"2024-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 1,024,200,000 United States dollar\", as of 2024-09-30 (until 2025-03-31). Claim clm_BD76635C9781, https://asof.is/claim/clm_BD76635C9781, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637524000200/0001156375-24-000200-index.htm.","url":"https://asof.is/claim/clm_BD76635C9781","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BCE769119FAC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637524000200/0001156375-24-000200-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2024","published_at":"2024-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2024, filed 2024-11-08"}},{"id":"clm_171F0EE8B16A","predicate":"cash_and_equivalents","value":"1,789,900,000 United States dollar","valid_from":"2024-06-30","valid_to":"2024-09-30","published":"2024-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,789,900,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_171F0EE8B16A, https://asof.is/claim/clm_171F0EE8B16A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637524000149/0001156375-24-000149-index.htm.","url":"https://asof.is/claim/clm_171F0EE8B16A","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A6A8A3657F5C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637524000149/0001156375-24-000149-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2024","published_at":"2024-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2024, filed 2024-08-05"}},{"id":"clm_6D66E2F6F131","predicate":"total_assets","value":"123,379,300,000 United States dollar","valid_from":"2024-06-30","valid_to":"2024-09-30","published":"2024-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 123,379,300,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_6D66E2F6F131, https://asof.is/claim/clm_6D66E2F6F131, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637524000149/0001156375-24-000149-index.htm.","url":"https://asof.is/claim/clm_6D66E2F6F131","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4ED23EBDA77B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637524000149/0001156375-24-000149-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2024","published_at":"2024-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2024, filed 2024-08-05"}},{"id":"clm_999DA765F985","predicate":"quarterly_revenue","value":"1,532,500,000 United States dollar","valid_from":"2024-06-30","valid_to":"2024-09-30","published":"2024-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 1,532,500,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_999DA765F985, https://asof.is/claim/clm_999DA765F985, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637524000149/0001156375-24-000149-index.htm.","url":"https://asof.is/claim/clm_999DA765F985","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6BA7F3A922FC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637524000149/0001156375-24-000149-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2024","published_at":"2024-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2024, filed 2024-08-05"}},{"id":"clm_B9803829BA2A","predicate":"quarterly_operating_income","value":"1,000,600,000 United States dollar","valid_from":"2024-06-30","valid_to":"2024-09-30","published":"2024-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 1,000,600,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_B9803829BA2A, https://asof.is/claim/clm_B9803829BA2A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637524000149/0001156375-24-000149-index.htm.","url":"https://asof.is/claim/clm_B9803829BA2A","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BD76635C9781","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637524000149/0001156375-24-000149-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2024","published_at":"2024-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2024, filed 2024-08-05"}},{"id":"clm_FFB6ED6E6E9C","predicate":"total_equity","value":"27,635,800,000 United States dollar","valid_from":"2024-06-30","valid_to":"2024-09-30","published":"2024-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 27,635,800,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_FFB6ED6E6E9C, https://asof.is/claim/clm_FFB6ED6E6E9C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637524000149/0001156375-24-000149-index.htm.","url":"https://asof.is/claim/clm_FFB6ED6E6E9C","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_445DF1B551AA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637524000149/0001156375-24-000149-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2024","published_at":"2024-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2024, filed 2024-08-05"}},{"id":"clm_481FBE3AE385","predicate":"total_assets","value":"132,053,700,000 United States dollar","valid_from":"2024-03-31","valid_to":"2024-06-30","published":"2024-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 132,053,700,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_481FBE3AE385, https://asof.is/claim/clm_481FBE3AE385, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637524000072/0001156375-24-000072-index.htm.","url":"https://asof.is/claim/clm_481FBE3AE385","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6D66E2F6F131","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637524000072/0001156375-24-000072-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2024","published_at":"2024-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2024, filed 2024-05-01"}},{"id":"clm_4CEE71B187C3","predicate":"quarterly_revenue","value":"1,487,900,000 United States dollar","valid_from":"2024-03-31","valid_to":"2024-06-30","published":"2024-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 1,487,900,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_4CEE71B187C3, https://asof.is/claim/clm_4CEE71B187C3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637524000072/0001156375-24-000072-index.htm.","url":"https://asof.is/claim/clm_4CEE71B187C3","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_999DA765F985","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637524000072/0001156375-24-000072-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2024","published_at":"2024-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2024, filed 2024-05-01"}},{"id":"clm_C966D8BBD006","predicate":"total_equity","value":"27,154,200,000 United States dollar","valid_from":"2024-03-31","valid_to":"2024-06-30","published":"2024-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 27,154,200,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_C966D8BBD006, https://asof.is/claim/clm_C966D8BBD006, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637524000072/0001156375-24-000072-index.htm.","url":"https://asof.is/claim/clm_C966D8BBD006","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_FFB6ED6E6E9C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637524000072/0001156375-24-000072-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2024","published_at":"2024-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2024, filed 2024-05-01"}},{"id":"clm_CE4E46E2C97D","predicate":"quarterly_operating_income","value":"959,600,000 United States dollar","valid_from":"2024-03-31","valid_to":"2024-06-30","published":"2024-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 959,600,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_CE4E46E2C97D, https://asof.is/claim/clm_CE4E46E2C97D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637524000072/0001156375-24-000072-index.htm.","url":"https://asof.is/claim/clm_CE4E46E2C97D","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B9803829BA2A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637524000072/0001156375-24-000072-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2024","published_at":"2024-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2024, filed 2024-05-01"}},{"id":"clm_F4AFA5556FDC","predicate":"cash_and_equivalents","value":"1,436,900,000 United States dollar","valid_from":"2024-03-31","valid_to":"2024-06-30","published":"2024-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,436,900,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_F4AFA5556FDC, https://asof.is/claim/clm_F4AFA5556FDC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637524000072/0001156375-24-000072-index.htm.","url":"https://asof.is/claim/clm_F4AFA5556FDC","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_171F0EE8B16A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637524000072/0001156375-24-000072-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2024","published_at":"2024-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2024, filed 2024-05-01"}},{"id":"clm_4BFFC5DB8E0E","predicate":"total_assets","value":"129,706,100,000 United States dollar","valid_from":"2023-12-31","valid_to":"2024-03-31","published":"2024-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 129,706,100,000 United States dollar\", as of 2023-12-31 (until 2024-03-31). Claim clm_4BFFC5DB8E0E, https://asof.is/claim/clm_4BFFC5DB8E0E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637524000010/0001156375-24-000010-index.htm.","url":"https://asof.is/claim/clm_4BFFC5DB8E0E","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_481FBE3AE385","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637524000010/0001156375-24-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2023","published_at":"2024-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2023, filed 2024-02-28"}},{"id":"clm_53990E38E85F","predicate":"net_income","value":"3,226,200,000 United States dollar","valid_from":"2023-12-31","valid_to":"2024-12-31","published":"2024-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group net income: 3,226,200,000 United States dollar\", as of 2023-12-31 (until 2024-12-31). Claim clm_53990E38E85F, https://asof.is/claim/clm_53990E38E85F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637524000010/0001156375-24-000010-index.htm.","url":"https://asof.is/claim/clm_53990E38E85F","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_EE5F09DEEA75","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637524000010/0001156375-24-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2023","published_at":"2024-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2023, filed 2024-02-28"}},{"id":"clm_5B8661EDC3B5","predicate":"total_equity","value":"26,737,900,000 United States dollar","valid_from":"2023-12-31","valid_to":"2024-03-31","published":"2024-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 26,737,900,000 United States dollar\", as of 2023-12-31 (until 2024-03-31). Claim clm_5B8661EDC3B5, https://asof.is/claim/clm_5B8661EDC3B5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637524000010/0001156375-24-000010-index.htm.","url":"https://asof.is/claim/clm_5B8661EDC3B5","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C966D8BBD006","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637524000010/0001156375-24-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2023","published_at":"2024-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2023, filed 2024-02-28"}},{"id":"clm_70495439CCF4","predicate":"revenue","value":"5,578,900,000 United States dollar","valid_from":"2023-12-31","valid_to":"2024-12-31","published":"2024-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group revenue: 5,578,900,000 United States dollar\", as of 2023-12-31 (until 2024-12-31). Claim clm_70495439CCF4, https://asof.is/claim/clm_70495439CCF4, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637524000010/0001156375-24-000010-index.htm.","url":"https://asof.is/claim/clm_70495439CCF4","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_538397AFAA43","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637524000010/0001156375-24-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2023","published_at":"2024-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2023, filed 2024-02-28"}},{"id":"clm_C8528CCD0FB7","predicate":"cash_and_equivalents","value":"2,912,000,000 United States dollar","valid_from":"2023-12-31","valid_to":"2024-03-31","published":"2024-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 2,912,000,000 United States dollar\", as of 2023-12-31 (until 2024-03-31). Claim clm_C8528CCD0FB7, https://asof.is/claim/clm_C8528CCD0FB7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637524000010/0001156375-24-000010-index.htm.","url":"https://asof.is/claim/clm_C8528CCD0FB7","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F4AFA5556FDC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637524000010/0001156375-24-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2023","published_at":"2024-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2023, filed 2024-02-28"}},{"id":"clm_E374A8441EF6","predicate":"operating_income","value":"3,435,700,000 United States dollar","valid_from":"2023-12-31","valid_to":"2024-12-31","published":"2024-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group operating income: 3,435,700,000 United States dollar\", as of 2023-12-31 (until 2024-12-31). Claim clm_E374A8441EF6, https://asof.is/claim/clm_E374A8441EF6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637524000010/0001156375-24-000010-index.htm.","url":"https://asof.is/claim/clm_E374A8441EF6","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_916F1A91188B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637524000010/0001156375-24-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2023","published_at":"2024-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2023, filed 2024-02-28"}},{"id":"clm_72AFB22E2F59","predicate":"total_assets","value":"125,598,200,000 United States dollar","valid_from":"2023-09-30","valid_to":"2023-12-31","published":"2023-11-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 125,598,200,000 United States dollar\", as of 2023-09-30 (until 2023-12-31). Claim clm_72AFB22E2F59, https://asof.is/claim/clm_72AFB22E2F59, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637523000190/0001156375-23-000190-index.htm.","url":"https://asof.is/claim/clm_72AFB22E2F59","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4BFFC5DB8E0E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637523000190/0001156375-23-000190-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2023","published_at":"2023-11-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2023, filed 2023-11-01"}},{"id":"clm_9096473E272F","predicate":"quarterly_operating_income","value":"820,200,000 United States dollar","valid_from":"2023-09-30","valid_to":"2024-03-31","published":"2023-11-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 820,200,000 United States dollar\", as of 2023-09-30 (until 2024-03-31). Claim clm_9096473E272F, https://asof.is/claim/clm_9096473E272F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637523000190/0001156375-23-000190-index.htm.","url":"https://asof.is/claim/clm_9096473E272F","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_CE4E46E2C97D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637523000190/0001156375-23-000190-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2023","published_at":"2023-11-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2023, filed 2023-11-01"}},{"id":"clm_9FD627C5B104","predicate":"quarterly_revenue","value":"1,337,800,000 United States dollar","valid_from":"2023-09-30","valid_to":"2024-03-31","published":"2023-11-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 1,337,800,000 United States dollar\", as of 2023-09-30 (until 2024-03-31). Claim clm_9FD627C5B104, https://asof.is/claim/clm_9FD627C5B104, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637523000190/0001156375-23-000190-index.htm.","url":"https://asof.is/claim/clm_9FD627C5B104","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4CEE71B187C3","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637523000190/0001156375-23-000190-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2023","published_at":"2023-11-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2023, filed 2023-11-01"}},{"id":"clm_B2C40DC2CFFF","predicate":"total_equity","value":"28,151,600,000 United States dollar","valid_from":"2023-09-30","valid_to":"2023-12-31","published":"2023-11-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 28,151,600,000 United States dollar\", as of 2023-09-30 (until 2023-12-31). Claim clm_B2C40DC2CFFF, https://asof.is/claim/clm_B2C40DC2CFFF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637523000190/0001156375-23-000190-index.htm.","url":"https://asof.is/claim/clm_B2C40DC2CFFF","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5B8661EDC3B5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637523000190/0001156375-23-000190-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2023","published_at":"2023-11-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2023, filed 2023-11-01"}},{"id":"clm_E54DFBD0F9C9","predicate":"cash_and_equivalents","value":"2,300,200,000 United States dollar","valid_from":"2023-09-30","valid_to":"2023-12-31","published":"2023-11-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 2,300,200,000 United States dollar\", as of 2023-09-30 (until 2023-12-31). Claim clm_E54DFBD0F9C9, https://asof.is/claim/clm_E54DFBD0F9C9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637523000190/0001156375-23-000190-index.htm.","url":"https://asof.is/claim/clm_E54DFBD0F9C9","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C8528CCD0FB7","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637523000190/0001156375-23-000190-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2023","published_at":"2023-11-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2023, filed 2023-11-01"}},{"id":"clm_289EB8A85641","predicate":"quarterly_operating_income","value":"838,600,000 United States dollar","valid_from":"2023-06-30","valid_to":"2023-09-30","published":"2023-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 838,600,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_289EB8A85641, https://asof.is/claim/clm_289EB8A85641, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637523000129/0001156375-23-000129-index.htm.","url":"https://asof.is/claim/clm_289EB8A85641","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9096473E272F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637523000129/0001156375-23-000129-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2023","published_at":"2023-08-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2023, filed 2023-08-02"}},{"id":"clm_6103E5464C09","predicate":"total_assets","value":"151,296,700,000 United States dollar","valid_from":"2023-06-30","valid_to":"2023-09-30","published":"2023-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 151,296,700,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_6103E5464C09, https://asof.is/claim/clm_6103E5464C09, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637523000129/0001156375-23-000129-index.htm.","url":"https://asof.is/claim/clm_6103E5464C09","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_72AFB22E2F59","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637523000129/0001156375-23-000129-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2023","published_at":"2023-08-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2023, filed 2023-08-02"}},{"id":"clm_714842D2F532","predicate":"cash_and_equivalents","value":"1,880,100,000 United States dollar","valid_from":"2023-06-30","valid_to":"2023-09-30","published":"2023-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,880,100,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_714842D2F532, https://asof.is/claim/clm_714842D2F532, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637523000129/0001156375-23-000129-index.htm.","url":"https://asof.is/claim/clm_714842D2F532","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E54DFBD0F9C9","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637523000129/0001156375-23-000129-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2023","published_at":"2023-08-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2023, filed 2023-08-02"}},{"id":"clm_75AFE78279A6","predicate":"quarterly_revenue","value":"1,360,200,000 United States dollar","valid_from":"2023-06-30","valid_to":"2023-09-30","published":"2023-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 1,360,200,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_75AFE78279A6, https://asof.is/claim/clm_75AFE78279A6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637523000129/0001156375-23-000129-index.htm.","url":"https://asof.is/claim/clm_75AFE78279A6","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9FD627C5B104","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637523000129/0001156375-23-000129-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2023","published_at":"2023-08-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2023, filed 2023-08-02"}},{"id":"clm_98A8F7E37297","predicate":"total_equity","value":"27,817,800,000 United States dollar","valid_from":"2023-06-30","valid_to":"2023-09-30","published":"2023-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 27,817,800,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_98A8F7E37297, https://asof.is/claim/clm_98A8F7E37297, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637523000129/0001156375-23-000129-index.htm.","url":"https://asof.is/claim/clm_98A8F7E37297","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B2C40DC2CFFF","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637523000129/0001156375-23-000129-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2023","published_at":"2023-08-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2023, filed 2023-08-02"}},{"id":"clm_55EC6A6C7816","predicate":"cash_and_equivalents","value":"1,565,200,000 United States dollar","valid_from":"2023-03-31","valid_to":"2023-06-30","published":"2023-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,565,200,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_55EC6A6C7816, https://asof.is/claim/clm_55EC6A6C7816, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637523000066/0001156375-23-000066-index.htm.","url":"https://asof.is/claim/clm_55EC6A6C7816","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_714842D2F532","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637523000066/0001156375-23-000066-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2023","published_at":"2023-05-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2023, filed 2023-05-03"}},{"id":"clm_5DC411E5B222","predicate":"total_equity","value":"27,384,400,000 United States dollar","valid_from":"2023-03-31","valid_to":"2023-06-30","published":"2023-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 27,384,400,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_5DC411E5B222, https://asof.is/claim/clm_5DC411E5B222, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637523000066/0001156375-23-000066-index.htm.","url":"https://asof.is/claim/clm_5DC411E5B222","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_98A8F7E37297","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637523000066/0001156375-23-000066-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2023","published_at":"2023-05-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2023, filed 2023-05-03"}},{"id":"clm_77B47E34D7F1","predicate":"quarterly_revenue","value":"1,441,600,000 United States dollar","valid_from":"2023-03-31","valid_to":"2023-06-30","published":"2023-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 1,441,600,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_77B47E34D7F1, https://asof.is/claim/clm_77B47E34D7F1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637523000066/0001156375-23-000066-index.htm.","url":"https://asof.is/claim/clm_77B47E34D7F1","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_75AFE78279A6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637523000066/0001156375-23-000066-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2023","published_at":"2023-05-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2023, filed 2023-05-03"}},{"id":"clm_9E2092FC08B5","predicate":"quarterly_operating_income","value":"913,700,000 United States dollar","valid_from":"2023-03-31","valid_to":"2023-06-30","published":"2023-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 913,700,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_9E2092FC08B5, https://asof.is/claim/clm_9E2092FC08B5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637523000066/0001156375-23-000066-index.htm.","url":"https://asof.is/claim/clm_9E2092FC08B5","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_289EB8A85641","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637523000066/0001156375-23-000066-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2023","published_at":"2023-05-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2023, filed 2023-05-03"}},{"id":"clm_EF02D383790B","predicate":"total_assets","value":"166,039,200,000 United States dollar","valid_from":"2023-03-31","valid_to":"2023-06-30","published":"2023-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 166,039,200,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_EF02D383790B, https://asof.is/claim/clm_EF02D383790B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637523000066/0001156375-23-000066-index.htm.","url":"https://asof.is/claim/clm_EF02D383790B","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6103E5464C09","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637523000066/0001156375-23-000066-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2023","published_at":"2023-05-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2023, filed 2023-05-03"}},{"id":"clm_4FA31383D3D7","predicate":"revenue","value":"5,019,400,000 United States dollar","valid_from":"2022-12-31","valid_to":"2023-12-31","published":"2023-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group revenue: 5,019,400,000 United States dollar\", as of 2022-12-31 (until 2023-12-31). Claim clm_4FA31383D3D7, https://asof.is/claim/clm_4FA31383D3D7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637523000020/0001156375-23-000020-index.htm.","url":"https://asof.is/claim/clm_4FA31383D3D7","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_70495439CCF4","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637523000020/0001156375-23-000020-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2022","published_at":"2023-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2022, filed 2023-02-27"}},{"id":"clm_53DDB7774346","predicate":"total_assets","value":"174,175,700,000 United States dollar","valid_from":"2022-12-31","valid_to":"2023-03-31","published":"2023-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 174,175,700,000 United States dollar\", as of 2022-12-31 (until 2023-03-31). Claim clm_53DDB7774346, https://asof.is/claim/clm_53DDB7774346, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637523000020/0001156375-23-000020-index.htm.","url":"https://asof.is/claim/clm_53DDB7774346","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_EF02D383790B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637523000020/0001156375-23-000020-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2022","published_at":"2023-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2022, filed 2023-02-27"}},{"id":"clm_67EE0C7BAB21","predicate":"cash_and_equivalents","value":"2,720,100,000 United States dollar","valid_from":"2022-12-31","valid_to":"2023-03-31","published":"2023-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 2,720,100,000 United States dollar\", as of 2022-12-31 (until 2023-03-31). Claim clm_67EE0C7BAB21, https://asof.is/claim/clm_67EE0C7BAB21, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637523000020/0001156375-23-000020-index.htm.","url":"https://asof.is/claim/clm_67EE0C7BAB21","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_55EC6A6C7816","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637523000020/0001156375-23-000020-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2022","published_at":"2023-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2022, filed 2023-02-27"}},{"id":"clm_77689A9165C4","predicate":"operating_income","value":"3,015,900,000 United States dollar","valid_from":"2022-12-31","valid_to":"2023-12-31","published":"2023-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group operating income: 3,015,900,000 United States dollar\", as of 2022-12-31 (until 2023-12-31). Claim clm_77689A9165C4, https://asof.is/claim/clm_77689A9165C4, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637523000020/0001156375-23-000020-index.htm.","url":"https://asof.is/claim/clm_77689A9165C4","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E374A8441EF6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637523000020/0001156375-23-000020-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2022","published_at":"2023-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2022, filed 2023-02-27"}},{"id":"clm_81AE001F8E5C","predicate":"total_equity","value":"26,878,700,000 United States dollar","valid_from":"2022-12-31","valid_to":"2023-03-31","published":"2023-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 26,878,700,000 United States dollar\", as of 2022-12-31 (until 2023-03-31). Claim clm_81AE001F8E5C, https://asof.is/claim/clm_81AE001F8E5C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637523000020/0001156375-23-000020-index.htm.","url":"https://asof.is/claim/clm_81AE001F8E5C","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5DC411E5B222","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637523000020/0001156375-23-000020-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2022","published_at":"2023-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2022, filed 2023-02-27"}},{"id":"clm_89C377B9C156","predicate":"net_income","value":"2,691,000,000 United States dollar","valid_from":"2022-12-31","valid_to":"2023-12-31","published":"2023-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group net income: 2,691,000,000 United States dollar\", as of 2022-12-31 (until 2023-12-31). Claim clm_89C377B9C156, https://asof.is/claim/clm_89C377B9C156, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637523000020/0001156375-23-000020-index.htm.","url":"https://asof.is/claim/clm_89C377B9C156","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_53990E38E85F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637523000020/0001156375-23-000020-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2022","published_at":"2023-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2022, filed 2023-02-27"}},{"id":"clm_365B61C9D33A","predicate":"quarterly_operating_income","value":"738,800,000 United States dollar","valid_from":"2022-09-30","valid_to":"2023-03-31","published":"2022-11-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 738,800,000 United States dollar\", as of 2022-09-30 (until 2023-03-31). Claim clm_365B61C9D33A, https://asof.is/claim/clm_365B61C9D33A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637522000312/0001156375-22-000312-index.htm.","url":"https://asof.is/claim/clm_365B61C9D33A","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9E2092FC08B5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637522000312/0001156375-22-000312-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2022","published_at":"2022-11-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2022, filed 2022-11-02"}},{"id":"clm_4F2F331E4CB6","predicate":"total_equity","value":"28,250,800,000 United States dollar","valid_from":"2022-09-30","valid_to":"2022-12-31","published":"2022-11-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 28,250,800,000 United States dollar\", as of 2022-09-30 (until 2022-12-31). Claim clm_4F2F331E4CB6, https://asof.is/claim/clm_4F2F331E4CB6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637522000312/0001156375-22-000312-index.htm.","url":"https://asof.is/claim/clm_4F2F331E4CB6","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_81AE001F8E5C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637522000312/0001156375-22-000312-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2022","published_at":"2022-11-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2022, filed 2022-11-02"}},{"id":"clm_5F447764F0D7","predicate":"quarterly_revenue","value":"1,227,800,000 United States dollar","valid_from":"2022-09-30","valid_to":"2023-03-31","published":"2022-11-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 1,227,800,000 United States dollar\", as of 2022-09-30 (until 2023-03-31). Claim clm_5F447764F0D7, https://asof.is/claim/clm_5F447764F0D7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637522000312/0001156375-22-000312-index.htm.","url":"https://asof.is/claim/clm_5F447764F0D7","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_77B47E34D7F1","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637522000312/0001156375-22-000312-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2022","published_at":"2022-11-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2022, filed 2022-11-02"}},{"id":"clm_6D4DE1BCF4E5","predicate":"total_assets","value":"178,431,500,000 United States dollar","valid_from":"2022-09-30","valid_to":"2022-12-31","published":"2022-11-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 178,431,500,000 United States dollar\", as of 2022-09-30 (until 2022-12-31). Claim clm_6D4DE1BCF4E5, https://asof.is/claim/clm_6D4DE1BCF4E5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637522000312/0001156375-22-000312-index.htm.","url":"https://asof.is/claim/clm_6D4DE1BCF4E5","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_53DDB7774346","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637522000312/0001156375-22-000312-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2022","published_at":"2022-11-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2022, filed 2022-11-02"}},{"id":"clm_95B2D2DBDF82","predicate":"cash_and_equivalents","value":"2,130,100,000 United States dollar","valid_from":"2022-09-30","valid_to":"2022-12-31","published":"2022-11-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 2,130,100,000 United States dollar\", as of 2022-09-30 (until 2022-12-31). Claim clm_95B2D2DBDF82, https://asof.is/claim/clm_95B2D2DBDF82, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637522000312/0001156375-22-000312-index.htm.","url":"https://asof.is/claim/clm_95B2D2DBDF82","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_67EE0C7BAB21","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637522000312/0001156375-22-000312-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2022","published_at":"2022-11-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2022, filed 2022-11-02"}},{"id":"clm_BEDD6C812353","predicate":"quarterly_net_income","value":"679,600,000 United States dollar","valid_from":"2022-09-30","valid_to":"2025-06-30","published":"2022-11-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 679,600,000 United States dollar\", as of 2022-09-30 (until 2025-06-30). Claim clm_BEDD6C812353, https://asof.is/claim/clm_BEDD6C812353, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637522000312/0001156375-22-000312-index.htm.","url":"https://asof.is/claim/clm_BEDD6C812353","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_AC0317628284","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637522000312/0001156375-22-000312-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2022","published_at":"2022-11-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2022, filed 2022-11-02"}},{"id":"clm_2311562B6AE6","predicate":"quarterly_net_income","value":"662,500,000 United States dollar","valid_from":"2022-06-30","valid_to":"2022-09-30","published":"2022-08-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 662,500,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_2311562B6AE6, https://asof.is/claim/clm_2311562B6AE6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637522000215/0001156375-22-000215-index.htm.","url":"https://asof.is/claim/clm_2311562B6AE6","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BEDD6C812353","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637522000215/0001156375-22-000215-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2022","published_at":"2022-08-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2022, filed 2022-08-03"}},{"id":"clm_55636C16F7E0","predicate":"total_equity","value":"28,001,700,000 United States dollar","valid_from":"2022-06-30","valid_to":"2022-09-30","published":"2022-08-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 28,001,700,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_55636C16F7E0, https://asof.is/claim/clm_55636C16F7E0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637522000215/0001156375-22-000215-index.htm.","url":"https://asof.is/claim/clm_55636C16F7E0","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4F2F331E4CB6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637522000215/0001156375-22-000215-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2022","published_at":"2022-08-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2022, filed 2022-08-03"}},{"id":"clm_90255C705153","predicate":"cash_and_equivalents","value":"1,879,500,000 United States dollar","valid_from":"2022-06-30","valid_to":"2022-09-30","published":"2022-08-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,879,500,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_90255C705153, https://asof.is/claim/clm_90255C705153, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637522000215/0001156375-22-000215-index.htm.","url":"https://asof.is/claim/clm_90255C705153","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_95B2D2DBDF82","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637522000215/0001156375-22-000215-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2022","published_at":"2022-08-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2022, filed 2022-08-03"}},{"id":"clm_953C6428B508","predicate":"quarterly_revenue","value":"1,237,200,000 United States dollar","valid_from":"2022-06-30","valid_to":"2022-09-30","published":"2022-08-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 1,237,200,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_953C6428B508, https://asof.is/claim/clm_953C6428B508, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637522000215/0001156375-22-000215-index.htm.","url":"https://asof.is/claim/clm_953C6428B508","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5F447764F0D7","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637522000215/0001156375-22-000215-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2022","published_at":"2022-08-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2022, filed 2022-08-03"}},{"id":"clm_F391EF3F5599","predicate":"total_assets","value":"176,671,300,000 United States dollar","valid_from":"2022-06-30","valid_to":"2022-09-30","published":"2022-08-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 176,671,300,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_F391EF3F5599, https://asof.is/claim/clm_F391EF3F5599, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637522000215/0001156375-22-000215-index.htm.","url":"https://asof.is/claim/clm_F391EF3F5599","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6D4DE1BCF4E5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637522000215/0001156375-22-000215-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2022","published_at":"2022-08-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2022, filed 2022-08-03"}},{"id":"clm_FED0A42BE7AF","predicate":"quarterly_operating_income","value":"749,700,000 United States dollar","valid_from":"2022-06-30","valid_to":"2022-09-30","published":"2022-08-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 749,700,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_FED0A42BE7AF, https://asof.is/claim/clm_FED0A42BE7AF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637522000215/0001156375-22-000215-index.htm.","url":"https://asof.is/claim/clm_FED0A42BE7AF","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_365B61C9D33A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637522000215/0001156375-22-000215-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2022","published_at":"2022-08-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2022, filed 2022-08-03"}},{"id":"clm_06F526C95FBB","predicate":"cash_and_equivalents","value":"2,045,700,000 United States dollar","valid_from":"2022-03-31","valid_to":"2022-06-30","published":"2022-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 2,045,700,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_06F526C95FBB, https://asof.is/claim/clm_06F526C95FBB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637522000158/0001156375-22-000158-index.htm.","url":"https://asof.is/claim/clm_06F526C95FBB","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_90255C705153","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637522000158/0001156375-22-000158-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2022","published_at":"2022-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2022, filed 2022-05-04"}},{"id":"clm_12E1AFC50745","predicate":"quarterly_operating_income","value":"859,100,000 United States dollar","valid_from":"2022-03-31","valid_to":"2022-06-30","published":"2022-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 859,100,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_12E1AFC50745, https://asof.is/claim/clm_12E1AFC50745, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637522000158/0001156375-22-000158-index.htm.","url":"https://asof.is/claim/clm_12E1AFC50745","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_FED0A42BE7AF","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637522000158/0001156375-22-000158-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2022","published_at":"2022-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2022, filed 2022-05-04"}},{"id":"clm_514435F71118","predicate":"quarterly_net_income","value":"711,000,000 United States dollar","valid_from":"2022-03-31","valid_to":"2022-06-30","published":"2022-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 711,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_514435F71118, https://asof.is/claim/clm_514435F71118, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637522000158/0001156375-22-000158-index.htm.","url":"https://asof.is/claim/clm_514435F71118","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2311562B6AE6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637522000158/0001156375-22-000158-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2022","published_at":"2022-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2022, filed 2022-05-04"}},{"id":"clm_AFE2A609ACEA","predicate":"quarterly_revenue","value":"1,346,600,000 United States dollar","valid_from":"2022-03-31","valid_to":"2022-06-30","published":"2022-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 1,346,600,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_AFE2A609ACEA, https://asof.is/claim/clm_AFE2A609ACEA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637522000158/0001156375-22-000158-index.htm.","url":"https://asof.is/claim/clm_AFE2A609ACEA","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_953C6428B508","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637522000158/0001156375-22-000158-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2022","published_at":"2022-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2022, filed 2022-05-04"}},{"id":"clm_D7449951557D","predicate":"total_equity","value":"27,736,800,000 United States dollar","valid_from":"2022-03-31","valid_to":"2022-06-30","published":"2022-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 27,736,800,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_D7449951557D, https://asof.is/claim/clm_D7449951557D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637522000158/0001156375-22-000158-index.htm.","url":"https://asof.is/claim/clm_D7449951557D","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_55636C16F7E0","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637522000158/0001156375-22-000158-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2022","published_at":"2022-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2022, filed 2022-05-04"}},{"id":"clm_F091516C0BDA","predicate":"total_assets","value":"205,917,700,000 United States dollar","valid_from":"2022-03-31","valid_to":"2022-06-30","published":"2022-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 205,917,700,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_F091516C0BDA, https://asof.is/claim/clm_F091516C0BDA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637522000158/0001156375-22-000158-index.htm.","url":"https://asof.is/claim/clm_F091516C0BDA","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F391EF3F5599","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637522000158/0001156375-22-000158-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2022","published_at":"2022-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2022, filed 2022-05-04"}},{"id":"clm_000F3130A6C3","predicate":"total_assets","value":"196,780,300,000 United States dollar","valid_from":"2021-12-31","valid_to":"2022-03-31","published":"2022-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 196,780,300,000 United States dollar\", as of 2021-12-31 (until 2022-03-31). Claim clm_000F3130A6C3, https://asof.is/claim/clm_000F3130A6C3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637522000076/0001156375-22-000076-index.htm.","url":"https://asof.is/claim/clm_000F3130A6C3","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F091516C0BDA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637522000076/0001156375-22-000076-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2021","published_at":"2022-02-25T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2021, filed 2022-02-25"}},{"id":"clm_65511DADB3CE","predicate":"operating_income","value":"2,645,200,000 United States dollar","valid_from":"2021-12-31","valid_to":"2022-12-31","published":"2022-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group operating income: 2,645,200,000 United States dollar\", as of 2021-12-31 (until 2022-12-31). Claim clm_65511DADB3CE, https://asof.is/claim/clm_65511DADB3CE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637522000076/0001156375-22-000076-index.htm.","url":"https://asof.is/claim/clm_65511DADB3CE","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_77689A9165C4","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637522000076/0001156375-22-000076-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2021","published_at":"2022-02-25T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2021, filed 2022-02-25"}},{"id":"clm_763AB30988FD","predicate":"net_income","value":"2,636,400,000 United States dollar","valid_from":"2021-12-31","valid_to":"2022-12-31","published":"2022-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group net income: 2,636,400,000 United States dollar\", as of 2021-12-31 (until 2022-12-31). Claim clm_763AB30988FD, https://asof.is/claim/clm_763AB30988FD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637522000076/0001156375-22-000076-index.htm.","url":"https://asof.is/claim/clm_763AB30988FD","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_89C377B9C156","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637522000076/0001156375-22-000076-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2021","published_at":"2022-02-25T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2021, filed 2022-02-25"}},{"id":"clm_B2C9ABEC32FD","predicate":"cash_and_equivalents","value":"2,834,900,000 United States dollar","valid_from":"2021-12-31","valid_to":"2022-03-31","published":"2022-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 2,834,900,000 United States dollar\", as of 2021-12-31 (until 2022-03-31). Claim clm_B2C9ABEC32FD, https://asof.is/claim/clm_B2C9ABEC32FD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637522000076/0001156375-22-000076-index.htm.","url":"https://asof.is/claim/clm_B2C9ABEC32FD","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_06F526C95FBB","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637522000076/0001156375-22-000076-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2021","published_at":"2022-02-25T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2021, filed 2022-02-25"}},{"id":"clm_BA6B43B6DF25","predicate":"total_equity","value":"27,399,300,000 United States dollar","valid_from":"2021-12-31","valid_to":"2022-03-31","published":"2022-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 27,399,300,000 United States dollar\", as of 2021-12-31 (until 2022-03-31). Claim clm_BA6B43B6DF25, https://asof.is/claim/clm_BA6B43B6DF25, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637522000076/0001156375-22-000076-index.htm.","url":"https://asof.is/claim/clm_BA6B43B6DF25","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D7449951557D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637522000076/0001156375-22-000076-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2021","published_at":"2022-02-25T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2021, filed 2022-02-25"}},{"id":"clm_C57B04FD11C4","predicate":"revenue","value":"4,689,700,000 United States dollar","valid_from":"2021-12-31","valid_to":"2022-12-31","published":"2022-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group revenue: 4,689,700,000 United States dollar\", as of 2021-12-31 (until 2022-12-31). Claim clm_C57B04FD11C4, https://asof.is/claim/clm_C57B04FD11C4, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637522000076/0001156375-22-000076-index.htm.","url":"https://asof.is/claim/clm_C57B04FD11C4","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4FA31383D3D7","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637522000076/0001156375-22-000076-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2021","published_at":"2022-02-25T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2021, filed 2022-02-25"}},{"id":"clm_02C3F3B7F57D","predicate":"quarterly_revenue","value":"1,109,900,000 United States dollar","valid_from":"2021-09-30","valid_to":"2022-03-31","published":"2021-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 1,109,900,000 United States dollar\", as of 2021-09-30 (until 2022-03-31). Claim clm_02C3F3B7F57D, https://asof.is/claim/clm_02C3F3B7F57D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637521000167/0001156375-21-000167-index.htm.","url":"https://asof.is/claim/clm_02C3F3B7F57D","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_AFE2A609ACEA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637521000167/0001156375-21-000167-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2021","published_at":"2021-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2021, filed 2021-11-03"}},{"id":"clm_076D5A1B4AB6","predicate":"cash_and_equivalents","value":"1,459,400,000 United States dollar","valid_from":"2021-09-30","valid_to":"2021-12-31","published":"2021-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,459,400,000 United States dollar\", as of 2021-09-30 (until 2021-12-31). Claim clm_076D5A1B4AB6, https://asof.is/claim/clm_076D5A1B4AB6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637521000167/0001156375-21-000167-index.htm.","url":"https://asof.is/claim/clm_076D5A1B4AB6","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B2C9ABEC32FD","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637521000167/0001156375-21-000167-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2021","published_at":"2021-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2021, filed 2021-11-03"}},{"id":"clm_3A317AC3BE60","predicate":"total_assets","value":"186,774,300,000 United States dollar","valid_from":"2021-09-30","valid_to":"2021-12-31","published":"2021-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 186,774,300,000 United States dollar\", as of 2021-09-30 (until 2021-12-31). Claim clm_3A317AC3BE60, https://asof.is/claim/clm_3A317AC3BE60, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637521000167/0001156375-21-000167-index.htm.","url":"https://asof.is/claim/clm_3A317AC3BE60","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_000F3130A6C3","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637521000167/0001156375-21-000167-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2021","published_at":"2021-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2021, filed 2021-11-03"}},{"id":"clm_6390EE6FE631","predicate":"quarterly_net_income","value":"926,500,000 United States dollar","valid_from":"2021-09-30","valid_to":"2022-03-31","published":"2021-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 926,500,000 United States dollar\", as of 2021-09-30 (until 2022-03-31). Claim clm_6390EE6FE631, https://asof.is/claim/clm_6390EE6FE631, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637521000167/0001156375-21-000167-index.htm.","url":"https://asof.is/claim/clm_6390EE6FE631","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_514435F71118","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637521000167/0001156375-21-000167-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2021","published_at":"2021-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2021, filed 2021-11-03"}},{"id":"clm_98A64FC14C17","predicate":"total_equity","value":"27,282,100,000 United States dollar","valid_from":"2021-09-30","valid_to":"2021-12-31","published":"2021-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 27,282,100,000 United States dollar\", as of 2021-09-30 (until 2021-12-31). Claim clm_98A64FC14C17, https://asof.is/claim/clm_98A64FC14C17, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637521000167/0001156375-21-000167-index.htm.","url":"https://asof.is/claim/clm_98A64FC14C17","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BA6B43B6DF25","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637521000167/0001156375-21-000167-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2021","published_at":"2021-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2021, filed 2021-11-03"}},{"id":"clm_C4693D0D90BA","predicate":"quarterly_operating_income","value":"613,700,000 United States dollar","valid_from":"2021-09-30","valid_to":"2022-03-31","published":"2021-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 613,700,000 United States dollar\", as of 2021-09-30 (until 2022-03-31). Claim clm_C4693D0D90BA, https://asof.is/claim/clm_C4693D0D90BA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637521000167/0001156375-21-000167-index.htm.","url":"https://asof.is/claim/clm_C4693D0D90BA","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_12E1AFC50745","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637521000167/0001156375-21-000167-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2021","published_at":"2021-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2021, filed 2021-11-03"}},{"id":"clm_3213EB069D81","predicate":"quarterly_net_income","value":"510,300,000 United States dollar","valid_from":"2021-06-30","valid_to":"2021-09-30","published":"2021-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 510,300,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_3213EB069D81, https://asof.is/claim/clm_3213EB069D81, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637521000093/0001156375-21-000093-index.htm.","url":"https://asof.is/claim/clm_3213EB069D81","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6390EE6FE631","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637521000093/0001156375-21-000093-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2021","published_at":"2021-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2021, filed 2021-08-05"}},{"id":"clm_3967BEB3AF67","predicate":"total_equity","value":"26,763,200,000 United States dollar","valid_from":"2021-06-30","valid_to":"2021-09-30","published":"2021-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 26,763,200,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_3967BEB3AF67, https://asof.is/claim/clm_3967BEB3AF67, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637521000093/0001156375-21-000093-index.htm.","url":"https://asof.is/claim/clm_3967BEB3AF67","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_98A64FC14C17","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637521000093/0001156375-21-000093-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2021","published_at":"2021-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2021, filed 2021-08-05"}},{"id":"clm_8353219B8816","predicate":"quarterly_revenue","value":"1,179,200,000 United States dollar","valid_from":"2021-06-30","valid_to":"2021-09-30","published":"2021-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 1,179,200,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_8353219B8816, https://asof.is/claim/clm_8353219B8816, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637521000093/0001156375-21-000093-index.htm.","url":"https://asof.is/claim/clm_8353219B8816","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_02C3F3B7F57D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637521000093/0001156375-21-000093-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2021","published_at":"2021-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2021, filed 2021-08-05"}},{"id":"clm_B928BC4C981D","predicate":"quarterly_operating_income","value":"674,700,000 United States dollar","valid_from":"2021-06-30","valid_to":"2021-09-30","published":"2021-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 674,700,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_B928BC4C981D, https://asof.is/claim/clm_B928BC4C981D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637521000093/0001156375-21-000093-index.htm.","url":"https://asof.is/claim/clm_B928BC4C981D","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C4693D0D90BA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637521000093/0001156375-21-000093-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2021","published_at":"2021-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2021, filed 2021-08-05"}},{"id":"clm_D8264CAB9655","predicate":"total_assets","value":"178,699,100,000 United States dollar","valid_from":"2021-06-30","valid_to":"2021-09-30","published":"2021-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 178,699,100,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_D8264CAB9655, https://asof.is/claim/clm_D8264CAB9655, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637521000093/0001156375-21-000093-index.htm.","url":"https://asof.is/claim/clm_D8264CAB9655","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3A317AC3BE60","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637521000093/0001156375-21-000093-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2021","published_at":"2021-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2021, filed 2021-08-05"}},{"id":"clm_FBAD15797CBF","predicate":"cash_and_equivalents","value":"1,081,000,000 United States dollar","valid_from":"2021-06-30","valid_to":"2021-09-30","published":"2021-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,081,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_FBAD15797CBF, https://asof.is/claim/clm_FBAD15797CBF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637521000093/0001156375-21-000093-index.htm.","url":"https://asof.is/claim/clm_FBAD15797CBF","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_076D5A1B4AB6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637521000093/0001156375-21-000093-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2021","published_at":"2021-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2021, filed 2021-08-05"}},{"id":"clm_54A4BA5A9371","predicate":"cash_and_equivalents","value":"936,400,000 United States dollar","valid_from":"2021-03-31","valid_to":"2021-06-30","published":"2021-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 936,400,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_54A4BA5A9371, https://asof.is/claim/clm_54A4BA5A9371, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637521000052/0001156375-21-000052-index.htm.","url":"https://asof.is/claim/clm_54A4BA5A9371","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_FBAD15797CBF","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637521000052/0001156375-21-000052-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2021","published_at":"2021-05-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2021, filed 2021-05-05"}},{"id":"clm_7AE92E978E6B","predicate":"total_equity","value":"26,527,900,000 United States dollar","valid_from":"2021-03-31","valid_to":"2021-06-30","published":"2021-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 26,527,900,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_7AE92E978E6B, https://asof.is/claim/clm_7AE92E978E6B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637521000052/0001156375-21-000052-index.htm.","url":"https://asof.is/claim/clm_7AE92E978E6B","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3967BEB3AF67","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637521000052/0001156375-21-000052-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2021","published_at":"2021-05-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2021, filed 2021-05-05"}},{"id":"clm_7C307117964B","predicate":"quarterly_net_income","value":"574,400,000 United States dollar","valid_from":"2021-03-31","valid_to":"2021-06-30","published":"2021-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 574,400,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_7C307117964B, https://asof.is/claim/clm_7C307117964B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637521000052/0001156375-21-000052-index.htm.","url":"https://asof.is/claim/clm_7C307117964B","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3213EB069D81","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637521000052/0001156375-21-000052-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2021","published_at":"2021-05-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2021, filed 2021-05-05"}},{"id":"clm_7D9BA9984CFE","predicate":"total_assets","value":"160,652,100,000 United States dollar","valid_from":"2021-03-31","valid_to":"2021-06-30","published":"2021-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 160,652,100,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_7D9BA9984CFE, https://asof.is/claim/clm_7D9BA9984CFE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637521000052/0001156375-21-000052-index.htm.","url":"https://asof.is/claim/clm_7D9BA9984CFE","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D8264CAB9655","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637521000052/0001156375-21-000052-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2021","published_at":"2021-05-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2021, filed 2021-05-05"}},{"id":"clm_915F581AD767","predicate":"quarterly_revenue","value":"1,253,300,000 United States dollar","valid_from":"2021-03-31","valid_to":"2021-06-30","published":"2021-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 1,253,300,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_915F581AD767, https://asof.is/claim/clm_915F581AD767, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637521000052/0001156375-21-000052-index.htm.","url":"https://asof.is/claim/clm_915F581AD767","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8353219B8816","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637521000052/0001156375-21-000052-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2021","published_at":"2021-05-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2021, filed 2021-05-05"}},{"id":"clm_D04D6F36FD0F","predicate":"quarterly_operating_income","value":"725,100,000 United States dollar","valid_from":"2021-03-31","valid_to":"2021-06-30","published":"2021-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 725,100,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_D04D6F36FD0F, https://asof.is/claim/clm_D04D6F36FD0F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637521000052/0001156375-21-000052-index.htm.","url":"https://asof.is/claim/clm_D04D6F36FD0F","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B928BC4C981D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637521000052/0001156375-21-000052-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2021","published_at":"2021-05-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2021, filed 2021-05-05"}},{"id":"clm_2B546F16E574","predicate":"revenue","value":"4,883,600,000 United States dollar","valid_from":"2020-12-31","valid_to":"2021-12-31","published":"2021-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group revenue: 4,883,600,000 United States dollar\", as of 2020-12-31 (until 2021-12-31). Claim clm_2B546F16E574, https://asof.is/claim/clm_2B546F16E574, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637521000020/0001156375-21-000020-index.htm.","url":"https://asof.is/claim/clm_2B546F16E574","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C57B04FD11C4","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637521000020/0001156375-21-000020-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2020","published_at":"2021-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2020, filed 2021-02-26"}},{"id":"clm_45062FE80390","predicate":"total_equity","value":"26,319,900,000 United States dollar","valid_from":"2020-12-31","valid_to":"2021-03-31","published":"2021-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 26,319,900,000 United States dollar\", as of 2020-12-31 (until 2021-03-31). Claim clm_45062FE80390, https://asof.is/claim/clm_45062FE80390, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637521000020/0001156375-21-000020-index.htm.","url":"https://asof.is/claim/clm_45062FE80390","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7AE92E978E6B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637521000020/0001156375-21-000020-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2020","published_at":"2021-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2020, filed 2021-02-26"}},{"id":"clm_5DD951A2743F","predicate":"total_assets","value":"124,659,600,000 United States dollar","valid_from":"2020-12-31","valid_to":"2021-03-31","published":"2021-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 124,659,600,000 United States dollar\", as of 2020-12-31 (until 2021-03-31). Claim clm_5DD951A2743F, https://asof.is/claim/clm_5DD951A2743F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637521000020/0001156375-21-000020-index.htm.","url":"https://asof.is/claim/clm_5DD951A2743F","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7D9BA9984CFE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637521000020/0001156375-21-000020-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2020","published_at":"2021-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2020, filed 2021-02-26"}},{"id":"clm_8215DF2B5D45","predicate":"operating_income","value":"2,637,400,000 United States dollar","valid_from":"2020-12-31","valid_to":"2021-12-31","published":"2021-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group operating income: 2,637,400,000 United States dollar\", as of 2020-12-31 (until 2021-12-31). Claim clm_8215DF2B5D45, https://asof.is/claim/clm_8215DF2B5D45, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637521000020/0001156375-21-000020-index.htm.","url":"https://asof.is/claim/clm_8215DF2B5D45","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_65511DADB3CE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637521000020/0001156375-21-000020-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2020","published_at":"2021-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2020, filed 2021-02-26"}},{"id":"clm_9FBE40036C91","predicate":"net_income","value":"2,105,200,000 United States dollar","valid_from":"2020-12-31","valid_to":"2021-12-31","published":"2021-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group net income: 2,105,200,000 United States dollar\", as of 2020-12-31 (until 2021-12-31). Claim clm_9FBE40036C91, https://asof.is/claim/clm_9FBE40036C91, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637521000020/0001156375-21-000020-index.htm.","url":"https://asof.is/claim/clm_9FBE40036C91","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_763AB30988FD","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637521000020/0001156375-21-000020-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2020","published_at":"2021-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2020, filed 2021-02-26"}},{"id":"clm_A6F2B762CCB8","predicate":"cash_and_equivalents","value":"1,633,200,000 United States dollar","valid_from":"2020-12-31","valid_to":"2021-03-31","published":"2021-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,633,200,000 United States dollar\", as of 2020-12-31 (until 2021-03-31). Claim clm_A6F2B762CCB8, https://asof.is/claim/clm_A6F2B762CCB8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637521000020/0001156375-21-000020-index.htm.","url":"https://asof.is/claim/clm_A6F2B762CCB8","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_54A4BA5A9371","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637521000020/0001156375-21-000020-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2020","published_at":"2021-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2020, filed 2021-02-26"}},{"id":"clm_2CE57BBB8D84","predicate":"cash_and_equivalents","value":"1,332,100,000 United States dollar","valid_from":"2020-09-30","valid_to":"2020-12-31","published":"2020-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,332,100,000 United States dollar\", as of 2020-09-30 (until 2020-12-31). Claim clm_2CE57BBB8D84, https://asof.is/claim/clm_2CE57BBB8D84, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637520000119/0001156375-20-000119-index.htm.","url":"https://asof.is/claim/clm_2CE57BBB8D84","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A6F2B762CCB8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637520000119/0001156375-20-000119-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2020","published_at":"2020-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2020, filed 2020-11-04"}},{"id":"clm_3109C2849132","predicate":"total_assets","value":"125,758,800,000 United States dollar","valid_from":"2020-09-30","valid_to":"2020-12-31","published":"2020-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 125,758,800,000 United States dollar\", as of 2020-09-30 (until 2020-12-31). Claim clm_3109C2849132, https://asof.is/claim/clm_3109C2849132, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637520000119/0001156375-20-000119-index.htm.","url":"https://asof.is/claim/clm_3109C2849132","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5DD951A2743F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637520000119/0001156375-20-000119-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2020","published_at":"2020-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2020, filed 2020-11-04"}},{"id":"clm_3EA081FEB1A9","predicate":"total_equity","value":"26,979,600,000 United States dollar","valid_from":"2020-09-30","valid_to":"2020-12-31","published":"2020-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 26,979,600,000 United States dollar\", as of 2020-09-30 (until 2020-12-31). Claim clm_3EA081FEB1A9, https://asof.is/claim/clm_3EA081FEB1A9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637520000119/0001156375-20-000119-index.htm.","url":"https://asof.is/claim/clm_3EA081FEB1A9","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_45062FE80390","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637520000119/0001156375-20-000119-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2020","published_at":"2020-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2020, filed 2020-11-04"}},{"id":"clm_663C0DFD2277","predicate":"quarterly_net_income","value":"411,700,000 United States dollar","valid_from":"2020-09-30","valid_to":"2021-03-31","published":"2020-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 411,700,000 United States dollar\", as of 2020-09-30 (until 2021-03-31). Claim clm_663C0DFD2277, https://asof.is/claim/clm_663C0DFD2277, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637520000119/0001156375-20-000119-index.htm.","url":"https://asof.is/claim/clm_663C0DFD2277","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7C307117964B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637520000119/0001156375-20-000119-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2020","published_at":"2020-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2020, filed 2020-11-04"}},{"id":"clm_9AAA4DC4ECF7","predicate":"quarterly_revenue","value":"1,080,700,000 United States dollar","valid_from":"2020-09-30","valid_to":"2021-03-31","published":"2020-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 1,080,700,000 United States dollar\", as of 2020-09-30 (until 2021-03-31). Claim clm_9AAA4DC4ECF7, https://asof.is/claim/clm_9AAA4DC4ECF7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637520000119/0001156375-20-000119-index.htm.","url":"https://asof.is/claim/clm_9AAA4DC4ECF7","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_915F581AD767","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637520000119/0001156375-20-000119-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2020","published_at":"2020-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2020, filed 2020-11-04"}},{"id":"clm_CFE19705F849","predicate":"quarterly_operating_income","value":"525,000,000 United States dollar","valid_from":"2020-09-30","valid_to":"2021-03-31","published":"2020-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 525,000,000 United States dollar\", as of 2020-09-30 (until 2021-03-31). Claim clm_CFE19705F849, https://asof.is/claim/clm_CFE19705F849, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637520000119/0001156375-20-000119-index.htm.","url":"https://asof.is/claim/clm_CFE19705F849","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D04D6F36FD0F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637520000119/0001156375-20-000119-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2020","published_at":"2020-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2020, filed 2020-11-04"}},{"id":"clm_14833608D22B","predicate":"cash_and_equivalents","value":"1,405,400,000 United States dollar","valid_from":"2020-06-30","valid_to":"2020-09-30","published":"2020-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,405,400,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_14833608D22B, https://asof.is/claim/clm_14833608D22B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637520000079/0001156375-20-000079-index.htm.","url":"https://asof.is/claim/clm_14833608D22B","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2CE57BBB8D84","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637520000079/0001156375-20-000079-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2020","published_at":"2020-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2020, filed 2020-08-05"}},{"id":"clm_1BEB983791FB","predicate":"total_equity","value":"26,807,900,000 United States dollar","valid_from":"2020-06-30","valid_to":"2020-09-30","published":"2020-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 26,807,900,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_1BEB983791FB, https://asof.is/claim/clm_1BEB983791FB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637520000079/0001156375-20-000079-index.htm.","url":"https://asof.is/claim/clm_1BEB983791FB","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3EA081FEB1A9","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637520000079/0001156375-20-000079-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2020","published_at":"2020-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2020, filed 2020-08-05"}},{"id":"clm_318544B3E0FC","predicate":"quarterly_revenue","value":"1,182,300,000 United States dollar","valid_from":"2020-06-30","valid_to":"2020-09-30","published":"2020-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 1,182,300,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_318544B3E0FC, https://asof.is/claim/clm_318544B3E0FC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637520000079/0001156375-20-000079-index.htm.","url":"https://asof.is/claim/clm_318544B3E0FC","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9AAA4DC4ECF7","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637520000079/0001156375-20-000079-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2020","published_at":"2020-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2020, filed 2020-08-05"}},{"id":"clm_3529959F9A31","predicate":"quarterly_operating_income","value":"637,500,000 United States dollar","valid_from":"2020-06-30","valid_to":"2020-09-30","published":"2020-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 637,500,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_3529959F9A31, https://asof.is/claim/clm_3529959F9A31, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637520000079/0001156375-20-000079-index.htm.","url":"https://asof.is/claim/clm_3529959F9A31","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_CFE19705F849","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637520000079/0001156375-20-000079-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2020","published_at":"2020-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2020, filed 2020-08-05"}},{"id":"clm_8AC460DDD7F2","predicate":"total_assets","value":"117,214,800,000 United States dollar","valid_from":"2020-06-30","valid_to":"2020-09-30","published":"2020-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 117,214,800,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_8AC460DDD7F2, https://asof.is/claim/clm_8AC460DDD7F2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637520000079/0001156375-20-000079-index.htm.","url":"https://asof.is/claim/clm_8AC460DDD7F2","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3109C2849132","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637520000079/0001156375-20-000079-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2020","published_at":"2020-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2020, filed 2020-08-05"}},{"id":"clm_9D7FAF2DEF3E","predicate":"quarterly_net_income","value":"503,300,000 United States dollar","valid_from":"2020-06-30","valid_to":"2020-09-30","published":"2020-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 503,300,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_9D7FAF2DEF3E, https://asof.is/claim/clm_9D7FAF2DEF3E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637520000079/0001156375-20-000079-index.htm.","url":"https://asof.is/claim/clm_9D7FAF2DEF3E","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_663C0DFD2277","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637520000079/0001156375-20-000079-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2020","published_at":"2020-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2020, filed 2020-08-05"}},{"id":"clm_0628BEC8E77C","predicate":"total_assets","value":"137,932,300,000 United States dollar","valid_from":"2020-03-31","valid_to":"2020-06-30","published":"2020-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 137,932,300,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_0628BEC8E77C, https://asof.is/claim/clm_0628BEC8E77C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637520000039/0001156375-20-000039-index.htm.","url":"https://asof.is/claim/clm_0628BEC8E77C","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8AC460DDD7F2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637520000039/0001156375-20-000039-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2020","published_at":"2020-05-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2020, filed 2020-05-06"}},{"id":"clm_0B1598316CE6","predicate":"total_equity","value":"26,567,700,000 United States dollar","valid_from":"2020-03-31","valid_to":"2020-06-30","published":"2020-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 26,567,700,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_0B1598316CE6, https://asof.is/claim/clm_0B1598316CE6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637520000039/0001156375-20-000039-index.htm.","url":"https://asof.is/claim/clm_0B1598316CE6","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1BEB983791FB","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637520000039/0001156375-20-000039-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2020","published_at":"2020-05-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2020, filed 2020-05-06"}},{"id":"clm_11115237AA4F","predicate":"cash_and_equivalents","value":"851,700,000 United States dollar","valid_from":"2020-03-31","valid_to":"2020-06-30","published":"2020-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 851,700,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_11115237AA4F, https://asof.is/claim/clm_11115237AA4F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637520000039/0001156375-20-000039-index.htm.","url":"https://asof.is/claim/clm_11115237AA4F","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_14833608D22B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637520000039/0001156375-20-000039-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2020","published_at":"2020-05-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2020, filed 2020-05-06"}},{"id":"clm_30EDD5430DC8","predicate":"quarterly_net_income","value":"766,200,000 United States dollar","valid_from":"2020-03-31","valid_to":"2020-06-30","published":"2020-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 766,200,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_30EDD5430DC8, https://asof.is/claim/clm_30EDD5430DC8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637520000039/0001156375-20-000039-index.htm.","url":"https://asof.is/claim/clm_30EDD5430DC8","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9D7FAF2DEF3E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637520000039/0001156375-20-000039-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2020","published_at":"2020-05-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2020, filed 2020-05-06"}},{"id":"clm_87E82C9C3343","predicate":"quarterly_revenue","value":"1,522,100,000 United States dollar","valid_from":"2020-03-31","valid_to":"2020-06-30","published":"2020-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 1,522,100,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_87E82C9C3343, https://asof.is/claim/clm_87E82C9C3343, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637520000039/0001156375-20-000039-index.htm.","url":"https://asof.is/claim/clm_87E82C9C3343","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_318544B3E0FC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637520000039/0001156375-20-000039-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2020","published_at":"2020-05-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2020, filed 2020-05-06"}},{"id":"clm_F76ADC18796F","predicate":"quarterly_operating_income","value":"959,900,000 United States dollar","valid_from":"2020-03-31","valid_to":"2020-06-30","published":"2020-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 959,900,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_F76ADC18796F, https://asof.is/claim/clm_F76ADC18796F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637520000039/0001156375-20-000039-index.htm.","url":"https://asof.is/claim/clm_F76ADC18796F","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3529959F9A31","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637520000039/0001156375-20-000039-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2020","published_at":"2020-05-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2020, filed 2020-05-06"}},{"id":"clm_0FFC2665C40C","predicate":"total_equity","value":"26,128,900,000 United States dollar","valid_from":"2019-12-31","valid_to":"2020-03-31","published":"2020-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 26,128,900,000 United States dollar\", as of 2019-12-31 (until 2020-03-31). Claim clm_0FFC2665C40C, https://asof.is/claim/clm_0FFC2665C40C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637520000013/0001156375-20-000013-index.htm.","url":"https://asof.is/claim/clm_0FFC2665C40C","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0B1598316CE6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637520000013/0001156375-20-000013-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2019","published_at":"2020-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2019, filed 2020-02-28"}},{"id":"clm_60A253DBA55E","predicate":"net_income","value":"2,116,500,000 United States dollar","valid_from":"2019-12-31","valid_to":"2020-12-31","published":"2020-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group net income: 2,116,500,000 United States dollar\", as of 2019-12-31 (until 2020-12-31). Claim clm_60A253DBA55E, https://asof.is/claim/clm_60A253DBA55E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637520000013/0001156375-20-000013-index.htm.","url":"https://asof.is/claim/clm_60A253DBA55E","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9FBE40036C91","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637520000013/0001156375-20-000013-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2019","published_at":"2020-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2019, filed 2020-02-28"}},{"id":"clm_6499256D488E","predicate":"operating_income","value":"2,587,800,000 United States dollar","valid_from":"2019-12-31","valid_to":"2020-12-31","published":"2020-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group operating income: 2,587,800,000 United States dollar\", as of 2019-12-31 (until 2020-12-31). Claim clm_6499256D488E, https://asof.is/claim/clm_6499256D488E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637520000013/0001156375-20-000013-index.htm.","url":"https://asof.is/claim/clm_6499256D488E","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8215DF2B5D45","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637520000013/0001156375-20-000013-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2019","published_at":"2020-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2019, filed 2020-02-28"}},{"id":"clm_8F0C9185E2E6","predicate":"cash_and_equivalents","value":"1,551,400,000 United States dollar","valid_from":"2019-12-31","valid_to":"2020-03-31","published":"2020-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,551,400,000 United States dollar\", as of 2019-12-31 (until 2020-03-31). Claim clm_8F0C9185E2E6, https://asof.is/claim/clm_8F0C9185E2E6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637520000013/0001156375-20-000013-index.htm.","url":"https://asof.is/claim/clm_8F0C9185E2E6","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_11115237AA4F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637520000013/0001156375-20-000013-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2019","published_at":"2020-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2019, filed 2020-02-28"}},{"id":"clm_992EDD7681DA","predicate":"revenue","value":"4,868,000,000 United States dollar","valid_from":"2019-12-31","valid_to":"2020-12-31","published":"2020-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group revenue: 4,868,000,000 United States dollar\", as of 2019-12-31 (until 2020-12-31). Claim clm_992EDD7681DA, https://asof.is/claim/clm_992EDD7681DA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637520000013/0001156375-20-000013-index.htm.","url":"https://asof.is/claim/clm_992EDD7681DA","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2B546F16E574","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637520000013/0001156375-20-000013-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2019","published_at":"2020-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2019, filed 2020-02-28"}},{"id":"clm_C465DCA0AE68","predicate":"total_assets","value":"75,215,300,000 United States dollar","valid_from":"2019-12-31","valid_to":"2020-03-31","published":"2020-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 75,215,300,000 United States dollar\", as of 2019-12-31 (until 2020-03-31). Claim clm_C465DCA0AE68, https://asof.is/claim/clm_C465DCA0AE68, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637520000013/0001156375-20-000013-index.htm.","url":"https://asof.is/claim/clm_C465DCA0AE68","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0628BEC8E77C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637520000013/0001156375-20-000013-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2019","published_at":"2020-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2019, filed 2020-02-28"}},{"id":"clm_0AE78056B965","predicate":"quarterly_revenue","value":"1,277,300,000 United States dollar","valid_from":"2019-09-30","valid_to":"2020-03-31","published":"2019-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 1,277,300,000 United States dollar\", as of 2019-09-30 (until 2020-03-31). Claim clm_0AE78056B965, https://asof.is/claim/clm_0AE78056B965, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637519000114/0001156375-19-000114-index.htm.","url":"https://asof.is/claim/clm_0AE78056B965","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_87E82C9C3343","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637519000114/0001156375-19-000114-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2019","published_at":"2019-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2019, filed 2019-11-06"}},{"id":"clm_0FFC1043DD0B","predicate":"cash_and_equivalents","value":"1,210,100,000 United States dollar","valid_from":"2019-09-30","valid_to":"2019-12-31","published":"2019-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,210,100,000 United States dollar\", as of 2019-09-30 (until 2019-12-31). Claim clm_0FFC1043DD0B, https://asof.is/claim/clm_0FFC1043DD0B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637519000114/0001156375-19-000114-index.htm.","url":"https://asof.is/claim/clm_0FFC1043DD0B","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8F0C9185E2E6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637519000114/0001156375-19-000114-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2019","published_at":"2019-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2019, filed 2019-11-06"}},{"id":"clm_29E3D5A3A703","predicate":"total_assets","value":"79,417,600,000 United States dollar","valid_from":"2019-09-30","valid_to":"2019-12-31","published":"2019-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 79,417,600,000 United States dollar\", as of 2019-09-30 (until 2019-12-31). Claim clm_29E3D5A3A703, https://asof.is/claim/clm_29E3D5A3A703, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637519000114/0001156375-19-000114-index.htm.","url":"https://asof.is/claim/clm_29E3D5A3A703","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C465DCA0AE68","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637519000114/0001156375-19-000114-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2019","published_at":"2019-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2019, filed 2019-11-06"}},{"id":"clm_54E9C21F199E","predicate":"quarterly_operating_income","value":"685,200,000 United States dollar","valid_from":"2019-09-30","valid_to":"2020-03-31","published":"2019-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 685,200,000 United States dollar\", as of 2019-09-30 (until 2020-03-31). Claim clm_54E9C21F199E, https://asof.is/claim/clm_54E9C21F199E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637519000114/0001156375-19-000114-index.htm.","url":"https://asof.is/claim/clm_54E9C21F199E","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F76ADC18796F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637519000114/0001156375-19-000114-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2019","published_at":"2019-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2019, filed 2019-11-06"}},{"id":"clm_6EC80BFB2AB1","predicate":"total_equity","value":"26,783,200,000 United States dollar","valid_from":"2019-09-30","valid_to":"2019-12-31","published":"2019-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 26,783,200,000 United States dollar\", as of 2019-09-30 (until 2019-12-31). Claim clm_6EC80BFB2AB1, https://asof.is/claim/clm_6EC80BFB2AB1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637519000114/0001156375-19-000114-index.htm.","url":"https://asof.is/claim/clm_6EC80BFB2AB1","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0FFC2665C40C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637519000114/0001156375-19-000114-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2019","published_at":"2019-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2019, filed 2019-11-06"}},{"id":"clm_AED0AD601956","predicate":"quarterly_net_income","value":"636,300,000 United States dollar","valid_from":"2019-09-30","valid_to":"2020-03-31","published":"2019-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 636,300,000 United States dollar\", as of 2019-09-30 (until 2020-03-31). Claim clm_AED0AD601956, https://asof.is/claim/clm_AED0AD601956, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637519000114/0001156375-19-000114-index.htm.","url":"https://asof.is/claim/clm_AED0AD601956","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_30EDD5430DC8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637519000114/0001156375-19-000114-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2019","published_at":"2019-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2019, filed 2019-11-06"}},{"id":"clm_24C2A22CA989","predicate":"total_equity","value":"26,455,200,000 United States dollar","valid_from":"2019-06-30","valid_to":"2019-09-30","published":"2019-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 26,455,200,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_24C2A22CA989, https://asof.is/claim/clm_24C2A22CA989, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637519000087/0001156375-19-000087-index.htm.","url":"https://asof.is/claim/clm_24C2A22CA989","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6EC80BFB2AB1","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637519000087/0001156375-19-000087-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2019","published_at":"2019-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2019, filed 2019-08-07"}},{"id":"clm_4178107C7373","predicate":"quarterly_net_income","value":"513,800,000 United States dollar","valid_from":"2019-06-30","valid_to":"2019-09-30","published":"2019-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 513,800,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_4178107C7373, https://asof.is/claim/clm_4178107C7373, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637519000087/0001156375-19-000087-index.htm.","url":"https://asof.is/claim/clm_4178107C7373","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_AED0AD601956","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637519000087/0001156375-19-000087-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2019","published_at":"2019-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2019, filed 2019-08-07"}},{"id":"clm_5BF446406215","predicate":"quarterly_operating_income","value":"698,600,000 United States dollar","valid_from":"2019-06-30","valid_to":"2019-09-30","published":"2019-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 698,600,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_5BF446406215, https://asof.is/claim/clm_5BF446406215, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637519000087/0001156375-19-000087-index.htm.","url":"https://asof.is/claim/clm_5BF446406215","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_54E9C21F199E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637519000087/0001156375-19-000087-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2019","published_at":"2019-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2019, filed 2019-08-07"}},{"id":"clm_96EA73DC5C1E","predicate":"quarterly_revenue","value":"1,272,700,000 United States dollar","valid_from":"2019-06-30","valid_to":"2019-09-30","published":"2019-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 1,272,700,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_96EA73DC5C1E, https://asof.is/claim/clm_96EA73DC5C1E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637519000087/0001156375-19-000087-index.htm.","url":"https://asof.is/claim/clm_96EA73DC5C1E","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0AE78056B965","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637519000087/0001156375-19-000087-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2019","published_at":"2019-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2019, filed 2019-08-07"}},{"id":"clm_97CB9FE1730D","predicate":"cash_and_equivalents","value":"937,700,000 United States dollar","valid_from":"2019-06-30","valid_to":"2019-09-30","published":"2019-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 937,700,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_97CB9FE1730D, https://asof.is/claim/clm_97CB9FE1730D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637519000087/0001156375-19-000087-index.htm.","url":"https://asof.is/claim/clm_97CB9FE1730D","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0FFC1043DD0B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637519000087/0001156375-19-000087-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2019","published_at":"2019-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2019, filed 2019-08-07"}},{"id":"clm_A7B545777075","predicate":"total_assets","value":"70,349,500,000 United States dollar","valid_from":"2019-06-30","valid_to":"2019-09-30","published":"2019-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 70,349,500,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_A7B545777075, https://asof.is/claim/clm_A7B545777075, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637519000087/0001156375-19-000087-index.htm.","url":"https://asof.is/claim/clm_A7B545777075","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_29E3D5A3A703","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637519000087/0001156375-19-000087-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2019","published_at":"2019-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2019, filed 2019-08-07"}},{"id":"clm_378CFE57244D","predicate":"quarterly_revenue","value":"1,179,600,000 United States dollar","valid_from":"2019-03-31","valid_to":"2019-06-30","published":"2019-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 1,179,600,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_378CFE57244D, https://asof.is/claim/clm_378CFE57244D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637519000039/0001156375-19-000039-index.htm.","url":"https://asof.is/claim/clm_378CFE57244D","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_96EA73DC5C1E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637519000039/0001156375-19-000039-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2019","published_at":"2019-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2019, filed 2019-05-08"}},{"id":"clm_487F5A61B4C2","predicate":"quarterly_net_income","value":"496,900,000 United States dollar","valid_from":"2019-03-31","valid_to":"2019-06-30","published":"2019-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 496,900,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_487F5A61B4C2, https://asof.is/claim/clm_487F5A61B4C2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637519000039/0001156375-19-000039-index.htm.","url":"https://asof.is/claim/clm_487F5A61B4C2","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4178107C7373","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637519000039/0001156375-19-000039-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2019","published_at":"2019-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2019, filed 2019-05-08"}},{"id":"clm_7F4D5FC091E2","predicate":"total_equity","value":"26,157,600,000 United States dollar","valid_from":"2019-03-31","valid_to":"2019-06-30","published":"2019-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 26,157,600,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_7F4D5FC091E2, https://asof.is/claim/clm_7F4D5FC091E2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637519000039/0001156375-19-000039-index.htm.","url":"https://asof.is/claim/clm_7F4D5FC091E2","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_24C2A22CA989","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637519000039/0001156375-19-000039-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2019","published_at":"2019-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2019, filed 2019-05-08"}},{"id":"clm_875C573CFAE0","predicate":"cash_and_equivalents","value":"997,400,000 United States dollar","valid_from":"2019-03-31","valid_to":"2019-06-30","published":"2019-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 997,400,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_875C573CFAE0, https://asof.is/claim/clm_875C573CFAE0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637519000039/0001156375-19-000039-index.htm.","url":"https://asof.is/claim/clm_875C573CFAE0","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_97CB9FE1730D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637519000039/0001156375-19-000039-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2019","published_at":"2019-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2019, filed 2019-05-08"}},{"id":"clm_972C08539329","predicate":"total_assets","value":"71,614,500,000 United States dollar","valid_from":"2019-03-31","valid_to":"2019-06-30","published":"2019-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 71,614,500,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_972C08539329, https://asof.is/claim/clm_972C08539329, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637519000039/0001156375-19-000039-index.htm.","url":"https://asof.is/claim/clm_972C08539329","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A7B545777075","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637519000039/0001156375-19-000039-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2019","published_at":"2019-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2019, filed 2019-05-08"}},{"id":"clm_F85311C82C0E","predicate":"quarterly_operating_income","value":"631,000,000 United States dollar","valid_from":"2019-03-31","valid_to":"2019-06-30","published":"2019-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 631,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_F85311C82C0E, https://asof.is/claim/clm_F85311C82C0E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637519000039/0001156375-19-000039-index.htm.","url":"https://asof.is/claim/clm_F85311C82C0E","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5BF446406215","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637519000039/0001156375-19-000039-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2019","published_at":"2019-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2019, filed 2019-05-08"}},{"id":"clm_45CA35A5B17E","predicate":"net_income","value":"1,962,200,000 United States dollar","valid_from":"2018-12-31","valid_to":"2019-12-31","published":"2019-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group net income: 1,962,200,000 United States dollar\", as of 2018-12-31 (until 2019-12-31). Claim clm_45CA35A5B17E, https://asof.is/claim/clm_45CA35A5B17E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637519000010/0001156375-19-000010-index.htm.","url":"https://asof.is/claim/clm_45CA35A5B17E","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_60A253DBA55E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637519000010/0001156375-19-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2018","published_at":"2019-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2018, filed 2019-02-28"}},{"id":"clm_5B6D108FE88D","predicate":"operating_income","value":"2,607,600,000 United States dollar","valid_from":"2018-12-31","valid_to":"2019-12-31","published":"2019-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group operating income: 2,607,600,000 United States dollar\", as of 2018-12-31 (until 2019-12-31). Claim clm_5B6D108FE88D, https://asof.is/claim/clm_5B6D108FE88D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637519000010/0001156375-19-000010-index.htm.","url":"https://asof.is/claim/clm_5B6D108FE88D","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6499256D488E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637519000010/0001156375-19-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2018","published_at":"2019-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2018, filed 2019-02-28"}},{"id":"clm_63690B3B856F","predicate":"revenue","value":"4,309,400,000 United States dollar","valid_from":"2018-12-31","valid_to":"2019-12-31","published":"2019-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group revenue: 4,309,400,000 United States dollar\", as of 2018-12-31 (until 2019-12-31). Claim clm_63690B3B856F, https://asof.is/claim/clm_63690B3B856F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637519000010/0001156375-19-000010-index.htm.","url":"https://asof.is/claim/clm_63690B3B856F","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_992EDD7681DA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637519000010/0001156375-19-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2018","published_at":"2019-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2018, filed 2019-02-28"}},{"id":"clm_6C836EE66A74","predicate":"cash_and_equivalents","value":"1,374,500,000 United States dollar","valid_from":"2018-12-31","valid_to":"2019-03-31","published":"2019-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,374,500,000 United States dollar\", as of 2018-12-31 (until 2019-03-31). Claim clm_6C836EE66A74, https://asof.is/claim/clm_6C836EE66A74, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637519000010/0001156375-19-000010-index.htm.","url":"https://asof.is/claim/clm_6C836EE66A74","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_875C573CFAE0","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637519000010/0001156375-19-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2018","published_at":"2019-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2018, filed 2019-02-28"}},{"id":"clm_71E1BFE5F141","predicate":"total_equity","value":"25,918,500,000 United States dollar","valid_from":"2018-12-31","valid_to":"2019-03-31","published":"2019-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 25,918,500,000 United States dollar\", as of 2018-12-31 (until 2019-03-31). Claim clm_71E1BFE5F141, https://asof.is/claim/clm_71E1BFE5F141, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637519000010/0001156375-19-000010-index.htm.","url":"https://asof.is/claim/clm_71E1BFE5F141","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7F4D5FC091E2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637519000010/0001156375-19-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2018","published_at":"2019-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2018, filed 2019-02-28"}},{"id":"clm_9746A54EC7A2","predicate":"total_assets","value":"77,475,700,000 United States dollar","valid_from":"2018-12-31","valid_to":"2019-03-31","published":"2019-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 77,475,700,000 United States dollar\", as of 2018-12-31 (until 2019-03-31). Claim clm_9746A54EC7A2, https://asof.is/claim/clm_9746A54EC7A2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637519000010/0001156375-19-000010-index.htm.","url":"https://asof.is/claim/clm_9746A54EC7A2","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_972C08539329","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637519000010/0001156375-19-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2018","published_at":"2019-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2018, filed 2019-02-28"}},{"id":"clm_665B890A8F2C","predicate":"quarterly_revenue","value":"904,200,000 United States dollar","valid_from":"2018-09-30","valid_to":"2019-03-31","published":"2018-11-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 904,200,000 United States dollar\", as of 2018-09-30 (until 2019-03-31). Claim clm_665B890A8F2C, https://asof.is/claim/clm_665B890A8F2C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637518000128/0001156375-18-000128-index.htm.","url":"https://asof.is/claim/clm_665B890A8F2C","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_378CFE57244D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637518000128/0001156375-18-000128-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2018","published_at":"2018-11-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2018, filed 2018-11-02"}},{"id":"clm_A341B5F8C422","predicate":"total_assets","value":"70,364,100,000 United States dollar","valid_from":"2018-09-30","valid_to":"2018-12-31","published":"2018-11-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 70,364,100,000 United States dollar\", as of 2018-09-30 (until 2018-12-31). Claim clm_A341B5F8C422, https://asof.is/claim/clm_A341B5F8C422, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637518000128/0001156375-18-000128-index.htm.","url":"https://asof.is/claim/clm_A341B5F8C422","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9746A54EC7A2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637518000128/0001156375-18-000128-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2018","published_at":"2018-11-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2018, filed 2018-11-02"}},{"id":"clm_A45BBD594BBD","predicate":"quarterly_net_income","value":"411,800,000 United States dollar","valid_from":"2018-09-30","valid_to":"2019-03-31","published":"2019-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 411,800,000 United States dollar\", as of 2018-09-30 (until 2019-03-31). Claim clm_A45BBD594BBD, https://asof.is/claim/clm_A45BBD594BBD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637519000114/0001156375-19-000114-index.htm.","url":"https://asof.is/claim/clm_A45BBD594BBD","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_487F5A61B4C2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637519000114/0001156375-19-000114-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2019","published_at":"2019-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2019, filed 2019-11-06"}},{"id":"clm_A75A696E155F","predicate":"quarterly_operating_income","value":"549,900,000 United States dollar","valid_from":"2018-09-30","valid_to":"2019-03-31","published":"2018-11-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 549,900,000 United States dollar\", as of 2018-09-30 (until 2019-03-31). Claim clm_A75A696E155F, https://asof.is/claim/clm_A75A696E155F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637518000128/0001156375-18-000128-index.htm.","url":"https://asof.is/claim/clm_A75A696E155F","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F85311C82C0E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637518000128/0001156375-18-000128-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2018","published_at":"2018-11-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2018, filed 2018-11-02"}},{"id":"clm_B85ECE0068F4","predicate":"cash_and_equivalents","value":"1,406,300,000 United States dollar","valid_from":"2018-09-30","valid_to":"2018-12-31","published":"2018-11-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,406,300,000 United States dollar\", as of 2018-09-30 (until 2018-12-31). Claim clm_B85ECE0068F4, https://asof.is/claim/clm_B85ECE0068F4, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637518000128/0001156375-18-000128-index.htm.","url":"https://asof.is/claim/clm_B85ECE0068F4","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6C836EE66A74","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637518000128/0001156375-18-000128-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2018","published_at":"2018-11-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2018, filed 2018-11-02"}},{"id":"clm_D5BCA3D19E84","predicate":"total_equity","value":"23,295,700,000 United States dollar","valid_from":"2018-09-30","valid_to":"2018-12-31","published":"2018-11-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 23,295,700,000 United States dollar\", as of 2018-09-30 (until 2018-12-31). Claim clm_D5BCA3D19E84, https://asof.is/claim/clm_D5BCA3D19E84, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637518000128/0001156375-18-000128-index.htm.","url":"https://asof.is/claim/clm_D5BCA3D19E84","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_71E1BFE5F141","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637518000128/0001156375-18-000128-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2018","published_at":"2018-11-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2018, filed 2018-11-02"}},{"id":"clm_30CCC49F4D73","predicate":"quarterly_net_income","value":"566,100,000 United States dollar","valid_from":"2018-06-30","valid_to":"2018-09-30","published":"2019-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 566,100,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_30CCC49F4D73, https://asof.is/claim/clm_30CCC49F4D73, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637519000087/0001156375-19-000087-index.htm.","url":"https://asof.is/claim/clm_30CCC49F4D73","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A45BBD594BBD","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637519000087/0001156375-19-000087-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2019","published_at":"2019-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2019, filed 2019-08-07"}},{"id":"clm_4273966CE0AE","predicate":"total_assets","value":"69,199,300,000 United States dollar","valid_from":"2018-06-30","valid_to":"2018-09-30","published":"2018-08-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 69,199,300,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_4273966CE0AE, https://asof.is/claim/clm_4273966CE0AE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637518000083/0001156375-18-000083-index.htm.","url":"https://asof.is/claim/clm_4273966CE0AE","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A341B5F8C422","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637518000083/0001156375-18-000083-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2018","published_at":"2018-08-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2018, filed 2018-08-01"}},{"id":"clm_49DF22B4BE7A","predicate":"total_equity","value":"23,123,600,000 United States dollar","valid_from":"2018-06-30","valid_to":"2018-09-30","published":"2018-08-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 23,123,600,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_49DF22B4BE7A, https://asof.is/claim/clm_49DF22B4BE7A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637518000083/0001156375-18-000083-index.htm.","url":"https://asof.is/claim/clm_49DF22B4BE7A","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D5BCA3D19E84","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637518000083/0001156375-18-000083-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2018","published_at":"2018-08-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2018, filed 2018-08-01"}},{"id":"clm_9DBDD153591A","predicate":"quarterly_operating_income","value":"666,900,000 United States dollar","valid_from":"2018-06-30","valid_to":"2018-09-30","published":"2018-08-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 666,900,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_9DBDD153591A, https://asof.is/claim/clm_9DBDD153591A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637518000083/0001156375-18-000083-index.htm.","url":"https://asof.is/claim/clm_9DBDD153591A","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A75A696E155F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637518000083/0001156375-18-000083-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2018","published_at":"2018-08-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2018, filed 2018-08-01"}},{"id":"clm_EC50267DD8DB","predicate":"cash_and_equivalents","value":"1,098,900,000 United States dollar","valid_from":"2018-06-30","valid_to":"2018-09-30","published":"2018-08-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,098,900,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_EC50267DD8DB, https://asof.is/claim/clm_EC50267DD8DB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637518000083/0001156375-18-000083-index.htm.","url":"https://asof.is/claim/clm_EC50267DD8DB","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B85ECE0068F4","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637518000083/0001156375-18-000083-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2018","published_at":"2018-08-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2018, filed 2018-08-01"}},{"id":"clm_EE666F37FE59","predicate":"quarterly_revenue","value":"1,059,600,000 United States dollar","valid_from":"2018-06-30","valid_to":"2018-09-30","published":"2018-08-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 1,059,600,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_EE666F37FE59, https://asof.is/claim/clm_EE666F37FE59, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637518000083/0001156375-18-000083-index.htm.","url":"https://asof.is/claim/clm_EE666F37FE59","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_665B890A8F2C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637518000083/0001156375-18-000083-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2018","published_at":"2018-08-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2018, filed 2018-08-01"}},{"id":"clm_260B9F904268","predicate":"quarterly_net_income","value":"598,800,000 United States dollar","valid_from":"2018-03-31","valid_to":"2018-06-30","published":"2019-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 598,800,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_260B9F904268, https://asof.is/claim/clm_260B9F904268, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637519000039/0001156375-19-000039-index.htm.","url":"https://asof.is/claim/clm_260B9F904268","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_30CCC49F4D73","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637519000039/0001156375-19-000039-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2019","published_at":"2019-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2019, filed 2019-05-08"}},{"id":"clm_43E1423DC997","predicate":"quarterly_operating_income","value":"740,900,000 United States dollar","valid_from":"2018-03-31","valid_to":"2018-06-30","published":"2018-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 740,900,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_43E1423DC997, https://asof.is/claim/clm_43E1423DC997, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637518000047/0001156375-18-000047-index.htm.","url":"https://asof.is/claim/clm_43E1423DC997","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9DBDD153591A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637518000047/0001156375-18-000047-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2018","published_at":"2018-05-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2018, filed 2018-05-03"}},{"id":"clm_4432EF2E435C","predicate":"total_equity","value":"22,772,800,000 United States dollar","valid_from":"2018-03-31","valid_to":"2018-06-30","published":"2018-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 22,772,800,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_4432EF2E435C, https://asof.is/claim/clm_4432EF2E435C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637518000047/0001156375-18-000047-index.htm.","url":"https://asof.is/claim/clm_4432EF2E435C","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_49DF22B4BE7A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637518000047/0001156375-18-000047-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2018","published_at":"2018-05-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2018, filed 2018-05-03"}},{"id":"clm_A300C7B7166A","predicate":"cash_and_equivalents","value":"784,600,000 United States dollar","valid_from":"2018-03-31","valid_to":"2018-06-30","published":"2018-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 784,600,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_A300C7B7166A, https://asof.is/claim/clm_A300C7B7166A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637518000047/0001156375-18-000047-index.htm.","url":"https://asof.is/claim/clm_A300C7B7166A","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_EC50267DD8DB","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637518000047/0001156375-18-000047-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2018","published_at":"2018-05-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2018, filed 2018-05-03"}},{"id":"clm_AB804DF9B1EE","predicate":"quarterly_revenue","value":"1,109,000,000 United States dollar","valid_from":"2018-03-31","valid_to":"2018-06-30","published":"2018-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 1,109,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_AB804DF9B1EE, https://asof.is/claim/clm_AB804DF9B1EE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637518000047/0001156375-18-000047-index.htm.","url":"https://asof.is/claim/clm_AB804DF9B1EE","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_EE666F37FE59","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637518000047/0001156375-18-000047-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2018","published_at":"2018-05-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2018, filed 2018-05-03"}},{"id":"clm_B94F5026848F","predicate":"total_assets","value":"69,919,300,000 United States dollar","valid_from":"2018-03-31","valid_to":"2018-06-30","published":"2018-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 69,919,300,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_B94F5026848F, https://asof.is/claim/clm_B94F5026848F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637518000047/0001156375-18-000047-index.htm.","url":"https://asof.is/claim/clm_B94F5026848F","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4273966CE0AE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637518000047/0001156375-18-000047-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2018","published_at":"2018-05-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2018, filed 2018-05-03"}},{"id":"clm_05CF1FD42488","predicate":"operating_income","value":"2,312,000,000 United States dollar","valid_from":"2017-12-31","valid_to":"2018-12-31","published":"2018-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group operating income: 2,312,000,000 United States dollar\", as of 2017-12-31 (until 2018-12-31). Claim clm_05CF1FD42488, https://asof.is/claim/clm_05CF1FD42488, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637518000026/0001156375-18-000026-index.htm.","url":"https://asof.is/claim/clm_05CF1FD42488","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5B6D108FE88D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637518000026/0001156375-18-000026-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2017","published_at":"2018-03-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2017, filed 2018-03-01"}},{"id":"clm_133EB2DCADFA","predicate":"total_assets","value":"75,791,200,000 United States dollar","valid_from":"2017-12-31","valid_to":"2018-03-31","published":"2018-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 75,791,200,000 United States dollar\", as of 2017-12-31 (until 2018-03-31). Claim clm_133EB2DCADFA, https://asof.is/claim/clm_133EB2DCADFA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637518000026/0001156375-18-000026-index.htm.","url":"https://asof.is/claim/clm_133EB2DCADFA","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B94F5026848F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637518000026/0001156375-18-000026-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2017","published_at":"2018-03-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2017, filed 2018-03-01"}},{"id":"clm_430146FC1CC2","predicate":"net_income","value":"4,063,400,000 United States dollar","valid_from":"2017-12-31","valid_to":"2018-12-31","published":"2018-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group net income: 4,063,400,000 United States dollar\", as of 2017-12-31 (until 2018-12-31). Claim clm_430146FC1CC2, https://asof.is/claim/clm_430146FC1CC2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637518000026/0001156375-18-000026-index.htm.","url":"https://asof.is/claim/clm_430146FC1CC2","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_45CA35A5B17E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637518000026/0001156375-18-000026-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2017","published_at":"2018-03-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2017, filed 2018-03-01"}},{"id":"clm_8F0C2C072F6B","predicate":"cash_and_equivalents","value":"1,903,600,000 United States dollar","valid_from":"2017-12-31","valid_to":"2018-03-31","published":"2018-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,903,600,000 United States dollar\", as of 2017-12-31 (until 2018-03-31). Claim clm_8F0C2C072F6B, https://asof.is/claim/clm_8F0C2C072F6B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637518000026/0001156375-18-000026-index.htm.","url":"https://asof.is/claim/clm_8F0C2C072F6B","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A300C7B7166A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637518000026/0001156375-18-000026-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2017","published_at":"2018-03-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2017, filed 2018-03-01"}},{"id":"clm_A5A3637E3708","predicate":"revenue","value":"3,644,700,000 United States dollar","valid_from":"2017-12-31","valid_to":"2018-12-31","published":"2018-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group revenue: 3,644,700,000 United States dollar\", as of 2017-12-31 (until 2018-12-31). Claim clm_A5A3637E3708, https://asof.is/claim/clm_A5A3637E3708, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637518000026/0001156375-18-000026-index.htm.","url":"https://asof.is/claim/clm_A5A3637E3708","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_63690B3B856F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637518000026/0001156375-18-000026-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2017","published_at":"2018-03-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2017, filed 2018-03-01"}},{"id":"clm_BAB2088ACA4E","predicate":"total_equity","value":"22,411,800,000 United States dollar","valid_from":"2017-12-31","valid_to":"2018-03-31","published":"2018-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 22,411,800,000 United States dollar\", as of 2017-12-31 (until 2018-03-31). Claim clm_BAB2088ACA4E, https://asof.is/claim/clm_BAB2088ACA4E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637518000026/0001156375-18-000026-index.htm.","url":"https://asof.is/claim/clm_BAB2088ACA4E","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4432EF2E435C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637518000026/0001156375-18-000026-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2017","published_at":"2018-03-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2017, filed 2018-03-01"}},{"id":"clm_1133F4A428BD","predicate":"quarterly_revenue","value":"890,800,000 United States dollar","valid_from":"2017-09-30","valid_to":"2018-03-31","published":"2017-11-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 890,800,000 United States dollar\", as of 2017-09-30 (until 2018-03-31). Claim clm_1133F4A428BD, https://asof.is/claim/clm_1133F4A428BD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637517000108/0001156375-17-000108-index.htm.","url":"https://asof.is/claim/clm_1133F4A428BD","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_AB804DF9B1EE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637517000108/0001156375-17-000108-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2017","published_at":"2017-11-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2017, filed 2017-11-02"}},{"id":"clm_975D282D839B","predicate":"cash_and_equivalents","value":"1,631,100,000 United States dollar","valid_from":"2017-09-30","valid_to":"2017-12-31","published":"2017-11-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,631,100,000 United States dollar\", as of 2017-09-30 (until 2017-12-31). Claim clm_975D282D839B, https://asof.is/claim/clm_975D282D839B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637517000108/0001156375-17-000108-index.htm.","url":"https://asof.is/claim/clm_975D282D839B","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8F0C2C072F6B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637517000108/0001156375-17-000108-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2017","published_at":"2017-11-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2017, filed 2017-11-02"}},{"id":"clm_AD6A959D2A4B","predicate":"total_equity","value":"20,863,900,000 United States dollar","valid_from":"2017-09-30","valid_to":"2017-12-31","published":"2017-11-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 20,863,900,000 United States dollar\", as of 2017-09-30 (until 2017-12-31). Claim clm_AD6A959D2A4B, https://asof.is/claim/clm_AD6A959D2A4B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637517000108/0001156375-17-000108-index.htm.","url":"https://asof.is/claim/clm_AD6A959D2A4B","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BAB2088ACA4E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637517000108/0001156375-17-000108-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2017","published_at":"2017-11-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2017, filed 2017-11-02"}},{"id":"clm_D57D96E70CC7","predicate":"total_assets","value":"78,323,000,000 United States dollar","valid_from":"2017-09-30","valid_to":"2017-12-31","published":"2017-11-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 78,323,000,000 United States dollar\", as of 2017-09-30 (until 2017-12-31). Claim clm_D57D96E70CC7, https://asof.is/claim/clm_D57D96E70CC7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637517000108/0001156375-17-000108-index.htm.","url":"https://asof.is/claim/clm_D57D96E70CC7","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_133EB2DCADFA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637517000108/0001156375-17-000108-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2017","published_at":"2017-11-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2017, filed 2017-11-02"}},{"id":"clm_D77E84B66F85","predicate":"quarterly_operating_income","value":"567,900,000 United States dollar","valid_from":"2017-09-30","valid_to":"2018-03-31","published":"2017-11-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 567,900,000 United States dollar\", as of 2017-09-30 (until 2018-03-31). Claim clm_D77E84B66F85, https://asof.is/claim/clm_D77E84B66F85, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637517000108/0001156375-17-000108-index.htm.","url":"https://asof.is/claim/clm_D77E84B66F85","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_43E1423DC997","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637517000108/0001156375-17-000108-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2017","published_at":"2017-11-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2017, filed 2017-11-02"}},{"id":"clm_2F94A3B33797","predicate":"total_equity","value":"20,776,800,000 United States dollar","valid_from":"2017-06-30","valid_to":"2017-09-30","published":"2017-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 20,776,800,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_2F94A3B33797, https://asof.is/claim/clm_2F94A3B33797, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637517000080/0001156375-17-000080-index.htm.","url":"https://asof.is/claim/clm_2F94A3B33797","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_AD6A959D2A4B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637517000080/0001156375-17-000080-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2017","published_at":"2017-08-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2017, filed 2017-08-02"}},{"id":"clm_2FAE738447F8","predicate":"total_assets","value":"78,543,800,000 United States dollar","valid_from":"2017-06-30","valid_to":"2017-09-30","published":"2017-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 78,543,800,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_2FAE738447F8, https://asof.is/claim/clm_2FAE738447F8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637517000080/0001156375-17-000080-index.htm.","url":"https://asof.is/claim/clm_2FAE738447F8","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D57D96E70CC7","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637517000080/0001156375-17-000080-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2017","published_at":"2017-08-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2017, filed 2017-08-02"}},{"id":"clm_946FAA13A0C7","predicate":"quarterly_operating_income","value":"605,600,000 United States dollar","valid_from":"2017-06-30","valid_to":"2017-09-30","published":"2017-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 605,600,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_946FAA13A0C7, https://asof.is/claim/clm_946FAA13A0C7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637517000080/0001156375-17-000080-index.htm.","url":"https://asof.is/claim/clm_946FAA13A0C7","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D77E84B66F85","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637517000080/0001156375-17-000080-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2017","published_at":"2017-08-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2017, filed 2017-08-02"}},{"id":"clm_D30A4C097FDD","predicate":"cash_and_equivalents","value":"1,362,300,000 United States dollar","valid_from":"2017-06-30","valid_to":"2017-09-30","published":"2017-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,362,300,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_D30A4C097FDD, https://asof.is/claim/clm_D30A4C097FDD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637517000080/0001156375-17-000080-index.htm.","url":"https://asof.is/claim/clm_D30A4C097FDD","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_975D282D839B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637517000080/0001156375-17-000080-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2017","published_at":"2017-08-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2017, filed 2017-08-02"}},{"id":"clm_FF7D88A9757A","predicate":"quarterly_revenue","value":"924,600,000 United States dollar","valid_from":"2017-06-30","valid_to":"2017-09-30","published":"2017-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 924,600,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_FF7D88A9757A, https://asof.is/claim/clm_FF7D88A9757A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637517000080/0001156375-17-000080-index.htm.","url":"https://asof.is/claim/clm_FF7D88A9757A","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1133F4A428BD","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637517000080/0001156375-17-000080-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2017","published_at":"2017-08-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2017, filed 2017-08-02"}},{"id":"clm_121CF7754B3E","predicate":"quarterly_revenue","value":"929,300,000 United States dollar","valid_from":"2017-03-31","valid_to":"2017-06-30","published":"2017-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 929,300,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_121CF7754B3E, https://asof.is/claim/clm_121CF7754B3E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637517000045/0001156375-17-000045-index.htm.","url":"https://asof.is/claim/clm_121CF7754B3E","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_FF7D88A9757A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637517000045/0001156375-17-000045-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2017","published_at":"2017-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2017, filed 2017-05-04"}},{"id":"clm_30AD5627C041","predicate":"quarterly_operating_income","value":"601,200,000 United States dollar","valid_from":"2017-03-31","valid_to":"2017-06-30","published":"2017-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 601,200,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_30AD5627C041, https://asof.is/claim/clm_30AD5627C041, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637517000045/0001156375-17-000045-index.htm.","url":"https://asof.is/claim/clm_30AD5627C041","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_946FAA13A0C7","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637517000045/0001156375-17-000045-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2017","published_at":"2017-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2017, filed 2017-05-04"}},{"id":"clm_3DECC9851D65","predicate":"quarterly_net_income","value":"399,800,000 United States dollar","valid_from":"2017-03-31","valid_to":"2018-03-31","published":"2017-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 399,800,000 United States dollar\", as of 2017-03-31 (until 2018-03-31). Claim clm_3DECC9851D65, https://asof.is/claim/clm_3DECC9851D65, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637517000045/0001156375-17-000045-index.htm.","url":"https://asof.is/claim/clm_3DECC9851D65","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_260B9F904268","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637517000045/0001156375-17-000045-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2017","published_at":"2017-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2017, filed 2017-05-04"}},{"id":"clm_532DF7787AE2","predicate":"total_equity","value":"20,554,200,000 United States dollar","valid_from":"2017-03-31","valid_to":"2017-06-30","published":"2017-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 20,554,200,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_532DF7787AE2, https://asof.is/claim/clm_532DF7787AE2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637517000045/0001156375-17-000045-index.htm.","url":"https://asof.is/claim/clm_532DF7787AE2","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2F94A3B33797","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637517000045/0001156375-17-000045-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2017","published_at":"2017-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2017, filed 2017-05-04"}},{"id":"clm_66AC6F930F00","predicate":"total_assets","value":"75,476,000,000 United States dollar","valid_from":"2017-03-31","valid_to":"2017-06-30","published":"2017-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 75,476,000,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_66AC6F930F00, https://asof.is/claim/clm_66AC6F930F00, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637517000045/0001156375-17-000045-index.htm.","url":"https://asof.is/claim/clm_66AC6F930F00","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2FAE738447F8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637517000045/0001156375-17-000045-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2017","published_at":"2017-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2017, filed 2017-05-04"}},{"id":"clm_ED46DA1DFDC2","predicate":"cash_and_equivalents","value":"1,287,800,000 United States dollar","valid_from":"2017-03-31","valid_to":"2017-06-30","published":"2017-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,287,800,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_ED46DA1DFDC2, https://asof.is/claim/clm_ED46DA1DFDC2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637517000045/0001156375-17-000045-index.htm.","url":"https://asof.is/claim/clm_ED46DA1DFDC2","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D30A4C097FDD","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637517000045/0001156375-17-000045-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2017","published_at":"2017-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2017, filed 2017-05-04"}},{"id":"clm_137FED7D9538","predicate":"total_assets","value":"69,369,400,000 United States dollar","valid_from":"2016-12-31","valid_to":"2017-03-31","published":"2017-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 69,369,400,000 United States dollar\", as of 2016-12-31 (until 2017-03-31). Claim clm_137FED7D9538, https://asof.is/claim/clm_137FED7D9538, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637517000016/0001156375-17-000016-index.htm.","url":"https://asof.is/claim/clm_137FED7D9538","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_66AC6F930F00","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637517000016/0001156375-17-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2016","published_at":"2017-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2016, filed 2017-02-27"}},{"id":"clm_4A734BEFF144","predicate":"net_income","value":"1,534,100,000 United States dollar","valid_from":"2016-12-31","valid_to":"2017-12-31","published":"2017-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group net income: 1,534,100,000 United States dollar\", as of 2016-12-31 (until 2017-12-31). Claim clm_4A734BEFF144, https://asof.is/claim/clm_4A734BEFF144, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637517000016/0001156375-17-000016-index.htm.","url":"https://asof.is/claim/clm_4A734BEFF144","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_430146FC1CC2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637517000016/0001156375-17-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2016","published_at":"2017-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2016, filed 2017-02-27"}},{"id":"clm_8BB832EC1BB4","predicate":"revenue","value":"3,595,200,000 United States dollar","valid_from":"2016-12-31","valid_to":"2017-12-31","published":"2017-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group revenue: 3,595,200,000 United States dollar\", as of 2016-12-31 (until 2017-12-31). Claim clm_8BB832EC1BB4, https://asof.is/claim/clm_8BB832EC1BB4, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637517000016/0001156375-17-000016-index.htm.","url":"https://asof.is/claim/clm_8BB832EC1BB4","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A5A3637E3708","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637517000016/0001156375-17-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2016","published_at":"2017-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2016, filed 2017-02-27"}},{"id":"clm_90DFDB9C0EFD","predicate":"cash_and_equivalents","value":"1,868,600,000 United States dollar","valid_from":"2016-12-31","valid_to":"2017-03-31","published":"2017-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,868,600,000 United States dollar\", as of 2016-12-31 (until 2017-03-31). Claim clm_90DFDB9C0EFD, https://asof.is/claim/clm_90DFDB9C0EFD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637517000016/0001156375-17-000016-index.htm.","url":"https://asof.is/claim/clm_90DFDB9C0EFD","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_ED46DA1DFDC2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637517000016/0001156375-17-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2016","published_at":"2017-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2016, filed 2017-02-27"}},{"id":"clm_B4F5439BAB9A","predicate":"total_equity","value":"20,340,700,000 United States dollar","valid_from":"2016-12-31","valid_to":"2017-03-31","published":"2017-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 20,340,700,000 United States dollar\", as of 2016-12-31 (until 2017-03-31). Claim clm_B4F5439BAB9A, https://asof.is/claim/clm_B4F5439BAB9A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637517000016/0001156375-17-000016-index.htm.","url":"https://asof.is/claim/clm_B4F5439BAB9A","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_532DF7787AE2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637517000016/0001156375-17-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2016","published_at":"2017-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2016, filed 2017-02-27"}},{"id":"clm_BED3C37CC862","predicate":"operating_income","value":"2,202,700,000 United States dollar","valid_from":"2016-12-31","valid_to":"2017-12-31","published":"2017-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group operating income: 2,202,700,000 United States dollar\", as of 2016-12-31 (until 2017-12-31). Claim clm_BED3C37CC862, https://asof.is/claim/clm_BED3C37CC862, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637517000016/0001156375-17-000016-index.htm.","url":"https://asof.is/claim/clm_BED3C37CC862","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_05CF1FD42488","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637517000016/0001156375-17-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2016","published_at":"2017-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2016, filed 2017-02-27"}},{"id":"clm_2CB3D081F0F0","predicate":"total_equity","value":"21,264,900,000 United States dollar","valid_from":"2016-09-30","valid_to":"2016-12-31","published":"2016-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 21,264,900,000 United States dollar\", as of 2016-09-30 (until 2016-12-31). Claim clm_2CB3D081F0F0, https://asof.is/claim/clm_2CB3D081F0F0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637516000255/0001156375-16-000255-index.htm.","url":"https://asof.is/claim/clm_2CB3D081F0F0","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B4F5439BAB9A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637516000255/0001156375-16-000255-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2016","published_at":"2016-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2016, filed 2016-11-04"}},{"id":"clm_2D5C347240E2","predicate":"cash_and_equivalents","value":"1,420,500,000 United States dollar","valid_from":"2016-09-30","valid_to":"2016-12-31","published":"2016-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,420,500,000 United States dollar\", as of 2016-09-30 (until 2016-12-31). Claim clm_2D5C347240E2, https://asof.is/claim/clm_2D5C347240E2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637516000255/0001156375-16-000255-index.htm.","url":"https://asof.is/claim/clm_2D5C347240E2","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_90DFDB9C0EFD","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637516000255/0001156375-16-000255-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2016","published_at":"2016-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2016, filed 2016-11-04"}},{"id":"clm_33057677BB6C","predicate":"quarterly_operating_income","value":"525,300,000 United States dollar","valid_from":"2016-09-30","valid_to":"2017-03-31","published":"2016-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 525,300,000 United States dollar\", as of 2016-09-30 (until 2017-03-31). Claim clm_33057677BB6C, https://asof.is/claim/clm_33057677BB6C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637516000255/0001156375-16-000255-index.htm.","url":"https://asof.is/claim/clm_33057677BB6C","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_30AD5627C041","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637516000255/0001156375-16-000255-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2016","published_at":"2016-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2016, filed 2016-11-04"}},{"id":"clm_47792AF70934","predicate":"total_assets","value":"63,251,300,000 United States dollar","valid_from":"2016-09-30","valid_to":"2016-12-31","published":"2016-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 63,251,300,000 United States dollar\", as of 2016-09-30 (until 2016-12-31). Claim clm_47792AF70934, https://asof.is/claim/clm_47792AF70934, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637516000255/0001156375-16-000255-index.htm.","url":"https://asof.is/claim/clm_47792AF70934","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_137FED7D9538","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637516000255/0001156375-16-000255-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2016","published_at":"2016-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2016, filed 2016-11-04"}},{"id":"clm_A5EC25D61F23","predicate":"quarterly_revenue","value":"841,700,000 United States dollar","valid_from":"2016-09-30","valid_to":"2017-03-31","published":"2016-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 841,700,000 United States dollar\", as of 2016-09-30 (until 2017-03-31). Claim clm_A5EC25D61F23, https://asof.is/claim/clm_A5EC25D61F23, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637516000255/0001156375-16-000255-index.htm.","url":"https://asof.is/claim/clm_A5EC25D61F23","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_121CF7754B3E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637516000255/0001156375-16-000255-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2016","published_at":"2016-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2016, filed 2016-11-04"}},{"id":"clm_186ECFE4FD7A","predicate":"quarterly_operating_income","value":"563,300,000 United States dollar","valid_from":"2016-06-30","valid_to":"2016-09-30","published":"2016-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 563,300,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_186ECFE4FD7A, https://asof.is/claim/clm_186ECFE4FD7A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637516000195/0001156375-16-000195-index.htm.","url":"https://asof.is/claim/clm_186ECFE4FD7A","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_33057677BB6C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637516000195/0001156375-16-000195-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2016","published_at":"2016-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2016, filed 2016-08-04"}},{"id":"clm_42610911D7A5","predicate":"total_assets","value":"67,625,600,000 United States dollar","valid_from":"2016-06-30","valid_to":"2016-09-30","published":"2016-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 67,625,600,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_42610911D7A5, https://asof.is/claim/clm_42610911D7A5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637516000195/0001156375-16-000195-index.htm.","url":"https://asof.is/claim/clm_42610911D7A5","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_47792AF70934","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637516000195/0001156375-16-000195-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2016","published_at":"2016-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2016, filed 2016-08-04"}},{"id":"clm_53254D8A9A1D","predicate":"total_equity","value":"21,073,900,000 United States dollar","valid_from":"2016-06-30","valid_to":"2016-09-30","published":"2016-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 21,073,900,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_53254D8A9A1D, https://asof.is/claim/clm_53254D8A9A1D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637516000195/0001156375-16-000195-index.htm.","url":"https://asof.is/claim/clm_53254D8A9A1D","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2CB3D081F0F0","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637516000195/0001156375-16-000195-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2016","published_at":"2016-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2016, filed 2016-08-04"}},{"id":"clm_9320F3010609","predicate":"cash_and_equivalents","value":"1,161,100,000 United States dollar","valid_from":"2016-06-30","valid_to":"2016-09-30","published":"2016-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,161,100,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_9320F3010609, https://asof.is/claim/clm_9320F3010609, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637516000195/0001156375-16-000195-index.htm.","url":"https://asof.is/claim/clm_9320F3010609","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2D5C347240E2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637516000195/0001156375-16-000195-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2016","published_at":"2016-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2016, filed 2016-08-04"}},{"id":"clm_B1959740262C","predicate":"quarterly_revenue","value":"906,400,000 United States dollar","valid_from":"2016-06-30","valid_to":"2016-09-30","published":"2016-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 906,400,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_B1959740262C, https://asof.is/claim/clm_B1959740262C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637516000195/0001156375-16-000195-index.htm.","url":"https://asof.is/claim/clm_B1959740262C","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A5EC25D61F23","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637516000195/0001156375-16-000195-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2016","published_at":"2016-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2016, filed 2016-08-04"}},{"id":"clm_024E86002FFB","predicate":"quarterly_net_income","value":"367,800,000 United States dollar","valid_from":"2016-03-31","valid_to":"2017-03-31","published":"2016-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 367,800,000 United States dollar\", as of 2016-03-31 (until 2017-03-31). Claim clm_024E86002FFB, https://asof.is/claim/clm_024E86002FFB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637516000149/0001156375-16-000149-index.htm.","url":"https://asof.is/claim/clm_024E86002FFB","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3DECC9851D65","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637516000149/0001156375-16-000149-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2016","published_at":"2016-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2016, filed 2016-05-04"}},{"id":"clm_0981A259C2CD","predicate":"quarterly_revenue","value":"934,200,000 United States dollar","valid_from":"2016-03-31","valid_to":"2016-06-30","published":"2016-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 934,200,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_0981A259C2CD, https://asof.is/claim/clm_0981A259C2CD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637516000149/0001156375-16-000149-index.htm.","url":"https://asof.is/claim/clm_0981A259C2CD","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B1959740262C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637516000149/0001156375-16-000149-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2016","published_at":"2016-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2016, filed 2016-05-04"}},{"id":"clm_3673FCB5A28E","predicate":"cash_and_equivalents","value":"1,146,000,000 United States dollar","valid_from":"2016-03-31","valid_to":"2016-06-30","published":"2016-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,146,000,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_3673FCB5A28E, https://asof.is/claim/clm_3673FCB5A28E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637516000149/0001156375-16-000149-index.htm.","url":"https://asof.is/claim/clm_3673FCB5A28E","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9320F3010609","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637516000149/0001156375-16-000149-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2016","published_at":"2016-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2016, filed 2016-05-04"}},{"id":"clm_43D502C73DE6","predicate":"quarterly_operating_income","value":"573,900,000 United States dollar","valid_from":"2016-03-31","valid_to":"2016-06-30","published":"2016-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 573,900,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_43D502C73DE6, https://asof.is/claim/clm_43D502C73DE6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637516000149/0001156375-16-000149-index.htm.","url":"https://asof.is/claim/clm_43D502C73DE6","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_186ECFE4FD7A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637516000149/0001156375-16-000149-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2016","published_at":"2016-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2016, filed 2016-05-04"}},{"id":"clm_449CFEF58900","predicate":"total_assets","value":"68,768,200,000 United States dollar","valid_from":"2016-03-31","valid_to":"2016-06-30","published":"2016-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 68,768,200,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_449CFEF58900, https://asof.is/claim/clm_449CFEF58900, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637516000149/0001156375-16-000149-index.htm.","url":"https://asof.is/claim/clm_449CFEF58900","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_42610911D7A5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637516000149/0001156375-16-000149-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2016","published_at":"2016-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2016, filed 2016-05-04"}},{"id":"clm_DA4964D0245D","predicate":"total_equity","value":"20,841,400,000 United States dollar","valid_from":"2016-03-31","valid_to":"2016-06-30","published":"2016-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 20,841,400,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_DA4964D0245D, https://asof.is/claim/clm_DA4964D0245D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637516000149/0001156375-16-000149-index.htm.","url":"https://asof.is/claim/clm_DA4964D0245D","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_53254D8A9A1D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637516000149/0001156375-16-000149-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2016","published_at":"2016-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2016, filed 2016-05-04"}},{"id":"clm_106630CCE2DB","predicate":"operating_income","value":"1,988,700,000 United States dollar","valid_from":"2015-12-31","valid_to":"2016-12-31","published":"2016-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group operating income: 1,988,700,000 United States dollar\", as of 2015-12-31 (until 2016-12-31). Claim clm_106630CCE2DB, https://asof.is/claim/clm_106630CCE2DB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637516000116/0001156375-16-000116-index.htm.","url":"https://asof.is/claim/clm_106630CCE2DB","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BED3C37CC862","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637516000116/0001156375-16-000116-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2015","published_at":"2016-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2015, filed 2016-02-26"}},{"id":"clm_2119E20D960B","predicate":"cash_and_equivalents","value":"1,692,600,000 United States dollar","valid_from":"2015-12-31","valid_to":"2016-03-31","published":"2016-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,692,600,000 United States dollar\", as of 2015-12-31 (until 2016-03-31). Claim clm_2119E20D960B, https://asof.is/claim/clm_2119E20D960B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637516000116/0001156375-16-000116-index.htm.","url":"https://asof.is/claim/clm_2119E20D960B","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3673FCB5A28E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637516000116/0001156375-16-000116-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2015","published_at":"2016-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2015, filed 2016-02-26"}},{"id":"clm_672F846DCC5F","predicate":"total_assets","value":"67,371,500,000 United States dollar","valid_from":"2015-12-31","valid_to":"2016-03-31","published":"2016-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 67,371,500,000 United States dollar\", as of 2015-12-31 (until 2016-03-31). Claim clm_672F846DCC5F, https://asof.is/claim/clm_672F846DCC5F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637516000116/0001156375-16-000116-index.htm.","url":"https://asof.is/claim/clm_672F846DCC5F","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_449CFEF58900","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637516000116/0001156375-16-000116-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2015","published_at":"2016-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2015, filed 2016-02-26"}},{"id":"clm_68FAEF4B9F46","predicate":"net_income","value":"1,247,000,000 United States dollar","valid_from":"2015-12-31","valid_to":"2016-12-31","published":"2016-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group net income: 1,247,000,000 United States dollar\", as of 2015-12-31 (until 2016-12-31). Claim clm_68FAEF4B9F46, https://asof.is/claim/clm_68FAEF4B9F46, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637516000116/0001156375-16-000116-index.htm.","url":"https://asof.is/claim/clm_68FAEF4B9F46","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4A734BEFF144","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637516000116/0001156375-16-000116-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2015","published_at":"2016-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2015, filed 2016-02-26"}},{"id":"clm_81137E11AAFB","predicate":"total_equity","value":"20,551,800,000 United States dollar","valid_from":"2015-12-31","valid_to":"2016-03-31","published":"2016-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 20,551,800,000 United States dollar\", as of 2015-12-31 (until 2016-03-31). Claim clm_81137E11AAFB, https://asof.is/claim/clm_81137E11AAFB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637516000116/0001156375-16-000116-index.htm.","url":"https://asof.is/claim/clm_81137E11AAFB","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_DA4964D0245D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637516000116/0001156375-16-000116-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2015","published_at":"2016-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2015, filed 2016-02-26"}},{"id":"clm_B23FE9CD92F3","predicate":"revenue","value":"3,326,800,000 United States dollar","valid_from":"2015-12-31","valid_to":"2016-12-31","published":"2016-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group revenue: 3,326,800,000 United States dollar\", as of 2015-12-31 (until 2016-12-31). Claim clm_B23FE9CD92F3, https://asof.is/claim/clm_B23FE9CD92F3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637516000116/0001156375-16-000116-index.htm.","url":"https://asof.is/claim/clm_B23FE9CD92F3","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8BB832EC1BB4","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637516000116/0001156375-16-000116-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2015","published_at":"2016-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2015, filed 2016-02-26"}},{"id":"clm_1B580A701BEE","predicate":"cash_and_equivalents","value":"1,434,300,000 United States dollar","valid_from":"2015-09-30","valid_to":"2015-12-31","published":"2015-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,434,300,000 United States dollar\", as of 2015-09-30 (until 2015-12-31). Claim clm_1B580A701BEE, https://asof.is/claim/clm_1B580A701BEE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637515000108/0001156375-15-000108-index.htm.","url":"https://asof.is/claim/clm_1B580A701BEE","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2119E20D960B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637515000108/0001156375-15-000108-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2015","published_at":"2015-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2015, filed 2015-11-06"}},{"id":"clm_331225FFA3C4","predicate":"quarterly_net_income","value":"359,900,000 United States dollar","valid_from":"2015-09-30","valid_to":"2016-03-31","published":"2015-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 359,900,000 United States dollar\", as of 2015-09-30 (until 2016-03-31). Claim clm_331225FFA3C4, https://asof.is/claim/clm_331225FFA3C4, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637515000108/0001156375-15-000108-index.htm.","url":"https://asof.is/claim/clm_331225FFA3C4","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_024E86002FFB","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637515000108/0001156375-15-000108-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2015","published_at":"2015-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2015, filed 2015-11-06"}},{"id":"clm_6ACC12978A65","predicate":"total_equity","value":"21,376,800,000 United States dollar","valid_from":"2015-09-30","valid_to":"2015-12-31","published":"2015-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 21,376,800,000 United States dollar\", as of 2015-09-30 (until 2015-12-31). Claim clm_6ACC12978A65, https://asof.is/claim/clm_6ACC12978A65, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637515000108/0001156375-15-000108-index.htm.","url":"https://asof.is/claim/clm_6ACC12978A65","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_81137E11AAFB","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637515000108/0001156375-15-000108-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2015","published_at":"2015-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2015, filed 2015-11-06"}},{"id":"clm_764638876A9B","predicate":"quarterly_operating_income","value":"516,400,000 United States dollar","valid_from":"2015-09-30","valid_to":"2016-03-31","published":"2015-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 516,400,000 United States dollar\", as of 2015-09-30 (until 2016-03-31). Claim clm_764638876A9B, https://asof.is/claim/clm_764638876A9B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637515000108/0001156375-15-000108-index.htm.","url":"https://asof.is/claim/clm_764638876A9B","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_43D502C73DE6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637515000108/0001156375-15-000108-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2015","published_at":"2015-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2015, filed 2015-11-06"}},{"id":"clm_7DCB98AFE8E8","predicate":"total_assets","value":"80,949,600,000 United States dollar","valid_from":"2015-09-30","valid_to":"2015-12-31","published":"2015-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 80,949,600,000 United States dollar\", as of 2015-09-30 (until 2015-12-31). Claim clm_7DCB98AFE8E8, https://asof.is/claim/clm_7DCB98AFE8E8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637515000108/0001156375-15-000108-index.htm.","url":"https://asof.is/claim/clm_7DCB98AFE8E8","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_672F846DCC5F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637515000108/0001156375-15-000108-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2015","published_at":"2015-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2015, filed 2015-11-06"}},{"id":"clm_905BE2E7A5AC","predicate":"quarterly_revenue","value":"850,300,000 United States dollar","valid_from":"2015-09-30","valid_to":"2016-03-31","published":"2015-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 850,300,000 United States dollar\", as of 2015-09-30 (until 2016-03-31). Claim clm_905BE2E7A5AC, https://asof.is/claim/clm_905BE2E7A5AC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637515000108/0001156375-15-000108-index.htm.","url":"https://asof.is/claim/clm_905BE2E7A5AC","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0981A259C2CD","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637515000108/0001156375-15-000108-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2015","published_at":"2015-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2015, filed 2015-11-06"}},{"id":"clm_18742CEA50E6","predicate":"quarterly_revenue","value":"820,000,000 United States dollar","valid_from":"2015-06-30","valid_to":"2015-09-30","published":"2015-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 820,000,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_18742CEA50E6, https://asof.is/claim/clm_18742CEA50E6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637515000067/0001156375-15-000067-index.htm.","url":"https://asof.is/claim/clm_18742CEA50E6","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_905BE2E7A5AC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637515000067/0001156375-15-000067-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2015","published_at":"2015-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2015, filed 2015-08-05"}},{"id":"clm_190DBEC98B96","predicate":"quarterly_net_income","value":"265,000,000 United States dollar","valid_from":"2015-06-30","valid_to":"2015-09-30","published":"2015-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 265,000,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_190DBEC98B96, https://asof.is/claim/clm_190DBEC98B96, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637515000067/0001156375-15-000067-index.htm.","url":"https://asof.is/claim/clm_190DBEC98B96","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_331225FFA3C4","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637515000067/0001156375-15-000067-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2015","published_at":"2015-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2015, filed 2015-08-05"}},{"id":"clm_55A174C79A7F","predicate":"quarterly_operating_income","value":"495,100,000 United States dollar","valid_from":"2015-06-30","valid_to":"2015-09-30","published":"2015-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 495,100,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_55A174C79A7F, https://asof.is/claim/clm_55A174C79A7F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637515000067/0001156375-15-000067-index.htm.","url":"https://asof.is/claim/clm_55A174C79A7F","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_764638876A9B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637515000067/0001156375-15-000067-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2015","published_at":"2015-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2015, filed 2015-08-05"}},{"id":"clm_608B8FD4BE59","predicate":"cash_and_equivalents","value":"1,151,000,000 United States dollar","valid_from":"2015-06-30","valid_to":"2015-09-30","published":"2015-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,151,000,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_608B8FD4BE59, https://asof.is/claim/clm_608B8FD4BE59, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637515000067/0001156375-15-000067-index.htm.","url":"https://asof.is/claim/clm_608B8FD4BE59","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1B580A701BEE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637515000067/0001156375-15-000067-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2015","published_at":"2015-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2015, filed 2015-08-05"}},{"id":"clm_71454FCD9398","predicate":"total_assets","value":"73,663,100,000 United States dollar","valid_from":"2015-06-30","valid_to":"2015-09-30","published":"2015-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 73,663,100,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_71454FCD9398, https://asof.is/claim/clm_71454FCD9398, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637515000067/0001156375-15-000067-index.htm.","url":"https://asof.is/claim/clm_71454FCD9398","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7DCB98AFE8E8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637515000067/0001156375-15-000067-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2015","published_at":"2015-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2015, filed 2015-08-05"}},{"id":"clm_ABC7A2453A13","predicate":"total_equity","value":"21,258,800,000 United States dollar","valid_from":"2015-06-30","valid_to":"2015-09-30","published":"2015-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 21,258,800,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_ABC7A2453A13, https://asof.is/claim/clm_ABC7A2453A13, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637515000067/0001156375-15-000067-index.htm.","url":"https://asof.is/claim/clm_ABC7A2453A13","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6ACC12978A65","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637515000067/0001156375-15-000067-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2015","published_at":"2015-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2015, filed 2015-08-05"}},{"id":"clm_17B513D3F0E1","predicate":"cash_and_equivalents","value":"1,694,800,000 United States dollar","valid_from":"2015-03-31","valid_to":"2015-06-30","published":"2015-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,694,800,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_17B513D3F0E1, https://asof.is/claim/clm_17B513D3F0E1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637515000046/0001156375-15-000046-index.htm.","url":"https://asof.is/claim/clm_17B513D3F0E1","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_608B8FD4BE59","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637515000046/0001156375-15-000046-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2015","published_at":"2015-05-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2015, filed 2015-05-06"}},{"id":"clm_473FFF1AA95D","predicate":"quarterly_operating_income","value":"507,300,000 United States dollar","valid_from":"2015-03-31","valid_to":"2015-06-30","published":"2015-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 507,300,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_473FFF1AA95D, https://asof.is/claim/clm_473FFF1AA95D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637515000046/0001156375-15-000046-index.htm.","url":"https://asof.is/claim/clm_473FFF1AA95D","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_55A174C79A7F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637515000046/0001156375-15-000046-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2015","published_at":"2015-05-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2015, filed 2015-05-06"}},{"id":"clm_74BC833990DA","predicate":"total_assets","value":"77,128,400,000 United States dollar","valid_from":"2015-03-31","valid_to":"2015-06-30","published":"2015-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 77,128,400,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_74BC833990DA, https://asof.is/claim/clm_74BC833990DA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637515000046/0001156375-15-000046-index.htm.","url":"https://asof.is/claim/clm_74BC833990DA","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_71454FCD9398","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637515000046/0001156375-15-000046-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2015","published_at":"2015-05-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2015, filed 2015-05-06"}},{"id":"clm_851B5A839B74","predicate":"quarterly_net_income","value":"330,400,000 United States dollar","valid_from":"2015-03-31","valid_to":"2015-06-30","published":"2015-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 330,400,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_851B5A839B74, https://asof.is/claim/clm_851B5A839B74, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637515000046/0001156375-15-000046-index.htm.","url":"https://asof.is/claim/clm_851B5A839B74","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_190DBEC98B96","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637515000046/0001156375-15-000046-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2015","published_at":"2015-05-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2015, filed 2015-05-06"}},{"id":"clm_9DDFF9523CDA","predicate":"quarterly_revenue","value":"842,700,000 United States dollar","valid_from":"2015-03-31","valid_to":"2015-06-30","published":"2015-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 842,700,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_9DDFF9523CDA, https://asof.is/claim/clm_9DDFF9523CDA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637515000046/0001156375-15-000046-index.htm.","url":"https://asof.is/claim/clm_9DDFF9523CDA","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_18742CEA50E6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637515000046/0001156375-15-000046-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2015","published_at":"2015-05-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2015, filed 2015-05-06"}},{"id":"clm_A70B5A4F228A","predicate":"total_equity","value":"21,095,500,000 United States dollar","valid_from":"2015-03-31","valid_to":"2015-06-30","published":"2015-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 21,095,500,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_A70B5A4F228A, https://asof.is/claim/clm_A70B5A4F228A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637515000046/0001156375-15-000046-index.htm.","url":"https://asof.is/claim/clm_A70B5A4F228A","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_ABC7A2453A13","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637515000046/0001156375-15-000046-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2015","published_at":"2015-05-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2015, filed 2015-05-06"}},{"id":"clm_06889F09605E","predicate":"total_assets","value":"72,241,500,000 United States dollar","valid_from":"2014-12-31","valid_to":"2015-03-31","published":"2015-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 72,241,500,000 United States dollar\", as of 2014-12-31 (until 2015-03-31). Claim clm_06889F09605E, https://asof.is/claim/clm_06889F09605E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637515000014/0001156375-15-000014-index.htm.","url":"https://asof.is/claim/clm_06889F09605E","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_74BC833990DA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637515000014/0001156375-15-000014-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2014","published_at":"2015-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2014, filed 2015-02-26"}},{"id":"clm_18A2EB46EC0A","predicate":"revenue","value":"3,112,500,000 United States dollar","valid_from":"2014-12-31","valid_to":"2015-12-31","published":"2015-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group revenue: 3,112,500,000 United States dollar\", as of 2014-12-31 (until 2015-12-31). Claim clm_18A2EB46EC0A, https://asof.is/claim/clm_18A2EB46EC0A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637515000014/0001156375-15-000014-index.htm.","url":"https://asof.is/claim/clm_18A2EB46EC0A","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B23FE9CD92F3","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637515000014/0001156375-15-000014-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2014","published_at":"2015-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2014, filed 2015-02-26"}},{"id":"clm_1BADCBBC4B30","predicate":"operating_income","value":"1,768,400,000 United States dollar","valid_from":"2014-12-31","valid_to":"2015-12-31","published":"2015-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group operating income: 1,768,400,000 United States dollar\", as of 2014-12-31 (until 2015-12-31). Claim clm_1BADCBBC4B30, https://asof.is/claim/clm_1BADCBBC4B30, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637515000014/0001156375-15-000014-index.htm.","url":"https://asof.is/claim/clm_1BADCBBC4B30","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_106630CCE2DB","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637515000014/0001156375-15-000014-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2014","published_at":"2015-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2014, filed 2015-02-26"}},{"id":"clm_AB3AF765BD4E","predicate":"cash_and_equivalents","value":"1,366,100,000 United States dollar","valid_from":"2014-12-31","valid_to":"2015-03-31","published":"2015-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,366,100,000 United States dollar\", as of 2014-12-31 (until 2015-03-31). Claim clm_AB3AF765BD4E, https://asof.is/claim/clm_AB3AF765BD4E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637515000014/0001156375-15-000014-index.htm.","url":"https://asof.is/claim/clm_AB3AF765BD4E","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_17B513D3F0E1","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637515000014/0001156375-15-000014-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2014","published_at":"2015-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2014, filed 2015-02-26"}},{"id":"clm_CA2A395ABAEF","predicate":"net_income","value":"1,127,100,000 United States dollar","valid_from":"2014-12-31","valid_to":"2015-12-31","published":"2015-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group net income: 1,127,100,000 United States dollar\", as of 2014-12-31 (until 2015-12-31). Claim clm_CA2A395ABAEF, https://asof.is/claim/clm_CA2A395ABAEF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637515000014/0001156375-15-000014-index.htm.","url":"https://asof.is/claim/clm_CA2A395ABAEF","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_68FAEF4B9F46","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637515000014/0001156375-15-000014-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2014","published_at":"2015-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2014, filed 2015-02-26"}},{"id":"clm_F7A710AD9933","predicate":"total_equity","value":"20,923,500,000 United States dollar","valid_from":"2014-12-31","valid_to":"2015-03-31","published":"2015-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 20,923,500,000 United States dollar\", as of 2014-12-31 (until 2015-03-31). Claim clm_F7A710AD9933, https://asof.is/claim/clm_F7A710AD9933, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637515000014/0001156375-15-000014-index.htm.","url":"https://asof.is/claim/clm_F7A710AD9933","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A70B5A4F228A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637515000014/0001156375-15-000014-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2014","published_at":"2015-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2014, filed 2015-02-26"}},{"id":"clm_2062CE903B74","predicate":"quarterly_net_income","value":"290,000,000 United States dollar","valid_from":"2014-09-30","valid_to":"2015-03-31","published":"2014-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 290,000,000 United States dollar\", as of 2014-09-30 (until 2015-03-31). Claim clm_2062CE903B74, https://asof.is/claim/clm_2062CE903B74, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637514000132/0001156375-14-000132-index.htm.","url":"https://asof.is/claim/clm_2062CE903B74","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_851B5A839B74","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637514000132/0001156375-14-000132-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2014","published_at":"2014-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2014, filed 2014-11-03"}},{"id":"clm_379514471C38","predicate":"quarterly_operating_income","value":"430,400,000 United States dollar","valid_from":"2014-09-30","valid_to":"2015-03-31","published":"2014-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 430,400,000 United States dollar\", as of 2014-09-30 (until 2015-03-31). Claim clm_379514471C38, https://asof.is/claim/clm_379514471C38, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637514000132/0001156375-14-000132-index.htm.","url":"https://asof.is/claim/clm_379514471C38","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_473FFF1AA95D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637514000132/0001156375-14-000132-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2014","published_at":"2014-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2014, filed 2014-11-03"}},{"id":"clm_7F278ECEEBD2","predicate":"total_equity","value":"21,537,100,000 United States dollar","valid_from":"2014-09-30","valid_to":"2014-12-31","published":"2014-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 21,537,100,000 United States dollar\", as of 2014-09-30 (until 2014-12-31). Claim clm_7F278ECEEBD2, https://asof.is/claim/clm_7F278ECEEBD2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637514000132/0001156375-14-000132-index.htm.","url":"https://asof.is/claim/clm_7F278ECEEBD2","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F7A710AD9933","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637514000132/0001156375-14-000132-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2014","published_at":"2014-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2014, filed 2014-11-03"}},{"id":"clm_A8EAA5B37F3F","predicate":"cash_and_equivalents","value":"1,087,900,000 United States dollar","valid_from":"2014-09-30","valid_to":"2014-12-31","published":"2014-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,087,900,000 United States dollar\", as of 2014-09-30 (until 2014-12-31). Claim clm_A8EAA5B37F3F, https://asof.is/claim/clm_A8EAA5B37F3F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637514000132/0001156375-14-000132-index.htm.","url":"https://asof.is/claim/clm_A8EAA5B37F3F","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_AB3AF765BD4E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637514000132/0001156375-14-000132-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2014","published_at":"2014-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2014, filed 2014-11-03"}},{"id":"clm_D9DDE95D694B","predicate":"total_assets","value":"63,970,300,000 United States dollar","valid_from":"2014-09-30","valid_to":"2014-12-31","published":"2014-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 63,970,300,000 United States dollar\", as of 2014-09-30 (until 2014-12-31). Claim clm_D9DDE95D694B, https://asof.is/claim/clm_D9DDE95D694B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637514000132/0001156375-14-000132-index.htm.","url":"https://asof.is/claim/clm_D9DDE95D694B","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_06889F09605E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637514000132/0001156375-14-000132-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2014","published_at":"2014-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2014, filed 2014-11-03"}},{"id":"clm_DC1999237C57","predicate":"quarterly_revenue","value":"762,400,000 United States dollar","valid_from":"2014-09-30","valid_to":"2015-03-31","published":"2014-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 762,400,000 United States dollar\", as of 2014-09-30 (until 2015-03-31). Claim clm_DC1999237C57, https://asof.is/claim/clm_DC1999237C57, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637514000132/0001156375-14-000132-index.htm.","url":"https://asof.is/claim/clm_DC1999237C57","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9DDFF9523CDA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637514000132/0001156375-14-000132-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2014","published_at":"2014-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2014, filed 2014-11-03"}},{"id":"clm_0344254AC1D3","predicate":"total_assets","value":"51,611,300,000 United States dollar","valid_from":"2014-06-30","valid_to":"2014-09-30","published":"2014-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 51,611,300,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_0344254AC1D3, https://asof.is/claim/clm_0344254AC1D3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637514000073/0001156375-14-000073-index.htm.","url":"https://asof.is/claim/clm_0344254AC1D3","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D9DDE95D694B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637514000073/0001156375-14-000073-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2014","published_at":"2014-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2014, filed 2014-08-04"}},{"id":"clm_08DDFC024A92","predicate":"cash_and_equivalents","value":"1,037,300,000 United States dollar","valid_from":"2014-06-30","valid_to":"2014-09-30","published":"2014-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,037,300,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_08DDFC024A92, https://asof.is/claim/clm_08DDFC024A92, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637514000073/0001156375-14-000073-index.htm.","url":"https://asof.is/claim/clm_08DDFC024A92","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A8EAA5B37F3F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637514000073/0001156375-14-000073-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2014","published_at":"2014-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2014, filed 2014-08-04"}},{"id":"clm_18FA8B8F9B34","predicate":"total_equity","value":"21,465,400,000 United States dollar","valid_from":"2014-06-30","valid_to":"2014-09-30","published":"2014-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 21,465,400,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_18FA8B8F9B34, https://asof.is/claim/clm_18FA8B8F9B34, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637514000073/0001156375-14-000073-index.htm.","url":"https://asof.is/claim/clm_18FA8B8F9B34","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7F278ECEEBD2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637514000073/0001156375-14-000073-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2014","published_at":"2014-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2014, filed 2014-08-04"}},{"id":"clm_30BE4E0E7BEE","predicate":"quarterly_revenue","value":"731,600,000 United States dollar","valid_from":"2014-06-30","valid_to":"2014-09-30","published":"2014-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 731,600,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_30BE4E0E7BEE, https://asof.is/claim/clm_30BE4E0E7BEE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637514000073/0001156375-14-000073-index.htm.","url":"https://asof.is/claim/clm_30BE4E0E7BEE","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_DC1999237C57","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637514000073/0001156375-14-000073-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2014","published_at":"2014-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2014, filed 2014-08-04"}},{"id":"clm_9DC2CD56CEAC","predicate":"quarterly_net_income","value":"263,800,000 United States dollar","valid_from":"2014-06-30","valid_to":"2014-09-30","published":"2014-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 263,800,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_9DC2CD56CEAC, https://asof.is/claim/clm_9DC2CD56CEAC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637514000073/0001156375-14-000073-index.htm.","url":"https://asof.is/claim/clm_9DC2CD56CEAC","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2062CE903B74","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637514000073/0001156375-14-000073-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2014","published_at":"2014-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2014, filed 2014-08-04"}},{"id":"clm_E9D3AA332B80","predicate":"quarterly_operating_income","value":"412,000,000 United States dollar","valid_from":"2014-06-30","valid_to":"2014-09-30","published":"2014-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 412,000,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_E9D3AA332B80, https://asof.is/claim/clm_E9D3AA332B80, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637514000073/0001156375-14-000073-index.htm.","url":"https://asof.is/claim/clm_E9D3AA332B80","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_379514471C38","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637514000073/0001156375-14-000073-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2014","published_at":"2014-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2014, filed 2014-08-04"}},{"id":"clm_01FF4AA18C88","predicate":"quarterly_operating_income","value":"454,500,000 United States dollar","valid_from":"2014-03-31","valid_to":"2014-06-30","published":"2014-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 454,500,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_01FF4AA18C88, https://asof.is/claim/clm_01FF4AA18C88, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637514000031/0001156375-14-000031-index.htm.","url":"https://asof.is/claim/clm_01FF4AA18C88","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E9D3AA332B80","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637514000031/0001156375-14-000031-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2014","published_at":"2014-05-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2014, filed 2014-05-07"}},{"id":"clm_0257482C941E","predicate":"quarterly_revenue","value":"777,400,000 United States dollar","valid_from":"2014-03-31","valid_to":"2014-06-30","published":"2014-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 777,400,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_0257482C941E, https://asof.is/claim/clm_0257482C941E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637514000031/0001156375-14-000031-index.htm.","url":"https://asof.is/claim/clm_0257482C941E","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_30BE4E0E7BEE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637514000031/0001156375-14-000031-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2014","published_at":"2014-05-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2014, filed 2014-05-07"}},{"id":"clm_1DD795E7222C","predicate":"total_equity","value":"21,304,600,000 United States dollar","valid_from":"2014-03-31","valid_to":"2014-06-30","published":"2014-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 21,304,600,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_1DD795E7222C, https://asof.is/claim/clm_1DD795E7222C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637514000031/0001156375-14-000031-index.htm.","url":"https://asof.is/claim/clm_1DD795E7222C","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_18FA8B8F9B34","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637514000031/0001156375-14-000031-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2014","published_at":"2014-05-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2014, filed 2014-05-07"}},{"id":"clm_7E566101A570","predicate":"cash_and_equivalents","value":"1,053,700,000 United States dollar","valid_from":"2014-03-31","valid_to":"2014-06-30","published":"2014-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,053,700,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_7E566101A570, https://asof.is/claim/clm_7E566101A570, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637514000031/0001156375-14-000031-index.htm.","url":"https://asof.is/claim/clm_7E566101A570","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_08DDFC024A92","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637514000031/0001156375-14-000031-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2014","published_at":"2014-05-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2014, filed 2014-05-07"}},{"id":"clm_839BDA06A1F5","predicate":"total_assets","value":"53,167,100,000 United States dollar","valid_from":"2014-03-31","valid_to":"2014-06-30","published":"2014-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 53,167,100,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_839BDA06A1F5, https://asof.is/claim/clm_839BDA06A1F5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637514000031/0001156375-14-000031-index.htm.","url":"https://asof.is/claim/clm_839BDA06A1F5","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0344254AC1D3","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637514000031/0001156375-14-000031-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2014","published_at":"2014-05-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2014, filed 2014-05-07"}},{"id":"clm_A1CD96CF426C","predicate":"quarterly_net_income","value":"266,800,000 United States dollar","valid_from":"2014-03-31","valid_to":"2014-06-30","published":"2014-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 266,800,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_A1CD96CF426C, https://asof.is/claim/clm_A1CD96CF426C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637514000031/0001156375-14-000031-index.htm.","url":"https://asof.is/claim/clm_A1CD96CF426C","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9DC2CD56CEAC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637514000031/0001156375-14-000031-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2014","published_at":"2014-05-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2014, filed 2014-05-07"}},{"id":"clm_00DE0BA9A87F","predicate":"total_equity","value":"21,154,800,000 United States dollar","valid_from":"2013-12-31","valid_to":"2014-03-31","published":"2014-03-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 21,154,800,000 United States dollar\", as of 2013-12-31 (until 2014-03-31). Claim clm_00DE0BA9A87F, https://asof.is/claim/clm_00DE0BA9A87F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637514000012/0001156375-14-000012-index.htm.","url":"https://asof.is/claim/clm_00DE0BA9A87F","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1DD795E7222C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637514000012/0001156375-14-000012-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2013","published_at":"2014-03-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2013, filed 2014-03-03"}},{"id":"clm_25762015D272","predicate":"operating_income","value":"1,637,000,000 United States dollar","valid_from":"2013-12-31","valid_to":"2014-12-31","published":"2014-03-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group operating income: 1,637,000,000 United States dollar\", as of 2013-12-31 (until 2014-12-31). Claim clm_25762015D272, https://asof.is/claim/clm_25762015D272, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637514000012/0001156375-14-000012-index.htm.","url":"https://asof.is/claim/clm_25762015D272","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1BADCBBC4B30","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637514000012/0001156375-14-000012-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2013","published_at":"2014-03-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2013, filed 2014-03-03"}},{"id":"clm_3A98C9DDA6B0","predicate":"revenue","value":"2,936,300,000 United States dollar","valid_from":"2013-12-31","valid_to":"2014-12-31","published":"2014-03-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group revenue: 2,936,300,000 United States dollar\", as of 2013-12-31 (until 2014-12-31). Claim clm_3A98C9DDA6B0, https://asof.is/claim/clm_3A98C9DDA6B0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637514000012/0001156375-14-000012-index.htm.","url":"https://asof.is/claim/clm_3A98C9DDA6B0","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_18A2EB46EC0A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637514000012/0001156375-14-000012-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2013","published_at":"2014-03-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2013, filed 2014-03-03"}},{"id":"clm_893DB1DB318C","predicate":"cash_and_equivalents","value":"2,469,700,000 United States dollar","valid_from":"2013-12-31","valid_to":"2014-03-31","published":"2014-03-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 2,469,700,000 United States dollar\", as of 2013-12-31 (until 2014-03-31). Claim clm_893DB1DB318C, https://asof.is/claim/clm_893DB1DB318C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637514000012/0001156375-14-000012-index.htm.","url":"https://asof.is/claim/clm_893DB1DB318C","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7E566101A570","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637514000012/0001156375-14-000012-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2013","published_at":"2014-03-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2013, filed 2014-03-03"}},{"id":"clm_A309E24B9001","predicate":"total_assets","value":"54,277,800,000 United States dollar","valid_from":"2013-12-31","valid_to":"2014-03-31","published":"2014-03-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 54,277,800,000 United States dollar\", as of 2013-12-31 (until 2014-03-31). Claim clm_A309E24B9001, https://asof.is/claim/clm_A309E24B9001, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637514000012/0001156375-14-000012-index.htm.","url":"https://asof.is/claim/clm_A309E24B9001","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_839BDA06A1F5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637514000012/0001156375-14-000012-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2013","published_at":"2014-03-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2013, filed 2014-03-03"}},{"id":"clm_FF6D66FDB123","predicate":"net_income","value":"976,800,000 United States dollar","valid_from":"2013-12-31","valid_to":"2014-12-31","published":"2014-03-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group net income: 976,800,000 United States dollar\", as of 2013-12-31 (until 2014-12-31). Claim clm_FF6D66FDB123, https://asof.is/claim/clm_FF6D66FDB123, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637514000012/0001156375-14-000012-index.htm.","url":"https://asof.is/claim/clm_FF6D66FDB123","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_CA2A395ABAEF","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637514000012/0001156375-14-000012-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2013","published_at":"2014-03-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2013, filed 2014-03-03"}},{"id":"clm_016E49A61C76","predicate":"quarterly_net_income","value":"236,700,000 United States dollar","valid_from":"2013-09-30","valid_to":"2014-03-31","published":"2013-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 236,700,000 United States dollar\", as of 2013-09-30 (until 2014-03-31). Claim clm_016E49A61C76, https://asof.is/claim/clm_016E49A61C76, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637513000140/0001156375-13-000140-index.htm.","url":"https://asof.is/claim/clm_016E49A61C76","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A1CD96CF426C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637513000140/0001156375-13-000140-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2013","published_at":"2013-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2013, filed 2013-11-08"}},{"id":"clm_0415C314B384","predicate":"quarterly_revenue","value":"714,600,000 United States dollar","valid_from":"2013-09-30","valid_to":"2014-03-31","published":"2013-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 714,600,000 United States dollar\", as of 2013-09-30 (until 2014-03-31). Claim clm_0415C314B384, https://asof.is/claim/clm_0415C314B384, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637513000140/0001156375-13-000140-index.htm.","url":"https://asof.is/claim/clm_0415C314B384","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0257482C941E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637513000140/0001156375-13-000140-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2013","published_at":"2013-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2013, filed 2013-11-08"}},{"id":"clm_52A824D14E4F","predicate":"total_equity","value":"21,972,300,000 United States dollar","valid_from":"2013-09-30","valid_to":"2013-12-31","published":"2013-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 21,972,300,000 United States dollar\", as of 2013-09-30 (until 2013-12-31). Claim clm_52A824D14E4F, https://asof.is/claim/clm_52A824D14E4F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637513000140/0001156375-13-000140-index.htm.","url":"https://asof.is/claim/clm_52A824D14E4F","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_00DE0BA9A87F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637513000140/0001156375-13-000140-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2013","published_at":"2013-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2013, filed 2013-11-08"}},{"id":"clm_5387A51E854A","predicate":"cash_and_equivalents","value":"2,065,000,000 United States dollar","valid_from":"2013-09-30","valid_to":"2013-12-31","published":"2013-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 2,065,000,000 United States dollar\", as of 2013-09-30 (until 2013-12-31). Claim clm_5387A51E854A, https://asof.is/claim/clm_5387A51E854A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637513000140/0001156375-13-000140-index.htm.","url":"https://asof.is/claim/clm_5387A51E854A","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_893DB1DB318C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637513000140/0001156375-13-000140-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2013","published_at":"2013-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2013, filed 2013-11-08"}},{"id":"clm_5E24AC717CE6","predicate":"quarterly_operating_income","value":"400,500,000 United States dollar","valid_from":"2013-09-30","valid_to":"2014-03-31","published":"2013-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 400,500,000 United States dollar\", as of 2013-09-30 (until 2014-03-31). Claim clm_5E24AC717CE6, https://asof.is/claim/clm_5E24AC717CE6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637513000140/0001156375-13-000140-index.htm.","url":"https://asof.is/claim/clm_5E24AC717CE6","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_01FF4AA18C88","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637513000140/0001156375-13-000140-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2013","published_at":"2013-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2013, filed 2013-11-08"}},{"id":"clm_B585B5FD49A4","predicate":"total_assets","value":"48,979,900,000 United States dollar","valid_from":"2013-09-30","valid_to":"2013-12-31","published":"2013-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 48,979,900,000 United States dollar\", as of 2013-09-30 (until 2013-12-31). Claim clm_B585B5FD49A4, https://asof.is/claim/clm_B585B5FD49A4, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637513000140/0001156375-13-000140-index.htm.","url":"https://asof.is/claim/clm_B585B5FD49A4","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A309E24B9001","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637513000140/0001156375-13-000140-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2013","published_at":"2013-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2013, filed 2013-11-08"}},{"id":"clm_63D16975BDB7","predicate":"quarterly_operating_income","value":"507,800,000 United States dollar","valid_from":"2013-06-30","valid_to":"2013-09-30","published":"2013-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 507,800,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_63D16975BDB7, https://asof.is/claim/clm_63D16975BDB7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637513000107/0001156375-13-000107-index.htm.","url":"https://asof.is/claim/clm_63D16975BDB7","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5E24AC717CE6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637513000107/0001156375-13-000107-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2013","published_at":"2013-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2013, filed 2013-08-08"}},{"id":"clm_B7A4CA202956","predicate":"cash_and_equivalents","value":"1,968,000,000 United States dollar","valid_from":"2013-06-30","valid_to":"2013-09-30","published":"2013-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,968,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_B7A4CA202956, https://asof.is/claim/clm_B7A4CA202956, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637513000107/0001156375-13-000107-index.htm.","url":"https://asof.is/claim/clm_B7A4CA202956","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5387A51E854A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637513000107/0001156375-13-000107-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2013","published_at":"2013-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2013, filed 2013-08-08"}},{"id":"clm_BF9FB2ED4520","predicate":"quarterly_revenue","value":"816,100,000 United States dollar","valid_from":"2013-06-30","valid_to":"2013-09-30","published":"2013-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 816,100,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_BF9FB2ED4520, https://asof.is/claim/clm_BF9FB2ED4520, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637513000107/0001156375-13-000107-index.htm.","url":"https://asof.is/claim/clm_BF9FB2ED4520","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0415C314B384","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637513000107/0001156375-13-000107-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2013","published_at":"2013-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2013, filed 2013-08-08"}},{"id":"clm_C03018B4C87E","predicate":"total_equity","value":"21,848,600,000 United States dollar","valid_from":"2013-06-30","valid_to":"2013-09-30","published":"2013-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 21,848,600,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_C03018B4C87E, https://asof.is/claim/clm_C03018B4C87E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637513000107/0001156375-13-000107-index.htm.","url":"https://asof.is/claim/clm_C03018B4C87E","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_52A824D14E4F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637513000107/0001156375-13-000107-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2013","published_at":"2013-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2013, filed 2013-08-08"}},{"id":"clm_D97F9F114D6B","predicate":"quarterly_net_income","value":"311,200,000 United States dollar","valid_from":"2013-06-30","valid_to":"2013-09-30","published":"2013-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 311,200,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_D97F9F114D6B, https://asof.is/claim/clm_D97F9F114D6B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637513000107/0001156375-13-000107-index.htm.","url":"https://asof.is/claim/clm_D97F9F114D6B","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_016E49A61C76","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637513000107/0001156375-13-000107-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2013","published_at":"2013-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2013, filed 2013-08-08"}},{"id":"clm_E95AB5E41EAB","predicate":"total_assets","value":"46,882,700,000 United States dollar","valid_from":"2013-06-30","valid_to":"2013-09-30","published":"2013-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 46,882,700,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_E95AB5E41EAB, https://asof.is/claim/clm_E95AB5E41EAB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637513000107/0001156375-13-000107-index.htm.","url":"https://asof.is/claim/clm_E95AB5E41EAB","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B585B5FD49A4","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637513000107/0001156375-13-000107-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2013","published_at":"2013-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2013, filed 2013-08-08"}},{"id":"clm_0A3879F4D1F5","predicate":"total_equity","value":"21,549,800,000 United States dollar","valid_from":"2013-03-31","valid_to":"2013-06-30","published":"2013-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 21,549,800,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_0A3879F4D1F5, https://asof.is/claim/clm_0A3879F4D1F5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637513000050/0001156375-13-000050-index.htm.","url":"https://asof.is/claim/clm_0A3879F4D1F5","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C03018B4C87E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637513000050/0001156375-13-000050-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2013","published_at":"2013-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2013, filed 2013-05-08"}},{"id":"clm_407041BCAF32","predicate":"cash_and_equivalents","value":"1,843,400,000 United States dollar","valid_from":"2013-03-31","valid_to":"2013-06-30","published":"2013-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,843,400,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_407041BCAF32, https://asof.is/claim/clm_407041BCAF32, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637513000050/0001156375-13-000050-index.htm.","url":"https://asof.is/claim/clm_407041BCAF32","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B7A4CA202956","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637513000050/0001156375-13-000050-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2013","published_at":"2013-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2013, filed 2013-05-08"}},{"id":"clm_7E40A07CD941","predicate":"quarterly_operating_income","value":"405,500,000 United States dollar","valid_from":"2013-03-31","valid_to":"2013-06-30","published":"2013-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 405,500,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_7E40A07CD941, https://asof.is/claim/clm_7E40A07CD941, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637513000050/0001156375-13-000050-index.htm.","url":"https://asof.is/claim/clm_7E40A07CD941","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_63D16975BDB7","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637513000050/0001156375-13-000050-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2013","published_at":"2013-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2013, filed 2013-05-08"}},{"id":"clm_8688F2EFEE98","predicate":"total_assets","value":"42,421,800,000 United States dollar","valid_from":"2013-03-31","valid_to":"2013-06-30","published":"2013-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 42,421,800,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_8688F2EFEE98, https://asof.is/claim/clm_8688F2EFEE98, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637513000050/0001156375-13-000050-index.htm.","url":"https://asof.is/claim/clm_8688F2EFEE98","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E95AB5E41EAB","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637513000050/0001156375-13-000050-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2013","published_at":"2013-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2013, filed 2013-05-08"}},{"id":"clm_AE84355AD106","predicate":"quarterly_revenue","value":"718,600,000 United States dollar","valid_from":"2013-03-31","valid_to":"2013-06-30","published":"2013-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 718,600,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_AE84355AD106, https://asof.is/claim/clm_AE84355AD106, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637513000050/0001156375-13-000050-index.htm.","url":"https://asof.is/claim/clm_AE84355AD106","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BF9FB2ED4520","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637513000050/0001156375-13-000050-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2013","published_at":"2013-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2013, filed 2013-05-08"}},{"id":"clm_E326754F6F44","predicate":"quarterly_net_income","value":"235,800,000 United States dollar","valid_from":"2013-03-31","valid_to":"2013-06-30","published":"2013-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 235,800,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_E326754F6F44, https://asof.is/claim/clm_E326754F6F44, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637513000050/0001156375-13-000050-index.htm.","url":"https://asof.is/claim/clm_E326754F6F44","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D97F9F114D6B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637513000050/0001156375-13-000050-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2013","published_at":"2013-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2013, filed 2013-05-08"}},{"id":"clm_5548777A9F79","predicate":"cash_and_equivalents","value":"1,604,700,000 United States dollar","valid_from":"2012-12-31","valid_to":"2013-03-31","published":"2013-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,604,700,000 United States dollar\", as of 2012-12-31 (until 2013-03-31). Claim clm_5548777A9F79, https://asof.is/claim/clm_5548777A9F79, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637513000007/0001156375-13-000007-index.htm.","url":"https://asof.is/claim/clm_5548777A9F79","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_407041BCAF32","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637513000007/0001156375-13-000007-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2012","published_at":"2013-03-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2012, filed 2013-03-01"}},{"id":"clm_B39BCC6CDE14","predicate":"total_equity","value":"21,419,100,000 United States dollar","valid_from":"2012-12-31","valid_to":"2013-03-31","published":"2013-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 21,419,100,000 United States dollar\", as of 2012-12-31 (until 2013-03-31). Claim clm_B39BCC6CDE14, https://asof.is/claim/clm_B39BCC6CDE14, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637513000007/0001156375-13-000007-index.htm.","url":"https://asof.is/claim/clm_B39BCC6CDE14","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0A3879F4D1F5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637513000007/0001156375-13-000007-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2012","published_at":"2013-03-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2012, filed 2013-03-01"}},{"id":"clm_B95FEB3446AB","predicate":"total_assets","value":"38,863,200,000 United States dollar","valid_from":"2012-12-31","valid_to":"2013-03-31","published":"2013-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 38,863,200,000 United States dollar\", as of 2012-12-31 (until 2013-03-31). Claim clm_B95FEB3446AB, https://asof.is/claim/clm_B95FEB3446AB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637513000007/0001156375-13-000007-index.htm.","url":"https://asof.is/claim/clm_B95FEB3446AB","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8688F2EFEE98","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637513000007/0001156375-13-000007-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2012","published_at":"2013-03-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2012, filed 2013-03-01"}},{"id":"clm_BF7A1EDFA1DA","predicate":"operating_income","value":"1,692,000,000 United States dollar","valid_from":"2012-12-31","valid_to":"2013-12-31","published":"2013-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group operating income: 1,692,000,000 United States dollar\", as of 2012-12-31 (until 2013-12-31). Claim clm_BF7A1EDFA1DA, https://asof.is/claim/clm_BF7A1EDFA1DA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637513000007/0001156375-13-000007-index.htm.","url":"https://asof.is/claim/clm_BF7A1EDFA1DA","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_25762015D272","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637513000007/0001156375-13-000007-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2012","published_at":"2013-03-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2012, filed 2013-03-01"}},{"id":"clm_C04B63BC941E","predicate":"revenue","value":"2,914,600,000 United States dollar","valid_from":"2012-12-31","valid_to":"2013-12-31","published":"2013-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group revenue: 2,914,600,000 United States dollar\", as of 2012-12-31 (until 2013-12-31). Claim clm_C04B63BC941E, https://asof.is/claim/clm_C04B63BC941E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637513000007/0001156375-13-000007-index.htm.","url":"https://asof.is/claim/clm_C04B63BC941E","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3A98C9DDA6B0","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637513000007/0001156375-13-000007-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2012","published_at":"2013-03-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2012, filed 2013-03-01"}},{"id":"clm_D104DEF5A00F","predicate":"net_income","value":"896,300,000 United States dollar","valid_from":"2012-12-31","valid_to":"2013-12-31","published":"2013-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group net income: 896,300,000 United States dollar\", as of 2012-12-31 (until 2013-12-31). Claim clm_D104DEF5A00F, https://asof.is/claim/clm_D104DEF5A00F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637513000007/0001156375-13-000007-index.htm.","url":"https://asof.is/claim/clm_D104DEF5A00F","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_FF6D66FDB123","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637513000007/0001156375-13-000007-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2012","published_at":"2013-03-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2012, filed 2013-03-01"}},{"id":"clm_1B9B35A8B92E","predicate":"quarterly_net_income","value":"218,000,000 United States dollar","valid_from":"2012-09-30","valid_to":"2013-03-31","published":"2012-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 218,000,000 United States dollar\", as of 2012-09-30 (until 2013-03-31). Claim clm_1B9B35A8B92E, https://asof.is/claim/clm_1B9B35A8B92E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637512000121/0001156375-12-000121-index.htm.","url":"https://asof.is/claim/clm_1B9B35A8B92E","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E326754F6F44","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637512000121/0001156375-12-000121-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2012","published_at":"2012-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2012, filed 2012-11-08"}},{"id":"clm_549FF5FB070F","predicate":"cash_and_equivalents","value":"2,016,900,000 United States dollar","valid_from":"2012-09-30","valid_to":"2012-12-31","published":"2012-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 2,016,900,000 United States dollar\", as of 2012-09-30 (until 2012-12-31). Claim clm_549FF5FB070F, https://asof.is/claim/clm_549FF5FB070F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637512000121/0001156375-12-000121-index.htm.","url":"https://asof.is/claim/clm_549FF5FB070F","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5548777A9F79","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637512000121/0001156375-12-000121-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2012","published_at":"2012-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2012, filed 2012-11-08"}},{"id":"clm_6C9B272000BD","predicate":"total_assets","value":"39,858,000,000 United States dollar","valid_from":"2012-09-30","valid_to":"2012-12-31","published":"2012-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 39,858,000,000 United States dollar\", as of 2012-09-30 (until 2012-12-31). Claim clm_6C9B272000BD, https://asof.is/claim/clm_6C9B272000BD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637512000121/0001156375-12-000121-index.htm.","url":"https://asof.is/claim/clm_6C9B272000BD","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B95FEB3446AB","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637512000121/0001156375-12-000121-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2012","published_at":"2012-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2012, filed 2012-11-08"}},{"id":"clm_78DE1B979787","predicate":"quarterly_revenue","value":"683,200,000 United States dollar","valid_from":"2012-09-30","valid_to":"2013-03-31","published":"2012-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 683,200,000 United States dollar\", as of 2012-09-30 (until 2013-03-31). Claim clm_78DE1B979787, https://asof.is/claim/clm_78DE1B979787, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637512000121/0001156375-12-000121-index.htm.","url":"https://asof.is/claim/clm_78DE1B979787","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_AE84355AD106","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637512000121/0001156375-12-000121-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2012","published_at":"2012-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2012, filed 2012-11-08"}},{"id":"clm_B8F7ED14F762","predicate":"quarterly_operating_income","value":"396,000,000 United States dollar","valid_from":"2012-09-30","valid_to":"2013-03-31","published":"2012-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 396,000,000 United States dollar\", as of 2012-09-30 (until 2013-03-31). Claim clm_B8F7ED14F762, https://asof.is/claim/clm_B8F7ED14F762, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637512000121/0001156375-12-000121-index.htm.","url":"https://asof.is/claim/clm_B8F7ED14F762","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7E40A07CD941","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637512000121/0001156375-12-000121-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2012","published_at":"2012-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2012, filed 2012-11-08"}},{"id":"clm_D7FC94C081BF","predicate":"total_equity","value":"21,708,800,000 United States dollar","valid_from":"2012-09-30","valid_to":"2012-12-31","published":"2012-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 21,708,800,000 United States dollar\", as of 2012-09-30 (until 2012-12-31). Claim clm_D7FC94C081BF, https://asof.is/claim/clm_D7FC94C081BF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637512000121/0001156375-12-000121-index.htm.","url":"https://asof.is/claim/clm_D7FC94C081BF","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B39BCC6CDE14","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637512000121/0001156375-12-000121-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2012","published_at":"2012-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2012, filed 2012-11-08"}},{"id":"clm_345B9A37A6B8","predicate":"cash_and_equivalents","value":"1,293,200,000 United States dollar","valid_from":"2012-06-30","valid_to":"2012-09-30","published":"2012-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,293,200,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_345B9A37A6B8, https://asof.is/claim/clm_345B9A37A6B8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637512000093/0001156375-12-000093-index.htm.","url":"https://asof.is/claim/clm_345B9A37A6B8","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_549FF5FB070F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637512000093/0001156375-12-000093-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2012","published_at":"2012-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2012, filed 2012-08-08"}},{"id":"clm_3BE872751883","predicate":"total_assets","value":"37,945,900,000 United States dollar","valid_from":"2012-06-30","valid_to":"2012-09-30","published":"2012-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 37,945,900,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_3BE872751883, https://asof.is/claim/clm_3BE872751883, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637512000093/0001156375-12-000093-index.htm.","url":"https://asof.is/claim/clm_3BE872751883","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6C9B272000BD","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637512000093/0001156375-12-000093-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2012","published_at":"2012-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2012, filed 2012-08-08"}},{"id":"clm_42AB462F9CB7","predicate":"total_equity","value":"21,620,000,000 United States dollar","valid_from":"2012-06-30","valid_to":"2012-09-30","published":"2012-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 21,620,000,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_42AB462F9CB7, https://asof.is/claim/clm_42AB462F9CB7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637512000093/0001156375-12-000093-index.htm.","url":"https://asof.is/claim/clm_42AB462F9CB7","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D7FC94C081BF","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637512000093/0001156375-12-000093-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2012","published_at":"2012-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2012, filed 2012-08-08"}},{"id":"clm_853F207545FE","predicate":"quarterly_net_income","value":"244,900,000 United States dollar","valid_from":"2012-06-30","valid_to":"2012-09-30","published":"2012-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 244,900,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_853F207545FE, https://asof.is/claim/clm_853F207545FE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637512000093/0001156375-12-000093-index.htm.","url":"https://asof.is/claim/clm_853F207545FE","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1B9B35A8B92E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637512000093/0001156375-12-000093-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2012","published_at":"2012-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2012, filed 2012-08-08"}},{"id":"clm_85F0DF0561E5","predicate":"quarterly_operating_income","value":"469,200,000 United States dollar","valid_from":"2012-06-30","valid_to":"2012-09-30","published":"2012-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 469,200,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_85F0DF0561E5, https://asof.is/claim/clm_85F0DF0561E5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637512000093/0001156375-12-000093-index.htm.","url":"https://asof.is/claim/clm_85F0DF0561E5","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B8F7ED14F762","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637512000093/0001156375-12-000093-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2012","published_at":"2012-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2012, filed 2012-08-08"}},{"id":"clm_B81AAA82ECF9","predicate":"quarterly_revenue","value":"795,900,000 United States dollar","valid_from":"2012-06-30","valid_to":"2012-09-30","published":"2012-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 795,900,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_B81AAA82ECF9, https://asof.is/claim/clm_B81AAA82ECF9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637512000093/0001156375-12-000093-index.htm.","url":"https://asof.is/claim/clm_B81AAA82ECF9","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_78DE1B979787","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637512000093/0001156375-12-000093-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2012","published_at":"2012-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2012, filed 2012-08-08"}},{"id":"clm_56096B627F1F","predicate":"quarterly_revenue","value":"774,600,000 United States dollar","valid_from":"2012-03-31","valid_to":"2012-06-30","published":"2012-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 774,600,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_56096B627F1F, https://asof.is/claim/clm_56096B627F1F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637512000044/0001156375-12-000044-index.htm.","url":"https://asof.is/claim/clm_56096B627F1F","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B81AAA82ECF9","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637512000044/0001156375-12-000044-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2012","published_at":"2012-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2012, filed 2012-05-08"}},{"id":"clm_8514D41F864B","predicate":"total_assets","value":"39,289,100,000 United States dollar","valid_from":"2012-03-31","valid_to":"2012-06-30","published":"2012-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 39,289,100,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_8514D41F864B, https://asof.is/claim/clm_8514D41F864B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637512000044/0001156375-12-000044-index.htm.","url":"https://asof.is/claim/clm_8514D41F864B","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3BE872751883","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637512000044/0001156375-12-000044-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2012","published_at":"2012-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2012, filed 2012-05-08"}},{"id":"clm_AEFB2B02149F","predicate":"quarterly_net_income","value":"266,600,000 United States dollar","valid_from":"2012-03-31","valid_to":"2012-06-30","published":"2012-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 266,600,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_AEFB2B02149F, https://asof.is/claim/clm_AEFB2B02149F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637512000044/0001156375-12-000044-index.htm.","url":"https://asof.is/claim/clm_AEFB2B02149F","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_853F207545FE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637512000044/0001156375-12-000044-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2012","published_at":"2012-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2012, filed 2012-05-08"}},{"id":"clm_AF01DE96C4A2","predicate":"total_equity","value":"21,549,100,000 United States dollar","valid_from":"2012-03-31","valid_to":"2012-06-30","published":"2012-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 21,549,100,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_AF01DE96C4A2, https://asof.is/claim/clm_AF01DE96C4A2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637512000044/0001156375-12-000044-index.htm.","url":"https://asof.is/claim/clm_AF01DE96C4A2","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_42AB462F9CB7","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637512000044/0001156375-12-000044-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2012","published_at":"2012-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2012, filed 2012-05-08"}},{"id":"clm_F8AF75707FAE","predicate":"quarterly_operating_income","value":"451,200,000 United States dollar","valid_from":"2012-03-31","valid_to":"2012-06-30","published":"2012-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 451,200,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_F8AF75707FAE, https://asof.is/claim/clm_F8AF75707FAE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637512000044/0001156375-12-000044-index.htm.","url":"https://asof.is/claim/clm_F8AF75707FAE","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_85F0DF0561E5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637512000044/0001156375-12-000044-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2012","published_at":"2012-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2012, filed 2012-05-08"}},{"id":"clm_FF17D3393AB6","predicate":"cash_and_equivalents","value":"1,061,700,000 United States dollar","valid_from":"2012-03-31","valid_to":"2012-06-30","published":"2012-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,061,700,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_FF17D3393AB6, https://asof.is/claim/clm_FF17D3393AB6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637512000044/0001156375-12-000044-index.htm.","url":"https://asof.is/claim/clm_FF17D3393AB6","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_345B9A37A6B8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637512000044/0001156375-12-000044-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2012","published_at":"2012-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2012, filed 2012-05-08"}},{"id":"clm_1BC76C963907","predicate":"revenue","value":"3,280,600,000 United States dollar","valid_from":"2011-12-31","valid_to":"2012-12-31","published":"2012-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group revenue: 3,280,600,000 United States dollar\", as of 2011-12-31 (until 2012-12-31). Claim clm_1BC76C963907, https://asof.is/claim/clm_1BC76C963907, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637512000016/0001156375-12-000016-index.htm.","url":"https://asof.is/claim/clm_1BC76C963907","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C04B63BC941E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637512000016/0001156375-12-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2011","published_at":"2012-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2011, filed 2012-02-28"}},{"id":"clm_56D9843F5DEF","predicate":"net_income","value":"1,812,300,000 United States dollar","valid_from":"2011-12-31","valid_to":"2012-12-31","published":"2012-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group net income: 1,812,300,000 United States dollar\", as of 2011-12-31 (until 2012-12-31). Claim clm_56D9843F5DEF, https://asof.is/claim/clm_56D9843F5DEF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637512000016/0001156375-12-000016-index.htm.","url":"https://asof.is/claim/clm_56D9843F5DEF","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D104DEF5A00F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637512000016/0001156375-12-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2011","published_at":"2012-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2011, filed 2012-02-28"}},{"id":"clm_76137B60D0DE","predicate":"total_assets","value":"40,758,700,000 United States dollar","valid_from":"2011-12-31","valid_to":"2012-03-31","published":"2012-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 40,758,700,000 United States dollar\", as of 2011-12-31 (until 2012-03-31). Claim clm_76137B60D0DE, https://asof.is/claim/clm_76137B60D0DE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637512000016/0001156375-12-000016-index.htm.","url":"https://asof.is/claim/clm_76137B60D0DE","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8514D41F864B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637512000016/0001156375-12-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2011","published_at":"2012-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2011, filed 2012-02-28"}},{"id":"clm_932439C807B7","predicate":"cash_and_equivalents","value":"1,042,300,000 United States dollar","valid_from":"2011-12-31","valid_to":"2012-03-31","published":"2012-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,042,300,000 United States dollar\", as of 2011-12-31 (until 2012-03-31). Claim clm_932439C807B7, https://asof.is/claim/clm_932439C807B7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637512000016/0001156375-12-000016-index.htm.","url":"https://asof.is/claim/clm_932439C807B7","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_FF17D3393AB6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637512000016/0001156375-12-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2011","published_at":"2012-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2011, filed 2012-02-28"}},{"id":"clm_BB1F7B5E614C","predicate":"total_equity","value":"21,552,000,000 United States dollar","valid_from":"2011-12-31","valid_to":"2012-03-31","published":"2012-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 21,552,000,000 United States dollar\", as of 2011-12-31 (until 2012-03-31). Claim clm_BB1F7B5E614C, https://asof.is/claim/clm_BB1F7B5E614C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637512000016/0001156375-12-000016-index.htm.","url":"https://asof.is/claim/clm_BB1F7B5E614C","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_AF01DE96C4A2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637512000016/0001156375-12-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2011","published_at":"2012-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2011, filed 2012-02-28"}},{"id":"clm_D5150D809988","predicate":"operating_income","value":"2,021,100,000 United States dollar","valid_from":"2011-12-31","valid_to":"2012-12-31","published":"2012-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group operating income: 2,021,100,000 United States dollar\", as of 2011-12-31 (until 2012-12-31). Claim clm_D5150D809988, https://asof.is/claim/clm_D5150D809988, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000115637512000016/0001156375-12-000016-index.htm.","url":"https://asof.is/claim/clm_D5150D809988","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BF7A1EDFA1DA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637512000016/0001156375-12-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2011","published_at":"2012-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2011, filed 2012-02-28"}},{"id":"clm_54C7D7CDBBB5","predicate":"total_equity","value":"20,864,300,000 United States dollar","valid_from":"2011-09-30","valid_to":"2011-12-31","published":"2011-11-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 20,864,300,000 United States dollar\", as of 2011-09-30 (until 2011-12-31). Claim clm_54C7D7CDBBB5, https://asof.is/claim/clm_54C7D7CDBBB5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312511304112/0001193125-11-304112-index.htm.","url":"https://asof.is/claim/clm_54C7D7CDBBB5","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BB1F7B5E614C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312511304112/0001193125-11-304112-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2011","published_at":"2011-11-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2011, filed 2011-11-09"}},{"id":"clm_61C798FE6F0F","predicate":"cash_and_equivalents","value":"829,300,000 United States dollar","valid_from":"2011-09-30","valid_to":"2011-12-31","published":"2011-11-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 829,300,000 United States dollar\", as of 2011-09-30 (until 2011-12-31). Claim clm_61C798FE6F0F, https://asof.is/claim/clm_61C798FE6F0F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312511304112/0001193125-11-304112-index.htm.","url":"https://asof.is/claim/clm_61C798FE6F0F","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_932439C807B7","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312511304112/0001193125-11-304112-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2011","published_at":"2011-11-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2011, filed 2011-11-09"}},{"id":"clm_84A37329BF43","predicate":"total_assets","value":"38,887,600,000 United States dollar","valid_from":"2011-09-30","valid_to":"2011-12-31","published":"2011-11-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 38,887,600,000 United States dollar\", as of 2011-09-30 (until 2011-12-31). Claim clm_84A37329BF43, https://asof.is/claim/clm_84A37329BF43, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312511304112/0001193125-11-304112-index.htm.","url":"https://asof.is/claim/clm_84A37329BF43","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_76137B60D0DE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312511304112/0001193125-11-304112-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2011","published_at":"2011-11-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2011, filed 2011-11-09"}},{"id":"clm_97A94A816B6D","predicate":"quarterly_operating_income","value":"572,100,000 United States dollar","valid_from":"2011-09-30","valid_to":"2012-03-31","published":"2011-11-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 572,100,000 United States dollar\", as of 2011-09-30 (until 2012-03-31). Claim clm_97A94A816B6D, https://asof.is/claim/clm_97A94A816B6D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312511304112/0001193125-11-304112-index.htm.","url":"https://asof.is/claim/clm_97A94A816B6D","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F8AF75707FAE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312511304112/0001193125-11-304112-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2011","published_at":"2011-11-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2011, filed 2011-11-09"}},{"id":"clm_B6CE7D4A9716","predicate":"quarterly_revenue","value":"874,200,000 United States dollar","valid_from":"2011-09-30","valid_to":"2012-03-31","published":"2011-11-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 874,200,000 United States dollar\", as of 2011-09-30 (until 2012-03-31). Claim clm_B6CE7D4A9716, https://asof.is/claim/clm_B6CE7D4A9716, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312511304112/0001193125-11-304112-index.htm.","url":"https://asof.is/claim/clm_B6CE7D4A9716","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_56096B627F1F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312511304112/0001193125-11-304112-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2011","published_at":"2011-11-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2011, filed 2011-11-09"}},{"id":"clm_BC29488FEB4D","predicate":"quarterly_net_income","value":"316,100,000 United States dollar","valid_from":"2011-09-30","valid_to":"2012-03-31","published":"2011-11-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 316,100,000 United States dollar\", as of 2011-09-30 (until 2012-03-31). Claim clm_BC29488FEB4D, https://asof.is/claim/clm_BC29488FEB4D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312511304112/0001193125-11-304112-index.htm.","url":"https://asof.is/claim/clm_BC29488FEB4D","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_AEFB2B02149F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312511304112/0001193125-11-304112-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2011","published_at":"2011-11-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2011, filed 2011-11-09"}},{"id":"clm_1260031293A6","predicate":"quarterly_revenue","value":"838,300,000 United States dollar","valid_from":"2011-06-30","valid_to":"2011-09-30","published":"2011-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 838,300,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_1260031293A6, https://asof.is/claim/clm_1260031293A6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312511212308/0001193125-11-212308-index.htm.","url":"https://asof.is/claim/clm_1260031293A6","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B6CE7D4A9716","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312511212308/0001193125-11-212308-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2011","published_at":"2011-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2011, filed 2011-08-05"}},{"id":"clm_381D252D2E0B","predicate":"quarterly_operating_income","value":"534,500,000 United States dollar","valid_from":"2011-06-30","valid_to":"2011-09-30","published":"2011-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 534,500,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_381D252D2E0B, https://asof.is/claim/clm_381D252D2E0B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312511212308/0001193125-11-212308-index.htm.","url":"https://asof.is/claim/clm_381D252D2E0B","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_97A94A816B6D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312511212308/0001193125-11-212308-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2011","published_at":"2011-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2011, filed 2011-08-05"}},{"id":"clm_38C3168E9935","predicate":"total_assets","value":"35,589,200,000 United States dollar","valid_from":"2011-06-30","valid_to":"2011-09-30","published":"2011-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 35,589,200,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_38C3168E9935, https://asof.is/claim/clm_38C3168E9935, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312511212308/0001193125-11-212308-index.htm.","url":"https://asof.is/claim/clm_38C3168E9935","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_84A37329BF43","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312511212308/0001193125-11-212308-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2011","published_at":"2011-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2011, filed 2011-08-05"}},{"id":"clm_ADF6BEF0D39B","predicate":"cash_and_equivalents","value":"693,600,000 United States dollar","valid_from":"2011-06-30","valid_to":"2011-09-30","published":"2011-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 693,600,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_ADF6BEF0D39B, https://asof.is/claim/clm_ADF6BEF0D39B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312511212308/0001193125-11-212308-index.htm.","url":"https://asof.is/claim/clm_ADF6BEF0D39B","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_61C798FE6F0F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312511212308/0001193125-11-212308-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2011","published_at":"2011-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2011, filed 2011-08-05"}},{"id":"clm_EA5842CF5C60","predicate":"quarterly_net_income","value":"293,700,000 United States dollar","valid_from":"2011-06-30","valid_to":"2011-09-30","published":"2011-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 293,700,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_EA5842CF5C60, https://asof.is/claim/clm_EA5842CF5C60, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312511212308/0001193125-11-212308-index.htm.","url":"https://asof.is/claim/clm_EA5842CF5C60","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BC29488FEB4D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312511212308/0001193125-11-212308-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2011","published_at":"2011-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2011, filed 2011-08-05"}},{"id":"clm_FB2993FF6D6D","predicate":"total_equity","value":"20,902,500,000 United States dollar","valid_from":"2011-06-30","valid_to":"2011-09-30","published":"2011-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 20,902,500,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_FB2993FF6D6D, https://asof.is/claim/clm_FB2993FF6D6D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312511212308/0001193125-11-212308-index.htm.","url":"https://asof.is/claim/clm_FB2993FF6D6D","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_54C7D7CDBBB5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312511212308/0001193125-11-212308-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2011","published_at":"2011-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2011, filed 2011-08-05"}},{"id":"clm_4BAB3FD4AC99","predicate":"cash_and_equivalents","value":"664,700,000 United States dollar","valid_from":"2011-03-31","valid_to":"2011-06-30","published":"2011-05-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 664,700,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_4BAB3FD4AC99, https://asof.is/claim/clm_4BAB3FD4AC99, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312511134231/0001193125-11-134231-index.htm.","url":"https://asof.is/claim/clm_4BAB3FD4AC99","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_ADF6BEF0D39B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312511134231/0001193125-11-134231-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2011","published_at":"2011-05-10T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2011, filed 2011-05-10"}},{"id":"clm_5EA7E57A78BD","predicate":"quarterly_operating_income","value":"524,100,000 United States dollar","valid_from":"2011-03-31","valid_to":"2011-06-30","published":"2011-05-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 524,100,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_5EA7E57A78BD, https://asof.is/claim/clm_5EA7E57A78BD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312511134231/0001193125-11-134231-index.htm.","url":"https://asof.is/claim/clm_5EA7E57A78BD","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_381D252D2E0B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312511134231/0001193125-11-134231-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2011","published_at":"2011-05-10T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2011, filed 2011-05-10"}},{"id":"clm_65B2C5BF7ACB","predicate":"total_equity","value":"20,787,500,000 United States dollar","valid_from":"2011-03-31","valid_to":"2011-06-30","published":"2011-05-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 20,787,500,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_65B2C5BF7ACB, https://asof.is/claim/clm_65B2C5BF7ACB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312511134231/0001193125-11-134231-index.htm.","url":"https://asof.is/claim/clm_65B2C5BF7ACB","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_FB2993FF6D6D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312511134231/0001193125-11-134231-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2011","published_at":"2011-05-10T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2011, filed 2011-05-10"}},{"id":"clm_8ACF6BAA846A","predicate":"quarterly_revenue","value":"831,600,000 United States dollar","valid_from":"2011-03-31","valid_to":"2011-06-30","published":"2011-05-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 831,600,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_8ACF6BAA846A, https://asof.is/claim/clm_8ACF6BAA846A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312511134231/0001193125-11-134231-index.htm.","url":"https://asof.is/claim/clm_8ACF6BAA846A","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1260031293A6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312511134231/0001193125-11-134231-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2011","published_at":"2011-05-10T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2011, filed 2011-05-10"}},{"id":"clm_912DCE1C2586","predicate":"quarterly_net_income","value":"456,600,000 United States dollar","valid_from":"2011-03-31","valid_to":"2011-06-30","published":"2011-05-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 456,600,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_912DCE1C2586, https://asof.is/claim/clm_912DCE1C2586, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312511134231/0001193125-11-134231-index.htm.","url":"https://asof.is/claim/clm_912DCE1C2586","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_EA5842CF5C60","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312511134231/0001193125-11-134231-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2011","published_at":"2011-05-10T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2011, filed 2011-05-10"}},{"id":"clm_C969A7EF58B5","predicate":"total_assets","value":"34,709,000,000 United States dollar","valid_from":"2011-03-31","valid_to":"2011-06-30","published":"2011-05-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 34,709,000,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_C969A7EF58B5, https://asof.is/claim/clm_C969A7EF58B5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312511134231/0001193125-11-134231-index.htm.","url":"https://asof.is/claim/clm_C969A7EF58B5","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_38C3168E9935","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312511134231/0001193125-11-134231-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2011","published_at":"2011-05-10T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2011, filed 2011-05-10"}},{"id":"clm_0F51BA3FC162","predicate":"net_income","value":"951,400,000 United States dollar","valid_from":"2010-12-31","valid_to":"2011-12-31","published":"2011-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group net income: 951,400,000 United States dollar\", as of 2010-12-31 (until 2011-12-31). Claim clm_0F51BA3FC162, https://asof.is/claim/clm_0F51BA3FC162, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312511050252/0001193125-11-050252-index.htm.","url":"https://asof.is/claim/clm_0F51BA3FC162","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_56D9843F5DEF","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312511050252/0001193125-11-050252-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2010","published_at":"2011-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2010, filed 2011-02-28"}},{"id":"clm_16E326617CB9","predicate":"total_equity","value":"20,060,100,000 United States dollar","valid_from":"2010-12-31","valid_to":"2011-03-31","published":"2011-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 20,060,100,000 United States dollar\", as of 2010-12-31 (until 2011-03-31). Claim clm_16E326617CB9, https://asof.is/claim/clm_16E326617CB9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312511050252/0001193125-11-050252-index.htm.","url":"https://asof.is/claim/clm_16E326617CB9","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_65B2C5BF7ACB","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312511050252/0001193125-11-050252-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2010","published_at":"2011-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2010, filed 2011-02-28"}},{"id":"clm_30C2E15095D8","predicate":"total_assets","value":"35,046,100,000 United States dollar","valid_from":"2010-12-31","valid_to":"2011-03-31","published":"2011-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 35,046,100,000 United States dollar\", as of 2010-12-31 (until 2011-03-31). Claim clm_30C2E15095D8, https://asof.is/claim/clm_30C2E15095D8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312511050252/0001193125-11-050252-index.htm.","url":"https://asof.is/claim/clm_30C2E15095D8","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C969A7EF58B5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312511050252/0001193125-11-050252-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2010","published_at":"2011-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2010, filed 2011-02-28"}},{"id":"clm_8426002C8D8D","predicate":"cash_and_equivalents","value":"855,200,000 United States dollar","valid_from":"2010-12-31","valid_to":"2011-03-31","published":"2011-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 855,200,000 United States dollar\", as of 2010-12-31 (until 2011-03-31). Claim clm_8426002C8D8D, https://asof.is/claim/clm_8426002C8D8D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312511050252/0001193125-11-050252-index.htm.","url":"https://asof.is/claim/clm_8426002C8D8D","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4BAB3FD4AC99","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312511050252/0001193125-11-050252-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2010","published_at":"2011-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2010, filed 2011-02-28"}},{"id":"clm_B8E14D655B6F","predicate":"operating_income","value":"1,831,100,000 United States dollar","valid_from":"2010-12-31","valid_to":"2011-12-31","published":"2011-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group operating income: 1,831,100,000 United States dollar\", as of 2010-12-31 (until 2011-12-31). Claim clm_B8E14D655B6F, https://asof.is/claim/clm_B8E14D655B6F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312511050252/0001193125-11-050252-index.htm.","url":"https://asof.is/claim/clm_B8E14D655B6F","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D5150D809988","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312511050252/0001193125-11-050252-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2010","published_at":"2011-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2010, filed 2011-02-28"}},{"id":"clm_BECB58078843","predicate":"revenue","value":"3,003,700,000 United States dollar","valid_from":"2010-12-31","valid_to":"2011-12-31","published":"2011-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group revenue: 3,003,700,000 United States dollar\", as of 2010-12-31 (until 2011-12-31). Claim clm_BECB58078843, https://asof.is/claim/clm_BECB58078843, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312511050252/0001193125-11-050252-index.htm.","url":"https://asof.is/claim/clm_BECB58078843","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1BC76C963907","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312511050252/0001193125-11-050252-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2010","published_at":"2011-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2010, filed 2011-02-28"}},{"id":"clm_072BE30EB3EC","predicate":"cash_and_equivalents","value":"568,200,000 United States dollar","valid_from":"2010-09-30","valid_to":"2010-12-31","published":"2010-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 568,200,000 United States dollar\", as of 2010-09-30 (until 2010-12-31). Claim clm_072BE30EB3EC, https://asof.is/claim/clm_072BE30EB3EC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510250139/0001193125-10-250139-index.htm.","url":"https://asof.is/claim/clm_072BE30EB3EC","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8426002C8D8D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510250139/0001193125-10-250139-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2010","published_at":"2010-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2010, filed 2010-11-05"}},{"id":"clm_A21FD9EBCDBA","predicate":"quarterly_net_income","value":"244,300,000 United States dollar","valid_from":"2010-09-30","valid_to":"2011-03-31","published":"2010-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 244,300,000 United States dollar\", as of 2010-09-30 (until 2011-03-31). Claim clm_A21FD9EBCDBA, https://asof.is/claim/clm_A21FD9EBCDBA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510250139/0001193125-10-250139-index.htm.","url":"https://asof.is/claim/clm_A21FD9EBCDBA","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_912DCE1C2586","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510250139/0001193125-10-250139-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2010","published_at":"2010-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2010, filed 2010-11-05"}},{"id":"clm_B6BC29711162","predicate":"total_equity","value":"19,900,800,000 United States dollar","valid_from":"2010-09-30","valid_to":"2010-12-31","published":"2010-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 19,900,800,000 United States dollar\", as of 2010-09-30 (until 2010-12-31). Claim clm_B6BC29711162, https://asof.is/claim/clm_B6BC29711162, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510250139/0001193125-10-250139-index.htm.","url":"https://asof.is/claim/clm_B6BC29711162","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_16E326617CB9","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510250139/0001193125-10-250139-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2010","published_at":"2010-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2010, filed 2010-11-05"}},{"id":"clm_B6BF5456A645","predicate":"quarterly_operating_income","value":"442,900,000 United States dollar","valid_from":"2010-09-30","valid_to":"2011-03-31","published":"2010-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 442,900,000 United States dollar\", as of 2010-09-30 (until 2011-03-31). Claim clm_B6BF5456A645, https://asof.is/claim/clm_B6BF5456A645, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510250139/0001193125-10-250139-index.htm.","url":"https://asof.is/claim/clm_B6BF5456A645","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5EA7E57A78BD","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510250139/0001193125-10-250139-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2010","published_at":"2010-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2010, filed 2010-11-05"}},{"id":"clm_E908163F6B38","predicate":"total_assets","value":"33,686,500,000 United States dollar","valid_from":"2010-09-30","valid_to":"2010-12-31","published":"2010-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 33,686,500,000 United States dollar\", as of 2010-09-30 (until 2010-12-31). Claim clm_E908163F6B38, https://asof.is/claim/clm_E908163F6B38, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510250139/0001193125-10-250139-index.htm.","url":"https://asof.is/claim/clm_E908163F6B38","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_30C2E15095D8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510250139/0001193125-10-250139-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2010","published_at":"2010-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2010, filed 2010-11-05"}},{"id":"clm_F5800761A197","predicate":"quarterly_revenue","value":"733,400,000 United States dollar","valid_from":"2010-09-30","valid_to":"2011-03-31","published":"2010-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 733,400,000 United States dollar\", as of 2010-09-30 (until 2011-03-31). Claim clm_F5800761A197, https://asof.is/claim/clm_F5800761A197, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510250139/0001193125-10-250139-index.htm.","url":"https://asof.is/claim/clm_F5800761A197","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8ACF6BAA846A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510250139/0001193125-10-250139-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2010","published_at":"2010-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2010, filed 2010-11-05"}},{"id":"clm_1D4786DEB62A","predicate":"quarterly_operating_income","value":"515,100,000 United States dollar","valid_from":"2010-06-30","valid_to":"2010-09-30","published":"2010-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 515,100,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_1D4786DEB62A, https://asof.is/claim/clm_1D4786DEB62A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510181102/0001193125-10-181102-index.htm.","url":"https://asof.is/claim/clm_1D4786DEB62A","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B6BF5456A645","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510181102/0001193125-10-181102-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2010","published_at":"2010-08-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2010, filed 2010-08-06"}},{"id":"clm_8E5FB8916146","predicate":"quarterly_revenue","value":"813,900,000 United States dollar","valid_from":"2010-06-30","valid_to":"2010-09-30","published":"2010-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 813,900,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_8E5FB8916146, https://asof.is/claim/clm_8E5FB8916146, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510181102/0001193125-10-181102-index.htm.","url":"https://asof.is/claim/clm_8E5FB8916146","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F5800761A197","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510181102/0001193125-10-181102-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2010","published_at":"2010-08-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2010, filed 2010-08-06"}},{"id":"clm_AECED482C49D","predicate":"total_equity","value":"19,383,500,000 United States dollar","valid_from":"2010-06-30","valid_to":"2010-09-30","published":"2010-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 19,383,500,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_AECED482C49D, https://asof.is/claim/clm_AECED482C49D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510181102/0001193125-10-181102-index.htm.","url":"https://asof.is/claim/clm_AECED482C49D","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B6BC29711162","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510181102/0001193125-10-181102-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2010","published_at":"2010-08-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2010, filed 2010-08-06"}},{"id":"clm_BC99B353B68C","predicate":"cash_and_equivalents","value":"363,600,000 United States dollar","valid_from":"2010-06-30","valid_to":"2010-09-30","published":"2010-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 363,600,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_BC99B353B68C, https://asof.is/claim/clm_BC99B353B68C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510181102/0001193125-10-181102-index.htm.","url":"https://asof.is/claim/clm_BC99B353B68C","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_072BE30EB3EC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510181102/0001193125-10-181102-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2010","published_at":"2010-08-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2010, filed 2010-08-06"}},{"id":"clm_C86DCA1FB148","predicate":"total_assets","value":"34,258,900,000 United States dollar","valid_from":"2010-06-30","valid_to":"2010-09-30","published":"2010-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 34,258,900,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_C86DCA1FB148, https://asof.is/claim/clm_C86DCA1FB148, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510181102/0001193125-10-181102-index.htm.","url":"https://asof.is/claim/clm_C86DCA1FB148","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E908163F6B38","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510181102/0001193125-10-181102-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2010","published_at":"2010-08-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2010, filed 2010-08-06"}},{"id":"clm_E0C6DC86115B","predicate":"quarterly_net_income","value":"270,700,000 United States dollar","valid_from":"2010-06-30","valid_to":"2010-09-30","published":"2010-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 270,700,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_E0C6DC86115B, https://asof.is/claim/clm_E0C6DC86115B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510181102/0001193125-10-181102-index.htm.","url":"https://asof.is/claim/clm_E0C6DC86115B","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A21FD9EBCDBA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510181102/0001193125-10-181102-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2010","published_at":"2010-08-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2010, filed 2010-08-06"}},{"id":"clm_1CB4E39E2058","predicate":"quarterly_operating_income","value":"414,700,000 United States dollar","valid_from":"2010-03-31","valid_to":"2010-06-30","published":"2010-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 414,700,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_1CB4E39E2058, https://asof.is/claim/clm_1CB4E39E2058, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510112933/0001193125-10-112933-index.htm.","url":"https://asof.is/claim/clm_1CB4E39E2058","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1D4786DEB62A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510112933/0001193125-10-112933-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2010","published_at":"2010-05-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2010, filed 2010-05-07"}},{"id":"clm_40B09ABA1BD2","predicate":"total_assets","value":"35,202,400,000 United States dollar","valid_from":"2010-03-31","valid_to":"2010-06-30","published":"2010-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 35,202,400,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_40B09ABA1BD2, https://asof.is/claim/clm_40B09ABA1BD2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510112933/0001193125-10-112933-index.htm.","url":"https://asof.is/claim/clm_40B09ABA1BD2","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C86DCA1FB148","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510112933/0001193125-10-112933-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2010","published_at":"2010-05-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2010, filed 2010-05-07"}},{"id":"clm_5E0CCF069C9D","predicate":"total_equity","value":"19,189,700,000 United States dollar","valid_from":"2010-03-31","valid_to":"2010-06-30","published":"2010-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 19,189,700,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_5E0CCF069C9D, https://asof.is/claim/clm_5E0CCF069C9D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510112933/0001193125-10-112933-index.htm.","url":"https://asof.is/claim/clm_5E0CCF069C9D","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_AECED482C49D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510112933/0001193125-10-112933-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2010","published_at":"2010-05-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2010, filed 2010-05-07"}},{"id":"clm_7447E470F28B","predicate":"cash_and_equivalents","value":"444,200,000 United States dollar","valid_from":"2010-03-31","valid_to":"2010-06-30","published":"2010-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 444,200,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_7447E470F28B, https://asof.is/claim/clm_7447E470F28B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510112933/0001193125-10-112933-index.htm.","url":"https://asof.is/claim/clm_7447E470F28B","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BC99B353B68C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510112933/0001193125-10-112933-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2010","published_at":"2010-05-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2010, filed 2010-05-07"}},{"id":"clm_E53D1B8A453E","predicate":"quarterly_revenue","value":"693,200,000 United States dollar","valid_from":"2010-03-31","valid_to":"2010-06-30","published":"2010-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 693,200,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_E53D1B8A453E, https://asof.is/claim/clm_E53D1B8A453E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510112933/0001193125-10-112933-index.htm.","url":"https://asof.is/claim/clm_E53D1B8A453E","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8E5FB8916146","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510112933/0001193125-10-112933-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2010","published_at":"2010-05-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2010, filed 2010-05-07"}},{"id":"clm_F32D152417B4","predicate":"quarterly_net_income","value":"240,200,000 United States dollar","valid_from":"2010-03-31","valid_to":"2010-06-30","published":"2010-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 240,200,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_F32D152417B4, https://asof.is/claim/clm_F32D152417B4, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510112933/0001193125-10-112933-index.htm.","url":"https://asof.is/claim/clm_F32D152417B4","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E0C6DC86115B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510112933/0001193125-10-112933-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2010","published_at":"2010-05-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2010, filed 2010-05-07"}},{"id":"clm_9A51629F9A48","predicate":"shares_outstanding","value":"66,643,583 shares","valid_from":"2010-02-17","valid_to":null,"published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group shares outstanding: 66,643,583 shares\", as of 2010-02-17. Claim clm_9A51629F9A48, https://asof.is/claim/clm_9A51629F9A48, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm.","url":"https://asof.is/claim/clm_9A51629F9A48","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_15EAF43EFE8A","predicate":"cash_and_equivalents","value":"260,600,000 United States dollar","valid_from":"2009-12-31","valid_to":"2010-03-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 260,600,000 United States dollar\", as of 2009-12-31 (until 2010-03-31). Claim clm_15EAF43EFE8A, https://asof.is/claim/clm_15EAF43EFE8A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm.","url":"https://asof.is/claim/clm_15EAF43EFE8A","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7447E470F28B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_5674F6977FF6","predicate":"operating_income","value":"1,589,100,000 United States dollar","valid_from":"2009-12-31","valid_to":"2010-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group operating income: 1,589,100,000 United States dollar\", as of 2009-12-31 (until 2010-12-31). Claim clm_5674F6977FF6, https://asof.is/claim/clm_5674F6977FF6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm.","url":"https://asof.is/claim/clm_5674F6977FF6","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B8E14D655B6F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_78ED7CF77046","predicate":"total_assets","value":"35,651,000,000 United States dollar","valid_from":"2009-12-31","valid_to":"2010-03-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 35,651,000,000 United States dollar\", as of 2009-12-31 (until 2010-03-31). Claim clm_78ED7CF77046, https://asof.is/claim/clm_78ED7CF77046, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm.","url":"https://asof.is/claim/clm_78ED7CF77046","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_40B09ABA1BD2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_9CF464C9086D","predicate":"total_equity","value":"19,301,000,000 United States dollar","valid_from":"2009-12-31","valid_to":"2010-03-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 19,301,000,000 United States dollar\", as of 2009-12-31 (until 2010-03-31). Claim clm_9CF464C9086D, https://asof.is/claim/clm_9CF464C9086D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm.","url":"https://asof.is/claim/clm_9CF464C9086D","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5E0CCF069C9D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_C6C00740CC5E","predicate":"revenue","value":"2,612,800,000 United States dollar","valid_from":"2009-12-31","valid_to":"2010-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group revenue: 2,612,800,000 United States dollar\", as of 2009-12-31 (until 2010-12-31). Claim clm_C6C00740CC5E, https://asof.is/claim/clm_C6C00740CC5E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm.","url":"https://asof.is/claim/clm_C6C00740CC5E","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BECB58078843","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_F9F99E0E4C24","predicate":"net_income","value":"825,800,000 United States dollar","valid_from":"2009-12-31","valid_to":"2010-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group net income: 825,800,000 United States dollar\", as of 2009-12-31 (until 2010-12-31). Claim clm_F9F99E0E4C24, https://asof.is/claim/clm_F9F99E0E4C24, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm.","url":"https://asof.is/claim/clm_F9F99E0E4C24","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0F51BA3FC162","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_2F279BA06C2A","predicate":"shares_outstanding","value":"66,519,078 shares","valid_from":"2009-10-21","valid_to":"2010-02-17","published":"2009-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group shares outstanding: 66,519,078 shares\", as of 2009-10-21 (until 2010-02-17). Claim clm_2F279BA06C2A, https://asof.is/claim/clm_2F279BA06C2A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312509227674/0001193125-09-227674-index.htm.","url":"https://asof.is/claim/clm_2F279BA06C2A","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9A51629F9A48","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312509227674/0001193125-09-227674-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2009","published_at":"2009-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2009, filed 2009-11-06"}},{"id":"clm_00A4E58A33CF","predicate":"quarterly_net_income","value":"202,300,000 United States dollar","valid_from":"2009-09-30","valid_to":"2010-03-31","published":"2009-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 202,300,000 United States dollar\", as of 2009-09-30 (until 2010-03-31). Claim clm_00A4E58A33CF, https://asof.is/claim/clm_00A4E58A33CF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312509227674/0001193125-09-227674-index.htm.","url":"https://asof.is/claim/clm_00A4E58A33CF","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F32D152417B4","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312509227674/0001193125-09-227674-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2009","published_at":"2009-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2009, filed 2009-11-06"}},{"id":"clm_43863C5737AC","predicate":"total_assets","value":"36,519,600,000 United States dollar","valid_from":"2009-09-30","valid_to":"2009-12-31","published":"2009-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 36,519,600,000 United States dollar\", as of 2009-09-30 (until 2009-12-31). Claim clm_43863C5737AC, https://asof.is/claim/clm_43863C5737AC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312509227674/0001193125-09-227674-index.htm.","url":"https://asof.is/claim/clm_43863C5737AC","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_78ED7CF77046","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312509227674/0001193125-09-227674-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2009","published_at":"2009-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2009, filed 2009-11-06"}},{"id":"clm_91660B9860F9","predicate":"cash_and_equivalents","value":"204,100,000 United States dollar","valid_from":"2009-09-30","valid_to":"2009-12-31","published":"2009-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 204,100,000 United States dollar\", as of 2009-09-30 (until 2009-12-31). Claim clm_91660B9860F9, https://asof.is/claim/clm_91660B9860F9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312509227674/0001193125-09-227674-index.htm.","url":"https://asof.is/claim/clm_91660B9860F9","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_15EAF43EFE8A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312509227674/0001193125-09-227674-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2009","published_at":"2009-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2009, filed 2009-11-06"}},{"id":"clm_CF02FC8AA3BB","predicate":"total_equity","value":"19,130,300,000 United States dollar","valid_from":"2009-09-30","valid_to":"2009-12-31","published":"2009-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 19,130,300,000 United States dollar\", as of 2009-09-30 (until 2009-12-31). Claim clm_CF02FC8AA3BB, https://asof.is/claim/clm_CF02FC8AA3BB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312509227674/0001193125-09-227674-index.htm.","url":"https://asof.is/claim/clm_CF02FC8AA3BB","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9CF464C9086D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312509227674/0001193125-09-227674-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2009","published_at":"2009-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2009, filed 2009-11-06"}},{"id":"clm_D02C24B05FAB","predicate":"quarterly_revenue","value":"650,400,000 United States dollar","valid_from":"2009-09-30","valid_to":"2010-03-31","published":"2009-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 650,400,000 United States dollar\", as of 2009-09-30 (until 2010-03-31). Claim clm_D02C24B05FAB, https://asof.is/claim/clm_D02C24B05FAB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312509227674/0001193125-09-227674-index.htm.","url":"https://asof.is/claim/clm_D02C24B05FAB","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E53D1B8A453E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312509227674/0001193125-09-227674-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2009","published_at":"2009-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2009, filed 2009-11-06"}},{"id":"clm_F91C8D3CC353","predicate":"quarterly_operating_income","value":"401,400,000 United States dollar","valid_from":"2009-09-30","valid_to":"2010-03-31","published":"2009-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 401,400,000 United States dollar\", as of 2009-09-30 (until 2010-03-31). Claim clm_F91C8D3CC353, https://asof.is/claim/clm_F91C8D3CC353, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312509227674/0001193125-09-227674-index.htm.","url":"https://asof.is/claim/clm_F91C8D3CC353","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1CB4E39E2058","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312509227674/0001193125-09-227674-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2009","published_at":"2009-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2009, filed 2009-11-06"}},{"id":"clm_32066C14257C","predicate":"total_equity","value":"18,981,300,000 United States dollar","valid_from":"2009-06-30","valid_to":"2009-09-30","published":"2009-09-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 18,981,300,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_32066C14257C, https://asof.is/claim/clm_32066C14257C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312509187481/0001193125-09-187481-index.htm.","url":"https://asof.is/claim/clm_32066C14257C","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_CF02FC8AA3BB","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312509187481/0001193125-09-187481-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q/A Q2 FY2009","published_at":"2009-09-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q/A Q2 FY2009, filed 2009-09-04"}},{"id":"clm_B5C0114280B6","predicate":"total_assets","value":"38,531,200,000 United States dollar","valid_from":"2009-06-30","valid_to":"2009-09-30","published":"2009-09-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 38,531,200,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_B5C0114280B6, https://asof.is/claim/clm_B5C0114280B6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312509187481/0001193125-09-187481-index.htm.","url":"https://asof.is/claim/clm_B5C0114280B6","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_43863C5737AC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312509187481/0001193125-09-187481-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q/A Q2 FY2009","published_at":"2009-09-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q/A Q2 FY2009, filed 2009-09-04"}},{"id":"clm_E2A4B3FD593B","predicate":"quarterly_revenue","value":"647,800,000 United States dollar","valid_from":"2009-06-30","valid_to":"2009-09-30","published":"2009-09-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 647,800,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_E2A4B3FD593B, https://asof.is/claim/clm_E2A4B3FD593B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312509187481/0001193125-09-187481-index.htm.","url":"https://asof.is/claim/clm_E2A4B3FD593B","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D02C24B05FAB","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312509187481/0001193125-09-187481-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q/A Q2 FY2009","published_at":"2009-09-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q/A Q2 FY2009, filed 2009-09-04"}},{"id":"clm_EAC1A98CB98C","predicate":"quarterly_net_income","value":"221,800,000 United States dollar","valid_from":"2009-06-30","valid_to":"2009-09-30","published":"2009-09-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 221,800,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_EAC1A98CB98C, https://asof.is/claim/clm_EAC1A98CB98C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312509187481/0001193125-09-187481-index.htm.","url":"https://asof.is/claim/clm_EAC1A98CB98C","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_00A4E58A33CF","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312509187481/0001193125-09-187481-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q/A Q2 FY2009","published_at":"2009-09-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q/A Q2 FY2009, filed 2009-09-04"}},{"id":"clm_F1F2148AB70A","predicate":"quarterly_operating_income","value":"398,800,000 United States dollar","valid_from":"2009-06-30","valid_to":"2009-09-30","published":"2009-09-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 398,800,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_F1F2148AB70A, https://asof.is/claim/clm_F1F2148AB70A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312509187481/0001193125-09-187481-index.htm.","url":"https://asof.is/claim/clm_F1F2148AB70A","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F91C8D3CC353","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312509187481/0001193125-09-187481-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q/A Q2 FY2009","published_at":"2009-09-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q/A Q2 FY2009, filed 2009-09-04"}},{"id":"clm_F4EA58F0621B","predicate":"cash_and_equivalents","value":"448,700,000 United States dollar","valid_from":"2009-06-30","valid_to":"2009-09-30","published":"2009-09-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 448,700,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_F4EA58F0621B, https://asof.is/claim/clm_F4EA58F0621B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312509187481/0001193125-09-187481-index.htm.","url":"https://asof.is/claim/clm_F4EA58F0621B","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_91660B9860F9","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312509187481/0001193125-09-187481-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q/A Q2 FY2009","published_at":"2009-09-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q/A Q2 FY2009, filed 2009-09-04"}},{"id":"clm_653525D6D239","predicate":"quarterly_operating_income","value":"386,400,000 United States dollar","valid_from":"2009-03-31","valid_to":"2009-06-30","published":"2010-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 386,400,000 United States dollar\", as of 2009-03-31 (until 2009-06-30). Claim clm_653525D6D239, https://asof.is/claim/clm_653525D6D239, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510112933/0001193125-10-112933-index.htm.","url":"https://asof.is/claim/clm_653525D6D239","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F1F2148AB70A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510112933/0001193125-10-112933-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2010","published_at":"2010-05-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2010, filed 2010-05-07"}},{"id":"clm_989FBF293F88","predicate":"quarterly_net_income","value":"199,100,000 United States dollar","valid_from":"2009-03-31","valid_to":"2009-06-30","published":"2010-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 199,100,000 United States dollar\", as of 2009-03-31 (until 2009-06-30). Claim clm_989FBF293F88, https://asof.is/claim/clm_989FBF293F88, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510112933/0001193125-10-112933-index.htm.","url":"https://asof.is/claim/clm_989FBF293F88","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_EAC1A98CB98C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510112933/0001193125-10-112933-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2010","published_at":"2010-05-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2010, filed 2010-05-07"}},{"id":"clm_B502A214A007","predicate":"cash_and_equivalents","value":"339,200,000 United States dollar","valid_from":"2009-03-31","valid_to":"2009-06-30","published":"2010-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 339,200,000 United States dollar\", as of 2009-03-31 (until 2009-06-30). Claim clm_B502A214A007, https://asof.is/claim/clm_B502A214A007, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510112933/0001193125-10-112933-index.htm.","url":"https://asof.is/claim/clm_B502A214A007","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F4EA58F0621B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510112933/0001193125-10-112933-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2010","published_at":"2010-05-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2010, filed 2010-05-07"}},{"id":"clm_CBD1D2B0B7D1","predicate":"quarterly_revenue","value":"647,100,000 United States dollar","valid_from":"2009-03-31","valid_to":"2009-06-30","published":"2010-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 647,100,000 United States dollar\", as of 2009-03-31 (until 2009-06-30). Claim clm_CBD1D2B0B7D1, https://asof.is/claim/clm_CBD1D2B0B7D1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510112933/0001193125-10-112933-index.htm.","url":"https://asof.is/claim/clm_CBD1D2B0B7D1","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E2A4B3FD593B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510112933/0001193125-10-112933-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2010","published_at":"2010-05-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2010, filed 2010-05-07"}},{"id":"clm_D7B70B966BDB","predicate":"total_equity","value":"18,799,100,000 United States dollar","valid_from":"2009-03-31","valid_to":"2009-06-30","published":"2010-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 18,799,100,000 United States dollar\", as of 2009-03-31 (until 2009-06-30). Claim clm_D7B70B966BDB, https://asof.is/claim/clm_D7B70B966BDB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510112933/0001193125-10-112933-index.htm.","url":"https://asof.is/claim/clm_D7B70B966BDB","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_32066C14257C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510112933/0001193125-10-112933-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2010","published_at":"2010-05-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2010, filed 2010-05-07"}},{"id":"clm_1A59D8DAE9A5","predicate":"net_income","value":"715,500,000 United States dollar","valid_from":"2008-12-31","valid_to":"2009-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group net income: 715,500,000 United States dollar\", as of 2008-12-31 (until 2009-12-31). Claim clm_1A59D8DAE9A5, https://asof.is/claim/clm_1A59D8DAE9A5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm.","url":"https://asof.is/claim/clm_1A59D8DAE9A5","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F9F99E0E4C24","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_1A5F193B1B1A","predicate":"total_equity","value":"18,688,600,000 United States dollar","valid_from":"2008-12-31","valid_to":"2009-03-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 18,688,600,000 United States dollar\", as of 2008-12-31 (until 2009-03-31). Claim clm_1A5F193B1B1A, https://asof.is/claim/clm_1A5F193B1B1A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm.","url":"https://asof.is/claim/clm_1A5F193B1B1A","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D7B70B966BDB","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_5003D99D8125","predicate":"cash_and_equivalents","value":"297,900,000 United States dollar","valid_from":"2008-12-31","valid_to":"2009-03-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 297,900,000 United States dollar\", as of 2008-12-31 (until 2009-03-31). Claim clm_5003D99D8125, https://asof.is/claim/clm_5003D99D8125, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm.","url":"https://asof.is/claim/clm_5003D99D8125","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B502A214A007","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_8CA5D20AFD61","predicate":"total_assets","value":"48,158,700,000 United States dollar","valid_from":"2008-12-31","valid_to":"2009-06-30","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total assets: 48,158,700,000 United States dollar\", as of 2008-12-31 (until 2009-06-30). Claim clm_8CA5D20AFD61, https://asof.is/claim/clm_8CA5D20AFD61, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm.","url":"https://asof.is/claim/clm_8CA5D20AFD61","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B5C0114280B6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_B17A544F3227","predicate":"operating_income","value":"1,582,200,000 United States dollar","valid_from":"2008-12-31","valid_to":"2009-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group operating income: 1,582,200,000 United States dollar\", as of 2008-12-31 (until 2009-12-31). Claim clm_B17A544F3227, https://asof.is/claim/clm_B17A544F3227, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm.","url":"https://asof.is/claim/clm_B17A544F3227","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5674F6977FF6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_D846F1997F77","predicate":"revenue","value":"2,561,000,000 United States dollar","valid_from":"2008-12-31","valid_to":"2009-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group revenue: 2,561,000,000 United States dollar\", as of 2008-12-31 (until 2009-12-31). Claim clm_D846F1997F77, https://asof.is/claim/clm_D846F1997F77, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm.","url":"https://asof.is/claim/clm_D846F1997F77","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C6C00740CC5E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_26A5EA68388D","predicate":"total_equity","value":"19,028,800,000 United States dollar","valid_from":"2008-09-30","valid_to":"2008-12-31","published":"2009-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 19,028,800,000 United States dollar\", as of 2008-09-30 (until 2008-12-31). Claim clm_26A5EA68388D, https://asof.is/claim/clm_26A5EA68388D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312509227674/0001193125-09-227674-index.htm.","url":"https://asof.is/claim/clm_26A5EA68388D","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1A5F193B1B1A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312509227674/0001193125-09-227674-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2009","published_at":"2009-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2009, filed 2009-11-06"}},{"id":"clm_4EE9F1CA6A92","predicate":"quarterly_operating_income","value":"420,700,000 United States dollar","valid_from":"2008-09-30","valid_to":"2009-03-31","published":"2009-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 420,700,000 United States dollar\", as of 2008-09-30 (until 2009-03-31). Claim clm_4EE9F1CA6A92, https://asof.is/claim/clm_4EE9F1CA6A92, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312509227674/0001193125-09-227674-index.htm.","url":"https://asof.is/claim/clm_4EE9F1CA6A92","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_653525D6D239","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312509227674/0001193125-09-227674-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2009","published_at":"2009-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2009, filed 2009-11-06"}},{"id":"clm_880127F47751","predicate":"quarterly_revenue","value":"680,900,000 United States dollar","valid_from":"2008-09-30","valid_to":"2009-03-31","published":"2009-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 680,900,000 United States dollar\", as of 2008-09-30 (until 2009-03-31). Claim clm_880127F47751, https://asof.is/claim/clm_880127F47751, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312509227674/0001193125-09-227674-index.htm.","url":"https://asof.is/claim/clm_880127F47751","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_CBD1D2B0B7D1","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312509227674/0001193125-09-227674-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2009","published_at":"2009-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2009, filed 2009-11-06"}},{"id":"clm_9E3BFECDA0DC","predicate":"quarterly_net_income","value":"168,700,000 United States dollar","valid_from":"2008-09-30","valid_to":"2009-03-31","published":"2009-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 168,700,000 United States dollar\", as of 2008-09-30 (until 2009-03-31). Claim clm_9E3BFECDA0DC, https://asof.is/claim/clm_9E3BFECDA0DC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312509227674/0001193125-09-227674-index.htm.","url":"https://asof.is/claim/clm_9E3BFECDA0DC","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_989FBF293F88","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312509227674/0001193125-09-227674-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2009","published_at":"2009-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2009, filed 2009-11-06"}},{"id":"clm_F2CF5262CE31","predicate":"cash_and_equivalents","value":"582,400,000 United States dollar","valid_from":"2008-09-30","valid_to":"2008-12-31","published":"2009-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 582,400,000 United States dollar\", as of 2008-09-30 (until 2008-12-31). Claim clm_F2CF5262CE31, https://asof.is/claim/clm_F2CF5262CE31, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312509227674/0001193125-09-227674-index.htm.","url":"https://asof.is/claim/clm_F2CF5262CE31","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5003D99D8125","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312509227674/0001193125-09-227674-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2009","published_at":"2009-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2009, filed 2009-11-06"}},{"id":"clm_24059C529F17","predicate":"quarterly_net_income","value":"201,200,000 United States dollar","valid_from":"2008-06-30","valid_to":"2008-09-30","published":"2009-09-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly net income: 201,200,000 United States dollar\", as of 2008-06-30 (until 2008-09-30). Claim clm_24059C529F17, https://asof.is/claim/clm_24059C529F17, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312509187481/0001193125-09-187481-index.htm.","url":"https://asof.is/claim/clm_24059C529F17","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9E3BFECDA0DC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312509187481/0001193125-09-187481-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q/A Q2 FY2009","published_at":"2009-09-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q/A Q2 FY2009, filed 2009-09-04"}},{"id":"clm_8D6B50915519","predicate":"cash_and_equivalents","value":"1,067,600,000 United States dollar","valid_from":"2008-06-30","valid_to":"2008-09-30","published":"2009-09-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 1,067,600,000 United States dollar\", as of 2008-06-30 (until 2008-09-30). Claim clm_8D6B50915519, https://asof.is/claim/clm_8D6B50915519, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312509187481/0001193125-09-187481-index.htm.","url":"https://asof.is/claim/clm_8D6B50915519","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F2CF5262CE31","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312509187481/0001193125-09-187481-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q/A Q2 FY2009","published_at":"2009-09-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q/A Q2 FY2009, filed 2009-09-04"}},{"id":"clm_AA8A7742C2D0","predicate":"quarterly_revenue","value":"563,200,000 United States dollar","valid_from":"2008-06-30","valid_to":"2008-09-30","published":"2009-09-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly revenue: 563,200,000 United States dollar\", as of 2008-06-30 (until 2008-09-30). Claim clm_AA8A7742C2D0, https://asof.is/claim/clm_AA8A7742C2D0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312509187481/0001193125-09-187481-index.htm.","url":"https://asof.is/claim/clm_AA8A7742C2D0","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_880127F47751","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312509187481/0001193125-09-187481-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q/A Q2 FY2009","published_at":"2009-09-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q/A Q2 FY2009, filed 2009-09-04"}},{"id":"clm_E04D6428E971","predicate":"quarterly_operating_income","value":"343,700,000 United States dollar","valid_from":"2008-06-30","valid_to":"2008-09-30","published":"2009-09-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group quarterly operating income: 343,700,000 United States dollar\", as of 2008-06-30 (until 2008-09-30). Claim clm_E04D6428E971, https://asof.is/claim/clm_E04D6428E971, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312509187481/0001193125-09-187481-index.htm.","url":"https://asof.is/claim/clm_E04D6428E971","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4EE9F1CA6A92","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312509187481/0001193125-09-187481-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q/A Q2 FY2009","published_at":"2009-09-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q/A Q2 FY2009, filed 2009-09-04"}},{"id":"clm_E8D023AE4E9A","predicate":"total_equity","value":"13,328,400,000 United States dollar","valid_from":"2008-06-30","valid_to":"2008-09-30","published":"2009-09-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 13,328,400,000 United States dollar\", as of 2008-06-30 (until 2008-09-30). Claim clm_E8D023AE4E9A, https://asof.is/claim/clm_E8D023AE4E9A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312509187481/0001193125-09-187481-index.htm.","url":"https://asof.is/claim/clm_E8D023AE4E9A","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_26A5EA68388D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312509187481/0001193125-09-187481-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q/A Q2 FY2009","published_at":"2009-09-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q/A Q2 FY2009, filed 2009-09-04"}},{"id":"clm_4E0570F0A8E9","predicate":"cash_and_equivalents","value":"845,300,000 United States dollar","valid_from":"2007-12-31","valid_to":"2008-06-30","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 845,300,000 United States dollar\", as of 2007-12-31 (until 2008-06-30). Claim clm_4E0570F0A8E9, https://asof.is/claim/clm_4E0570F0A8E9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm.","url":"https://asof.is/claim/clm_4E0570F0A8E9","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8D6B50915519","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_93084EA6D2D8","predicate":"net_income","value":"658,500,000 United States dollar","valid_from":"2007-12-31","valid_to":"2008-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group net income: 658,500,000 United States dollar\", as of 2007-12-31 (until 2008-12-31). Claim clm_93084EA6D2D8, https://asof.is/claim/clm_93084EA6D2D8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm.","url":"https://asof.is/claim/clm_93084EA6D2D8","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1A59D8DAE9A5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_AB8B7DB40382","predicate":"operating_income","value":"1,051,900,000 United States dollar","valid_from":"2007-12-31","valid_to":"2008-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group operating income: 1,051,900,000 United States dollar\", as of 2007-12-31 (until 2008-12-31). Claim clm_AB8B7DB40382, https://asof.is/claim/clm_AB8B7DB40382, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm.","url":"https://asof.is/claim/clm_AB8B7DB40382","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B17A544F3227","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_BD65C3E89D97","predicate":"revenue","value":"1,756,100,000 United States dollar","valid_from":"2007-12-31","valid_to":"2008-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group revenue: 1,756,100,000 United States dollar\", as of 2007-12-31 (until 2008-12-31). Claim clm_BD65C3E89D97, https://asof.is/claim/clm_BD65C3E89D97, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm.","url":"https://asof.is/claim/clm_BD65C3E89D97","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D846F1997F77","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_E21B670B1BCB","predicate":"total_equity","value":"12,305,600,000 United States dollar","valid_from":"2007-12-31","valid_to":"2008-06-30","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 12,305,600,000 United States dollar\", as of 2007-12-31 (until 2008-06-30). Claim clm_E21B670B1BCB, https://asof.is/claim/clm_E21B670B1BCB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm.","url":"https://asof.is/claim/clm_E21B670B1BCB","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E8D023AE4E9A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_64DA516B41AD","predicate":"registrant_name","value":"CME GROUP INC.","valid_from":"2007-07-13","valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group registrant name: CME GROUP INC.\", as of 2007-07-13. Claim clm_64DA516B41AD, https://asof.is/claim/clm_64DA516B41AD, accessed 2026-11-10. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001156375.","url":"https://asof.is/claim/clm_64DA516B41AD","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001156375","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_FA2539BBE7A0","predicate":"country","value":"United States","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group country: United States\", undated. Claim clm_FA2539BBE7A0, https://asof.is/claim/clm_FA2539BBE7A0, accessed 2026-11-10. Source: https://www.lobbyfacts.eu/datacard/cme-group?rid=259363314440-59.","url":"https://asof.is/claim/clm_FA2539BBE7A0","accessed":"2026-11-10"},"confidence":0.45,"status":"unverified","assertable":false,"why_not":"low_confidence","superseded_by":null,"sources":[{"url":"https://www.lobbyfacts.eu/datacard/cme-group?rid=259363314440-59","tier":"secondary","publisher":null,"published_at":null},{"url":"https://www.wikidata.org/wiki/Q1023876","tier":"secondary","publisher":"Wikidata","published_at":null}],"evidence":{"by":"page-read","on":"2026-11-10","quote":"Address Head Office South Wacker Drive, 20 Chicago Illinois 60606 UNITED STATES","url":"https://www.lobbyfacts.eu/datacard/cme-group?rid=259363314440-59"}},{"id":"clm_B15B35F3BD75","predicate":"total_equity","value":"1,519,100,000 United States dollar","valid_from":"2006-12-31","valid_to":"2007-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group total equity: 1,519,100,000 United States dollar\", as of 2006-12-31 (until 2007-12-31). Claim clm_B15B35F3BD75, https://asof.is/claim/clm_B15B35F3BD75, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm.","url":"https://asof.is/claim/clm_B15B35F3BD75","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E21B670B1BCB","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_EE0BD495A5BA","predicate":"cash_and_equivalents","value":"969,500,000 United States dollar","valid_from":"2006-12-31","valid_to":"2007-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cash and equivalents: 969,500,000 United States dollar\", as of 2006-12-31 (until 2007-12-31). Claim clm_EE0BD495A5BA, https://asof.is/claim/clm_EE0BD495A5BA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm.","url":"https://asof.is/claim/clm_EE0BD495A5BA","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4E0570F0A8E9","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312510043180/0001193125-10-043180-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_D25940C39C25","predicate":"registrant_name","value":"CHICAGO MERCANTILE EXCHANGE HOLDINGS INC","valid_from":"2001-08-07","valid_to":"2007-07-13","published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group registrant name: CHICAGO MERCANTILE EXCHANGE HOLDINGS INC\", as of 2001-08-07 (until 2007-07-13). Claim clm_D25940C39C25, https://asof.is/claim/clm_D25940C39C25, accessed 2026-11-10. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001156375.","url":"https://asof.is/claim/clm_D25940C39C25","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_64DA516B41AD","sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001156375","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_2566C71C835D","predicate":"headquarters","value":"Chicago","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group headquarters: Chicago\", undated. Claim clm_2566C71C835D, https://asof.is/claim/clm_2566C71C835D, accessed 2026-11-10. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001156375.","url":"https://asof.is/claim/clm_2566C71C835D","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001156375","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_3AAC4AC2EDBD","predicate":"sic_industry","value":"Security & Commodity Brokers, Dealers, Exchanges & Services (6200)","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group sic industry: Security & Commodity Brokers, Dealers, Exchanges & Services (6200)\", undated. Claim clm_3AAC4AC2EDBD, https://asof.is/claim/clm_3AAC4AC2EDBD, accessed 2026-11-10. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001156375.","url":"https://asof.is/claim/clm_3AAC4AC2EDBD","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001156375","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_3AEE7F550BFF","predicate":"state_of_incorporation","value":"DE","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group state of incorporation: DE\", undated. Claim clm_3AEE7F550BFF, https://asof.is/claim/clm_3AEE7F550BFF, accessed 2026-11-10. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001156375.","url":"https://asof.is/claim/clm_3AEE7F550BFF","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001156375","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_4C4F4CF08933","predicate":"cik","value":"0001156375","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group cik: 0001156375\", undated. Claim clm_4C4F4CF08933, https://asof.is/claim/clm_4C4F4CF08933, accessed 2026-11-10. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001156375.","url":"https://asof.is/claim/clm_4C4F4CF08933","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001156375","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_9C86F66CA9B0","predicate":"listed_on","value":"Nasdaq","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group listed on: Nasdaq\", undated. Claim clm_9C86F66CA9B0, https://asof.is/claim/clm_9C86F66CA9B0, accessed 2026-11-10. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001156375.","url":"https://asof.is/claim/clm_9C86F66CA9B0","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001156375","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_A00A1CE9A109","predicate":"ticker","value":"CME","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group ticker: CME\", undated. Claim clm_A00A1CE9A109, https://asof.is/claim/clm_A00A1CE9A109, accessed 2026-11-10. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001156375.","url":"https://asof.is/claim/clm_A00A1CE9A109","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001156375","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_C9276B05E252","predicate":"ceo","value":"Terrence A. Duffy","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group ceo: Terrence A. Duffy\", undated. Claim clm_C9276B05E252, https://asof.is/claim/clm_C9276B05E252, accessed 2026-11-10. Source: https://www.fia.org/hall-fame/articles/terry-duffy.","url":"https://asof.is/claim/clm_C9276B05E252","accessed":"2026-11-10"},"confidence":0.6,"status":"unverified","assertable":false,"why_not":"unverified","superseded_by":null,"sources":[{"url":"https://www.fia.org/hall-fame/articles/terry-duffy","tier":"secondary","publisher":"fia.org","published_at":null}],"evidence":{"by":"page-read","on":"2026-11-09","quote":"Terrence A. Duffy serves as chairman and chief executive officer of CME Group, the world’s leading derivatives marketplace.","url":"https://www.fia.org/hall-fame/articles/terry-duffy"}},{"id":"clm_E9517A30659E","predicate":"fiscal_year_end","value":"12-31","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CME Group fiscal year end: 12-31\", undated. Claim clm_E9517A30659E, https://asof.is/claim/clm_E9517A30659E, accessed 2026-11-10. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001156375.","url":"https://asof.is/claim/clm_E9517A30659E","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001156375","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}}],"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{"low_confidence":"Confidence below 0.5, the line the record asserts at.","unverified":"Unverified: one source that is not primary, or a primary source below confidence 0.7. Asserted once a primary source or a second independent domain confirms it."},"checked_by":{"sec-filing":"parsed from the SEC filing","page-read":"its source page states the value and the date"}}}